Fiche traitement
Therapies
University Health Network, Toronto • Cancer
Suivi actif
Non applicable
Résumé
Therapies est développé par University Health Network, Toronto. Le traitement est actuellement en Non applicable. Il est associé à Cancer. Son objectif thérapeutique principal est Ralentissement de la progression. Le statut actuel est : suivi actif.
À vérifier
Ralentissement de la progression
Non applicable
University Health Network, Toronto
Australia, Canada
Whole gland therapy (radical prostatectomy and radiotherapy) has been the conventional treatment for localized prostate cancer, but randomized controlled trials have not demonstrated survival benefits compared with watchful waiting or active surveillance. Whole gland therapy is also associated with significant long-term sequelae including urinary incontinence, erectile dysfunction, irradiation cystitis, and proctitis. Focal therapy has emerged as an alternative treatment modality, yet more data are needed to ensure its safety and efficacy. This is a prospective database/registry study designed to record all pre-operative, intra-operative, and post-operative parameters for patients undergoing focal therapies for prostate cancer, including but not limited to cryotherapy, high-intensity focused ultrasound (HIFU), focal laser therapy (FLA), irreversible electroporation (IRE), targeted microwave ablation (TMA). All patients who have undergone focal therapy at the Department of Surgery, Queen Mary Hospital for prostate cancer will be invited to participate, except those incapable of providing written informed consent. The primary outcome is the surgical outcomes (complications and effectiveness) of focal therapies. Secondary outcomes include identification of risk factors for treatment-related complications, provision of a readily available dataset for subsequent research, and identification of the best treatment allocation for prostate cancer patients. An estimated 200 patients will be included, with data collection from study start until 31 March 2030.
2026-06-04
Début phase actuelle
Non disponible dans les sources synchronisées
Timeline clinique
Non applicable
Début phase actuelle
Non disponible dans les sources synchronisées
Préclinique
Phase 1
Phase 2
Phase 3
Approuvé
Objectif scientifique de l’étude
classification automatique vérifiable
Ralentissement de la progression
Confiance automatique : 66%
Ce pourcentage n’est pas une probabilité de succès clinique.
Il mesure uniquement la force de la classification automatique de l’objectif scientifique. Le calcul part de 45 points, ajoute 7 points par unité de poids du mot-clé le plus fortement détecté, puis est plafonné à 95 %. Exemple : un score maximal de 2 donne 45 + (2 × 7) = 59 %.
Indices détectés : progression → Ralentissement de la progression
Ce score est heuristique et doit être vérifié dans le protocole ou une publication.
Description affichée depuis l’essai compatible NCT07792590, afin d’éviter le mélange entre plusieurs indications d’une même molécule.
Aucune incohérence majeure détectée entre la maladie, l’objectif et la description.
Transparence et qualité de la fiche
données vérifiablesClassificationCohérente automatiquement
Confiance de la fiche100 %
Source principaleSource officielle ou publication indexée
Dernière vérification2026-06-04
Anomalies détectées0
Validation humaineValidation humaine non effectuée
Donnée issue d’une source
Donnée normalisée automatiquement
Interprétation algorithmique
Classification scientifique multi-axes
ne pas confondre statut et résultatÉtat de l’étudeRecrutement en cours
Disponibilité des résultatsRésultats à vérifier
InterprétationImpossible à déterminer
Niveau de preuveNon évaluable
Un essai terminé n’est pas nécessairement positif. Un essai arrêté n’est classé comme échec scientifique que lorsqu’un résultat ou une raison explicite le confirme.
Indicateurs factuels
sans score subjectifPhase enregistréeNon applicable
Études associées116
Publications associées480
Statut consolidéSuivi actif
Aucune chance de succès, note d’innovation, potentiel thérapeutique ou probabilité de commercialisation n’est calculé tant qu’un modèle validé et des données suffisantes ne sont pas disponibles.
Historique factuel de la molécule
845 événement(s) daté(s)Cette liste reprend uniquement les dates trouvées dans les registres et publications liés. Elle ne constitue pas une prévision.
| Date | Événement | Source |
|---|---|---|
| 1992-07-23 | Début de l’étudeNCT00001248 | Registre d’essai clinique |
| 2003-09-08 | Début de l’étudeNCT00068003 | Registre d’essai clinique |
| 2004-06-10 | Début de l’étudeNCT00923065 | Registre d’essai clinique |
| 2006-02-01 | Début de l’étudeNCT00286078 | Registre d’essai clinique |
| 2006-05-01 | Début de l’étudeNCT00747812 | Registre d’essai clinique |
| 2006-10-01 | Début de l’étudeNCT00781872 | Registre d’essai clinique |
| 2009-11-01 | Début de l’étudeNCT01174498 | Registre d’essai clinique |
| 2009-12-01 | Fin de l’étude prévue / enregistréeNCT00781872 | Registre d’essai clinique |
| 2010-09-01 | Fin de l’étude prévue / enregistréeNCT01174498 | Registre d’essai clinique |
| 2011-12-01 | Début de l’étudeNCT01465087 | Registre d’essai clinique |
| 2012-04-11 | Début de l’étudeNCT02780492 | Registre d’essai clinique |
| 2012-05-01 | Fin de l’étude prévue / enregistréeNCT00747812 | Registre d’essai clinique |
| 2012-06-01 | Début de l’étudeNCT02433028 | Registre d’essai clinique |
| 2012-06-13 | Début de l’étudeNCT01738386 | Registre d’essai clinique |
| 2013-04-01 | Début de l’étudeNCT01845883 | Registre d’essai clinique |
| 2014-05-01 | Début de l’étudeNCT02090998 | Registre d’essai clinique |
| 2015-01-01 | Fin de l’étude prévue / enregistréeNCT01465087 | Registre d’essai clinique |
| 2016-02-24 | Fin de l’étude prévue / enregistréeNCT01738386 | Registre d’essai clinique |
| 2016-09-01 | Début de l’étudeNCT04017481 | Registre d’essai clinique |
| 2016-12-01 | Début de l’étudeNCT03010826 | Registre d’essai clinique |
| 2016-12-01 | Fin de l’étude prévue / enregistréeNCT01845883 | Registre d’essai clinique |
| 2017-07-01 | Début de l’étudeNCT03220113 | Registre d’essai clinique |
| 2017-08-02 | Début de l’étudeNCT03199469 | Registre d’essai clinique |
| 2017-08-11 | Début de l’étudeNCT03109288 | Registre d’essai clinique |
| 2017-12-01 | Début de l’étudeNCT03088839 | Registre d’essai clinique |
| 2018-01-01 | Début de l’étudeNCT07164924 | Registre d’essai clinique |
| 2018-05-02 | Début de l’étudeNCT03500328 | Registre d’essai clinique |
| 2018-06-14 | Début de l’étudeNCT03600779 | Registre d’essai clinique |
| 2018-09-11 | Début de l’étudeNCT03865420 | Registre d’essai clinique |
| 2018-11-07 | Fin de l’étude prévue / enregistréeNCT00286078 | Registre d’essai clinique |
| 2018-11-16 | Fin de l’étude prévue / enregistréeNCT03010826 | Registre d’essai clinique |
| 2018-12-01 | Début de l’étudeNCT02968966 | Registre d’essai clinique |
| 2019-01-03 | Début de l’étudeNCT03535298 | Registre d’essai clinique |
| 2019-04-01 | Début de l’étudeNCT03853746 | Registre d’essai clinique |
| 2019-06-17 | Début de l’étudeNCT03888924 | Registre d’essai clinique |
| 2019-07-01 | Fin de l’étude prévue / enregistréeNCT03220113 | Registre d’essai clinique |
| 2019-07-16 | Début de l’étudeNCT03816345 | Registre d’essai clinique |
| 2019-07-24 | Début de l’étudeNCT03621319 | Registre d’essai clinique |
| 2019-09-13 | Début de l’étudeNCT04115267 | Registre d’essai clinique |
| 2019-09-30 | Fin de l’étude prévue / enregistréeNCT04017481 | Registre d’essai clinique |
| 2019-10-22 | Début de l’étudeNCT07720895 | Registre d’essai clinique |
| 2019-10-29 | Début de l’étudeNCT03910738 | Registre d’essai clinique |
| 2020-01-14 | Début de l’étudeNCT06155123 | Registre d’essai clinique |
| 2020-02-01 | Début de l’étudeNCT04294979 | Registre d’essai clinique |
| 2020-03-16 | Fin de l’étude prévue / enregistréeNCT02090998 | Registre d’essai clinique |
| 2020-06-11 | Début de l’étudeNCT04495556 | Registre d’essai clinique |
| 2020-06-22 | Début de l’étudeNCT04833673 | Registre d’essai clinique |
| 2020-08-01 | Fin de l’étude prévue / enregistréeNCT02968966 | Registre d’essai clinique |
| 2020-09-22 | Début de l’étudeNCT04561557 | Registre d’essai clinique |
| 2021-03-01 | Début de l’étudeNCT05403788 | Registre d’essai clinique |
| 2021-03-15 | Fin de l’étude prévue / enregistréeNCT04833673 | Registre d’essai clinique |
| 2021-04-01 | Début de l’étudeNCT04863586 | Registre d’essai clinique |
| 2021-05-05 | Fin de l’étude prévue / enregistréeNCT03621319 | Registre d’essai clinique |
| 2021-07-28 | Début de l’étudeNCT05065060 | Registre d’essai clinique |
| 2021-08-01 | Début de l’étudeNCT05363228 | Registre d’essai clinique |
| 2021-09-15 | Début de l’étudeNCT05046119 | Registre d’essai clinique |
| 2021-10-19 | Début de l’étudeNCT05083481 | Registre d’essai clinique |
| 2021-10-27 | Début de l’étudeNCT06586177 | Registre d’essai clinique |
| 2021-11-08 | Début de l’étudeNCT04938427 | Registre d’essai clinique |
| 2022-01-11 | Début de l’étudeNCT05081609 | Registre d’essai clinique |
| 2022-03-10 | Début de l’étudeNCT05201248 | Registre d’essai clinique |
| 2022-03-18 | Début de l’étudeNCT05833633 | Registre d’essai clinique |
| 2022-03-31 | Fin de l’étude prévue / enregistréeNCT05403788 | Registre d’essai clinique |
| 2022-04-01 | Début de l’étudeNCT05374824 | Registre d’essai clinique |
| 2022-04-28 | Fin de l’étude prévue / enregistréeNCT02780492 | Registre d’essai clinique |
| 2022-05-31 | Fin de l’étude prévue / enregistréeNCT04863586 | Registre d’essai clinique |
| 2022-07-01 | Début de l’étudeNCT07753928 | Registre d’essai clinique |
| 2022-08-06 | Début de l’étudeNCT05406349 | Registre d’essai clinique |
| 2022-08-30 | Début de l’étudeNCT05338450 | Registre d’essai clinique |
| 2022-10-11 | Début de l’étudeNCT06526000 | Registre d’essai clinique |
| 2023-01-09 | Début de l’étudeNCT05597033 | Registre d’essai clinique |
| 2023-01-30 | Fin de l’étude prévue / enregistréeNCT05363228 | Registre d’essai clinique |
| 2023-03-07 | Début de l’étudeNCT07757568 | Registre d’essai clinique |
| 2023-04-17 | Début de l’étudeNCT05885139 | Registre d’essai clinique |
| 2023-08-01 | Début de l’étudeNCT05359653 | Registre d’essai clinique |
| 2023-10-01 | Début de l’étudeNCT07207343 | Registre d’essai clinique |
| 2023-10-03 | Début de l’étudeNCT06079567 | Registre d’essai clinique |
| 2023-10-22 | Fin de l’étude prévue / enregistréeNCT07720895 | Registre d’essai clinique |
| 2023-10-27 | Début de l’étudeNCT05658497 | Registre d’essai clinique |
| 2023-11-02 | Début de l’étudeNCT04244630 | Registre d’essai clinique |
| 2023-11-23 | Début de l’étudeNCT05417711 | Registre d’essai clinique |
| 2023-12-15 | Début de l’étudeNCT04604977 | Registre d’essai clinique |
| 2023-12-15 | Fin de l’étude prévue / enregistréeNCT04604977 | Registre d’essai clinique |
| 2024-01-01 | Début de l’étudeNCT05610852 | Registre d’essai clinique |
| 2024-01-25 | Fin de l’étude prévue / enregistréeNCT04938427 | Registre d’essai clinique |
| 2024-02-28 | Fin de l’étude prévue / enregistréeNCT06526000 | Registre d’essai clinique |
| 2024-03-06 | Début de l’étudeNCT06891118 | Registre d’essai clinique |
| 2024-03-28 | Début de l’étudeNCT06861270 | Registre d’essai clinique |
| 2024-04-01 | Fin de l’étude prévue / enregistréeNCT04294979 | Registre d’essai clinique |
| 2024-06-01 | Fin de l’étude prévue / enregistréeNCT06155123 | Registre d’essai clinique |
| 2024-06-05 | Début de l’étudeNCT06290713 | Registre d’essai clinique |
| 2024-06-20 | Début de l’étudeNCT06451159 | Registre d’essai clinique |
| 2024-07-01 | Fin de l’étude prévue / enregistréeNCT03853746 | Registre d’essai clinique |
| 2024-08-07 | Début de l’étudeNCT06445972 | Registre d’essai clinique |
| 2024-09-15 | Fin de l’étude prévue / enregistréeNCT05046119 | Registre d’essai clinique |
| 2024-09-30 | Début de l’étudeNCT07213440 | Registre d’essai clinique |
| 2024-11-25 | Début de l’étudeNCT06959979 | Registre d’essai clinique |
| 2024-12-01 | Fin de l’étude prévue / enregistréeNCT03088839 | Registre d’essai clinique |
| 2024-12-08 | Fin de l’étude prévue / enregistréeNCT07164924 | Registre d’essai clinique |
| 2024-12-18 | Début de l’étudeNCT06701526 | Registre d’essai clinique |
| 2025-01-01 | Début de l’étudeNCT06764914 | Registre d’essai clinique |
| 2025-02-06 | Début de l’étudeNCT06800313 | Registre d’essai clinique |
| 2025-02-18 | Début de l’étudeNCT06727565 | Registre d’essai clinique |
| 2025-02-20 | Début de l’étudeNCT06865274 | Registre d’essai clinique |
| 2025-03-01 | Début de l’étudeNCT06692088 | Registre d’essai clinique |
| 2025-03-10 | Début de l’étudeNCT07743281 | Registre d’essai clinique |
| 2025-04-01 | Début de l’étudeNCT06724562 | Registre d’essai clinique |
| 2025-05-01 | Début de l’étudeNCT04276857 | Registre d’essai clinique |
| 2025-06-24 | Fin de l’étude prévue / enregistréeNCT05597033 | Registre d’essai clinique |
| 2025-06-30 | Fin de l’étude prévue / enregistréeNCT05833633 | Registre d’essai clinique |
| 2025-07-30 | Fin de l’étude prévue / enregistréeNCT07743281 | Registre d’essai clinique |
| 2025-07-31 | Fin de l’étude prévue / enregistréeNCT06861270 | Registre d’essai clinique |
| 2025-08-15 | Fin de l’étude prévue / enregistréeNCT05338450 | Registre d’essai clinique |
| 2025-09-09 | Début de l’étudeNCT07054190 | Registre d’essai clinique |
| 2025-09-19 | Début de l’étudeNCT07072988 | Registre d’essai clinique |
| 2025-10-01 | Début de l’étudeNCT07283913 | Registre d’essai clinique |
| 2025-10-31 | Début de l’étudeNCT07792590 | Registre d’essai clinique |
| 2025-11-26 | Début de l’étudeNCT07038252 | Registre d’essai clinique |
| 2025-12-03 | Début de l’étudeNCT07051525 | Registre d’essai clinique |
| 2025-12-15 | Début de l’étudeNCT07272070 | Registre d’essai clinique |
| 2025-12-15 | Début de l’étudeNCT07052929 | Registre d’essai clinique |
| 2025-12-30 | Fin de l’étude prévue / enregistréeNCT06891118 | Registre d’essai clinique |
| 2025-12-31 | Fin de l’étude prévue / enregistréeNCT05885139 | Registre d’essai clinique |
| 2026-01-01 | Début de l’étudeNCT07292090 | Registre d’essai clinique |
| 2026-01-01 | Début de l’étudeNCT07337395 | Registre d’essai clinique |
| 2026-01-25 | Début de l’étudeNCT07206355 | Registre d’essai clinique |
| 2026-01-26 | Début de l’étudeNCT07233148 | Registre d’essai clinique |
| 2026-02-20 | Début de l’étudeNCT07487701 | Registre d’essai clinique |
| 2026-03-01 | Début de l’étudeNCT07313800 | Registre d’essai clinique |
| 2026-03-20 | Début de l’étudeNCT07499323 | Registre d’essai clinique |
| 2026-04-15 | Fin de l’étude prévue / enregistréeNCT07487701 | Registre d’essai clinique |
| 2026-04-23 | Début de l’étudeNCT07419295 | Registre d’essai clinique |
| 2026-05-01 | Début de l’étudeNCT06864936 | Registre d’essai clinique |
| 2026-05-01 | Fin de l’étude prévue / enregistréeNCT07283913 | Registre d’essai clinique |
| 2026-05-01 | Début de l’étudeNCT07348783 | Registre d’essai clinique |
| 2026-05-11 | Début de l’étudeNCT07628751 | Registre d’essai clinique |
| 2026-05-11 | Fin de l’étude prévue / enregistréeNCT05083481 | Registre d’essai clinique |
| 2026-06-01 | Début de l’étudeNCT07521384 | Registre d’essai clinique |
| 2026-06-04 | Dernière mise à jour des donnéesTherapies | Biomedical Watch |
| 2026-06-12 | Début de l’étudeNCT07710105 | Registre d’essai clinique |
| 2026-07-01 | Début de l’étudeNCT07617441 | Registre d’essai clinique |
| 2026-07-06 | Début de l’étudeNCT06957418 | Registre d’essai clinique |
| 2026-07-08 | Création de l’enregistrementNCT06290713 | Registre d’essai clinique |
| 2026-07-08 | Création de l’enregistrementNCT02968966 | Registre d’essai clinique |
| 2026-07-08 | Création de l’enregistrementNCT03888924 | Registre d’essai clinique |
| 2026-07-08 | PublicationLong-term eculizumab treatment failure in C3 glomerulonephritis: two case reports. | Clinical kidney journal |
| 2026-07-08 | PublicationCD19-CAR-DNT cells (RJMty19) in patients with relapsed or refractory large B-cell lymphoma: a phase 1, first-in-human study. | EClinicalMedicine |
| 2026-07-08 | PublicationEnigmatic Case of Adult-Onset Langerhans Cell Histiocytosis with Aggressive Bony Involvement. | Journal of Brown hospital medicine |
| 2026-07-08 | PublicationSynthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 Activity. | ChemMedChem |
| 2026-07-08 | PublicationTime to Meaningful Clinical Response Across Approved and Emerging Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Network Meta-Analysis. | Journal of clinical medicine |
| 2026-07-08 | PublicationEmerging Role of BTK Inhibitors in Multiple Sclerosis: From Immunobiology to Clinical Translation. | Brain sciences |
| 2026-07-08 | Publication[Pharmacological properties and clinical efficacy of sphingosine 1-phosphate (S1P) receptor modulator, Ozanimod (ZEPOSIA)]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica |
| 2026-07-08 | PublicationInitial specialist validation of clinical decision support recommendations from a machine learning-enabled digital cognitive assessment. | Frontiers in neurology |
| 2026-07-08 | PublicationSingle low-dose daratumumab enhances rituximab efficacy for sustained remission in treatment-refractory autoimmune cytopenias. | Annals of hematology |
| 2026-07-08 | PublicationH3K27M-mutant diffuse midline glioma pharmacotherapy: Clinical evidence and practice implications of dordaviprone. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners |
| 2026-07-08 | PublicationCancerHERVdb: Human Endogenous Retrovirus (HERV) Expression Database for Human Cancer Accelerates Studies of the Retrovirome and Predictions for HERV-Based Therapies. | Journal of virology |
| 2026-07-08 | PublicationNose-to-brain delivery of riluzole-loaded nanoemulsion in a controlled cortical impact-induced traumatic brain injury: Insights fromIn vitro,Ex vivo, andIn vivostudies. | Colloids and surfaces. B, Biointerfaces |
| 2026-07-08 | PublicationRecent advances in universal chimeric antigen receptor T cell therapy. | Journal of hematology & oncology |
| 2026-07-08 | PublicationUniversal CAR-T Cell Therapy for Cancer Treatment: Advances and Challenges. | Oncology research |
| 2026-07-08 | PublicationSafety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial. | The Lancet. Neurology |
| 2026-07-08 | PublicationA Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple Sclerosis. | Neurology and therapy |
| 2026-07-08 | PublicationImpact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion. | Multiple sclerosis (Houndmills, Basingstoke, England) |
| 2026-07-10 | Création de l’enregistrementNCT03088839 | Registre d’essai clinique |
| 2026-07-10 | Création de l’enregistrementNCT02780492 | Registre d’essai clinique |
| 2026-07-10 | Création de l’enregistrementNCT04833673 | Registre d’essai clinique |
| 2026-07-10 | PublicationBeyond motor symptoms: efficacy of pharmacotherapies on motor, functional, and cognitive domains in Huntington's disease - a systematic review. | European journal of pharmacology |
| 2026-07-10 | PublicationAutologous bone marrow mononuclear cell administration for neurological sequelae after traumatic brain injury: a matched control study. | Brain communications |
| 2026-07-10 | Publication2025 Update of Cellular Immunotherapy for Plasma Cell Disorders. | Turkish journal of haematology : official journal of Turkish Society of Haematology |
| 2026-07-10 | Publication[Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits (PGNMID) Associated with Marginal Zone B-cell Lymphoma: A Case of MGRS in a Patient with Nephrotic Syndrome and Rapidly Progressive Renal Failure]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia |
| 2026-07-10 | Publication[Atypical hemolytic uremic syndrome: key points in differential diagnosis and recent advances in treatment]. | [Rinsho ketsueki] The Japanese journal of clinical hematology |
| 2026-07-10 | PublicationComplement System Inhibitors in Nephrology: A Comprehensive Review. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia |
| 2026-07-10 | PublicationThe efficacy and safety of hyoscyamine, dicyclomine, and desipramine in the treatment of irritable pouch syndrome-a retrospective cohort study. | Crohn's & colitis 360 |
| 2026-07-10 | PublicationFDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook. | RNA biology |
| 2026-07-10 | PublicationThe Efficacy of Laser and Botox Therapies for Post-Thyroidectomy Scar Management: A Comprehensive Systematic Review and Meta-Analysis. | Aesthetic plastic surgery |
| 2026-07-10 | PublicationEngineered iMSCs delivering wild-type IL-2 achieve dose-sparing tumor control via CD25-dependent CD8 T-cell activation. | BMC medicine |
| 2026-07-10 | PublicationHelping Underdeveloped Lungs with Cells (HULC-2): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - a study protocol of a phase 2 multicentre double blind randomised controlled trial in Canada. | BMJ open |
| 2026-07-10 | PublicationAllogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial. | Nature medicine |
| 2026-07-10 | PublicationPathway-level proteomics identifies subcellular trafficking dysregulation as a molecular signature in severe traumatic brain injury. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] |
| 2026-07-10 | PublicationMonoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions. | International journal of molecular sciences |
| 2026-07-10 | PublicationThe impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry. | Journal of neurology |
| 2026-07-12 | Création de l’enregistrementNCT07337395 | Registre d’essai clinique |
| 2026-07-12 | Création de l’enregistrementNCT04017481 | Registre d’essai clinique |
| 2026-07-12 | PublicationDevelopments in Pharmacotherapy for Acromegaly: Current and Emerging Approaches. | Drugs |
| 2026-07-12 | PublicationEnsemble Machine Learning- and Deep Learning-Driven Identification and Validation of Sennidin B as a Novel Dipeptidyl Peptidase-4 Inhibitor. | International journal of molecular sciences |
| 2026-07-12 | PublicationDysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids. | Journal of medicinal chemistry |
| 2026-07-12 | PublicationS-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancers. | Cell death and differentiation |
| 2026-07-12 | PublicationAntimetabolites synergize with non-genotoxic antibody drug conjugate conditioning in hematopoietic stem cell lentiviral gene therapy. | Molecular therapy. Advances |
| 2026-07-12 | PublicationFoslevodopa/Foscarbidopa: A Review in Advanced Parkinson's Disease. | CNS drugs |
| 2026-07-12 | PublicationWest Nile Neuroinvasive Disease: Current Management, Emerging Therapies and Future Clinical Trial Priorities. | Reviews in medical virology |
| 2026-07-13 | Dernière mise à jour du registreNCT07337395 | Registre d’essai clinique |
| 2026-07-13 | Dernière mise à jour du registreNCT04017481 | Registre d’essai clinique |
| 2026-07-13 | Dernière mise à jour du registreNCT03088839 | Registre d’essai clinique |
| 2026-07-13 | Dernière mise à jour du registreNCT02780492 | Registre d’essai clinique |
| 2026-07-13 | Dernière mise à jour du registreNCT04833673 | Registre d’essai clinique |
| 2026-07-13 | Dernière mise à jour du registreNCT06290713 | Registre d’essai clinique |
| 2026-07-13 | Dernière mise à jour du registreNCT02968966 | Registre d’essai clinique |
| 2026-07-13 | Dernière mise à jour du registreNCT03888924 | Registre d’essai clinique |
| 2026-07-14 | PublicationImpact of anti-TNF and anti-IL-12/IL-23 antibody therapy on periodontal inflammation and gingival crevicular fluid IL-6 in patients with inflammatory bowel diseases. | Frontiers in immunology |
| 2026-07-14 | PublicationTopical resiniferatoxin for the treatment of vestibulodynia: a prospective observational trial. | AJOG global reports |
| 2026-07-14 | PublicationAdvances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances. | Journal of drug targeting |
| 2026-07-14 | PublicationEfficacy at a cost: camrelizumab and famitinib within the expanding landscape of combination therapies. | Gynecology and pelvic medicine |
| 2026-07-14 | PublicationPharmacological and non-pharmacological therapies for chronic pancreatitis pain: a narrative review. | Frontiers in physiology |
| 2026-07-14 | PublicationVirus-biomimetic melanin nanoparticles with spiky structures and neutral zwitterionic shell for non-invasive prevention of dry AMD. | Journal of controlled release : official journal of the Controlled Release Society |
| 2026-07-14 | PublicationBCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial. | Nature medicine |
| 2026-07-14 | PublicationTherapeutic progress in rosacea: targeting the neuro-vascular-immune triad. | Frontiers in immunology |
| 2026-07-14 | PublicationAdvanced on Minimally Invasive Techniques in Facial Rejuvenation: A Comprehensive Review. | World journal of plastic surgery |
| 2026-07-14 | PublicationPlant-derived mitochondria mitigate aging-related neurodegeneration by reprogramming microglial mitochondrial energy metabolism. | Translational neurodegeneration |
| 2026-07-14 | Publication[Modality strategy in Eisai drug discovery: challenges toward next-generation therapeutics using proximity-inducing compound]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica |
| 2026-07-14 | PublicationSelpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies. | Frontiers in endocrinology |
| 2026-07-14 | PublicationDual resistance to asparaginase and PD-1 blockade in extranodal natural killer/T-cell lymphoma: dismal outcomes from a multicenter cohort. | Haematologica |
| 2026-07-14 | PublicationDiscovery of Tivumecirnon (FLX475), a Potent and Selective CCR4 Antagonist That Inhibits the Migration of Immunosuppressive Regulatory T Cells into the Tumor Microenvironment to Restore Antitumor Immunity. | Journal of medicinal chemistry |
| 2026-07-14 | PublicationPulvinar subdivisions and connectivity patterns across primate species: a comparative perspective. | Frontiers in neuroanatomy |
| 2026-07-14 | PublicationReal-world pharmacovigilance analysis of the association between multiple sclerosis disease-modifying therapies and intervertebral disc herniation. | Frontiers in pharmacology |
| 2026-07-14 | PublicationPontine Autosomal Dominant Microangiopathy with Leukoencephalopathy in a Hispanic Man Without a Family History. | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association |
| 2026-07-15 | PublicationSafety and Microvascular Effect of Four-Year Aminaphtone Administration in Systemic Sclerosis Patients. | Open access rheumatology : research and reviews |
| 2026-07-15 | PublicationHigh Volume Hemofiltration : what are the last indications in 2026 - a narrative review. | Blood purification |
| 2026-07-18 | Création de l’enregistrementNCT05403788 | Registre d’essai clinique |
| 2026-07-18 | PublicationSilence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder. | Journal of psychopharmacology (Oxford, England) |
| 2026-07-18 | PublicationComparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis. | Neurology and therapy |
| 2026-07-18 | PublicationKnowledge graph visualization and bibliometric analysis of research on coronary artery lesions in Kawasaki disease. | Medicine |
| 2026-07-18 | PublicationTwo Cases of Malaria-Associated Acute Respiratory Distress Syndrome and Severe Pulmonary Complications From Plasmodium falciparum in Tanzania. | The American journal of case reports |
| 2026-07-18 | PublicationIn situ engineering of a self-healing drug-scaffold hydrogel to block platelet-driven postoperative metastasis. | Biomaterials |
| 2026-07-18 | PublicationRAS signaling at the crossroads of radioresistance and tumor immunity. | Journal for immunotherapy of cancer |
| 2026-07-18 | PublicationFacial solitary morphea profunda presenting with painful trigeminal neuropathy: A case report. | Cephalalgia : an international journal of headache |
| 2026-07-18 | PublicationRational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells. | Bioorganic chemistry |
| 2026-07-18 | PublicationPlant-Based Therapies to Ameliorate Neuroinflammation in Parkinson's Disease, Alzheimer's Disease, and Epilepsy: A Narrative Review. | Chemistry & biodiversity |
| 2026-07-18 | PublicationTreatment strategies for motor fluctuations in Parkinson's disease: a systematic review of efficacy, functionality, and drug accessibility with a focus on Latin America. | Frontiers in pharmacology |
| 2026-07-18 | PublicationThe Art of Sequencing Disease-Modifying Therapies in Multiple Sclerosis. | Neurology(R) neuroimmunology & neuroinflammation |
| 2026-07-18 | PublicationIGF2R: a new player in the IGF2 loop sustaining adrenocortical carcinogenesis. | Cell communication and signaling : CCS |
| 2026-07-22 | Création de l’enregistrementNCT03865420 | Registre d’essai clinique |
| 2026-07-22 | Création de l’enregistrementNCT01738386 | Registre d’essai clinique |
| 2026-07-22 | PublicationInvestigating the role of serum NfL, FGF21, NCAM1 and GDF15 as disease biomarkers for Charcot-Marie-Tooth type 2A. | Scientific reports |
| 2026-07-22 | PublicationCo-development of a genetic care pathway for ALS: real-world perspectives from the North of England. | Orphanet journal of rare diseases |
| 2026-07-22 | PublicationUnraveling the Potential of Stem Cell Therapy in Motor Neuron Disease: A Narrative Review. | CNS & neurological disorders drug targets |
| 2026-07-22 | PublicationGeneralizable structure-function covariation predictive of antidepressant response revealed by target-oriented multimodal fusion. | Nature. Mental health |
| 2026-07-22 | PublicationFrom Visceral Pain to Emotional Distress: Comparative Effectiveness of Antispasmodics and Antidepressants in Irritable Bowel Syndrome - Systematic Review and Network Meta-analysis. | Journal of gastrointestinal and liver diseases : JGLD |
| 2026-07-22 | PublicationSix approved drugs for alcohol use disorder: algorithms for their use according to the aims of treatment. | Alcohol and alcoholism (Oxford, Oxfordshire) |
| 2026-07-22 | PublicationSuccessful Trifarotene Treatment of a Typical Kyrle's Disease With Overview of Topical Therapies. | Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) |
| 2026-07-22 | PublicationFrom Molecular Pathophysiology to Clinical Trial Design in Sjögren's Disease: A Three-Axis Framework. | International journal of molecular sciences |
| 2026-07-22 | PublicationChronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives. | Frontiers in pain research (Lausanne, Switzerland) |
| 2026-07-22 | PublicationThe role and interaction of hypothalamic-related neurotransmitters in migraine. | The journal of headache and pain |
| 2026-07-22 | PublicationBeyond intraocular pressure: vascular and metabolic modifiers of optic nerve vulnerability in glaucoma. | International ophthalmology |
| 2026-07-22 | PublicationTiming of Mortality Benefit in Outcomes Trials in Transthyretin Amyloidosis. | Journal of the American College of Cardiology |
| 2026-07-22 | PublicationNon-Pharmacological Treatments of Migraine: Current Evidence and Clinical Practice. | Current pain and headache reports |
| 2026-07-22 | PublicationFrench guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder. | Revue neurologique |
| 2026-07-23 | PublicationComparative Endophthalmitis Rates of Anti-VEGF, Corticosteroid Implants and Anti-Complement Injections: An IRIS® Registry Analysis. | American journal of ophthalmology |
| 2026-07-23 | PublicationMechanisms of open and hidden placebo in stroke recovery: targeting neuroplasticity insights of the placebo effect - study protocol for a controlled, parallel, randomised clinical trial. | BMJ open |
| 2026-07-23 | PublicationAge outweighs route for AAV-PHP.eB transgene distribution via inner ear delivery. | Drug delivery and translational research |
| 2026-07-23 | PublicationEfficacy and Safety of Canakinumab Compared With Standard Therapy for the Treatment of Non-Small Cell Lung Cancer (NSCLC): A Systematic Review. | Cancer reports (Hoboken, N.J.) |
| 2026-07-23 | PublicationDrug repurposing as a promising therapeutic strategy against renal cell carcinoma. | Cancer chemotherapy and pharmacology |
| 2026-07-23 | PublicationCross-task, explainable and real-time decoding of human emotion states by integrating gray and white matter intracranial neural activity. | Nature computational science |
| 2026-07-23 | PublicationEfficacy and Safety of Mesenchymal Stem Cell Therapy for Alzheimer's Disease: A Systematic Review and Meta-Analysis. | Stem cells and development |
| 2026-07-23 | PublicationA Phase II Study to Evaluate the Efficacy of Commercially Available Molecularly Matched Targeted Therapies in the Second-Line Setting. | The oncologist |
| 2026-07-23 | PublicationA bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β1 (SHR1701) enhanced preclinical antitumor activity in oral squamous cell carcinoma. | Oral oncology |
| 2026-07-23 | PublicationDiagnostic performance of plasma p-Tau217, p-Tau181, and p-Tau231 across the Alzheimer's disease continuum: a network meta-analysis. | Frontiers in aging neuroscience |
| 2026-07-23 | PublicationComparative efficacy and safety of photobiomodulation, transcranial direct current stimulation, and repetitive transcranial magnetic stimulation in Alzheimer's disease: a network meta-analysis of randomized controlled trials. | Lasers in medical science |
| 2026-07-23 | PublicationTargeting progressive multiple sclerosis: Toward mechanism-informed precision medicine. | Journal of internal medicine |
| 2026-07-23 | PublicationPotential benefits of music-based therapies on rehabilitation outcomes in people with multiple sclerosis: a systematic review. | BMJ open |
| 2026-07-24 | Création de l’enregistrementNCT03853746 | Registre d’essai clinique |
| 2026-07-24 | Création de l’enregistrementNCT03535298 | Registre d’essai clinique |
| 2026-07-29 | Création de l’enregistrementNCT07664124 | Registre d’essai clinique |
| 2026-07-29 | Création de l’enregistrementNCT07164924 | Registre d’essai clinique |
| 2026-07-29 | PublicationImmunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination. | Inflammopharmacology |
| 2026-07-29 | PublicationMicroRNA Expression Profiles as Biomarkers of Response to Disease-Modifying Therapies in Multiple Sclerosis: A Systematic Review. | International journal of molecular sciences |
| 2026-07-30 | Début de l’étudeNCT07664124 | Registre d’essai clinique |
| 2026-08-01 | Début de l’étudeNCT07788573 | Registre d’essai clinique |
| 2026-08-05 | Création de l’enregistrementNCT07051525 | Registre d’essai clinique |
| 2026-08-05 | Création de l’enregistrementNCT06891118 | Registre d’essai clinique |
| 2026-08-05 | Création de l’enregistrementNCT07348783 | Registre d’essai clinique |
| 2026-08-08 | PublicationDrugs and Cell-Based Therapies for the Prevention and Treatment of Neonatal Brain Injury. | Clinics in perinatology |
| 2026-08-08 | PublicationSimultaneous Analysis of a Combination of Anti-Hypertensive Drugs, Fimasartan, Amlodipine, and Hydrochlorothiazide, in Rats Using LC-MS/MS and Subsequent Application to Pharmacokinetic Drug Interaction with Red Ginseng Extract. | Toxics |
| 2026-08-08 | PublicationAssessment of periodontal regeneration with blood derivatives: a systematic review and network meta-analysis. | Odontology |
| 2026-08-08 | PublicationConcurrent herpetic hypertensive anterior uveitis and cytomegalovirus retinitis in a non-HIV patient with melanoma differentiation-associated gene-5 dermatomyositis: intravenous immunoglobulin comes to the rescue. | Reumatismo |
| 2026-08-08 | PublicationArtificial Intelligence and Advanced Digital Health for Hypertension: Evolving Tools for Precision Cardiovascular Care. | Medicina (Kaunas, Lithuania) |
| 2026-08-08 | PublicationCGRP-pathway exposure during the pre-EBP interval in spontaneous intracranial hypotension: an exploratory retrospective case series. | BMC neurology |
| 2026-08-08 | PublicationComparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when? | Expert review of neurotherapeutics |
| 2026-08-08 | PublicationNon-Pharmacological Treatment of Primary Headaches-A Focused Review. | Brain sciences |
| 2026-08-08 | Publication2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. | Headache |
| 2026-08-08 | PublicationPeripheral Neuromodulation for the Management of Headache. | Anesthesiology and pain medicine |
| 2026-08-08 | PublicationSpecies-specific functions of CSRP3 in satellite cell-driven muscle regeneration and relevance to porcine stem cell therapy. | Cell regeneration (London, England) |
| 2026-08-08 | PublicationChronic Migraine Resistance: A Case Report Highlights an Overlooked Factors in Family Medicine Clinics. | Healthcare (Basel, Switzerland) |
| 2026-08-08 | PublicationReview: An Update on CGRP Monoclonal Antibodies for the Preventive Treatment of Episodic Migraine. | Current pain and headache reports |
| 2026-08-08 | PublicationEffectiveness of acupuncture and related therapies for post-stroke insomnia: A systematic review and Bayesian network analysis. | Medicine |
| 2026-08-08 | PublicationA multi-centre, tolerability study of a cannabidiol-enriched Cannabis Herbal Extract for chronic headaches in adolescents: The CAN-CHA protocol. | PloS one |
| 2026-08-08 | PublicationPost-Craniotomy Headache: Current Concepts and Emerging Procedural Therapies. | Current pain and headache reports |
| 2026-08-08 | PublicationEmerging Neurovascular Interventions for the Prevention of Cerebral Vasospasm and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review. | Cureus |
| 2026-08-08 | PublicationLong-term neuropsychiatric outcomes after neuromodulation in epilepsy patients: a systematic review and meta-analysis. | Acta neurologica Belgica |
| 2026-08-08 | PublicationParvalbumin interneuron activation rescues both seizures and impaired social novelty in digenic absence epilepsy mice. | Science advances |
| 2026-08-08 | PublicationEffects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes. | Alzheimer's & dementia : the journal of the Alzheimer's Association |
| 2026-08-08 | PublicationImmunotherapeutic approaches for Alzheimer's disease: Exploring active and passive vaccine progress. | Brain research |
| 2026-08-08 | PublicationAdjunctive EGb 761 treatment in patients with Parkinson's disease: a case series. | Frontiers in aging neuroscience |
| 2026-08-08 | PublicationAdherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence. | American journal of cardiovascular drugs : drugs, devices, and other interventions |
| 2026-08-08 | PublicationCognitive Impairment Associated with Chemotherapy: Neuroimmunological Interactions, Gut-Brain Axis, and Therapeutic Approaches. | Brain sciences |
| 2026-08-08 | PublicationEfficacy of citicoline as an add-on therapy in Parkinson's disease: a randomized, double-blind trial. | Parkinsonism & related disorders |
| 2026-08-08 | PublicationDecoding pre-movement neural activity from thalamic LFPs for adaptive neurostimulation in tremor patients. | Neurocomputing |
| 2026-08-08 | PublicationA Translational Readiness Checklist for Stem-Cell-Based Trials in Movement Disorders: A Practical Roadmap. | Journal of central nervous system disease |
| 2026-08-08 | PublicationA Transgenic mouse tolerant to syngeneic cancer cells expressing truncated human epidermal growth factor receptor. | PloS one |
| 2026-08-08 | PublicationExperience of using anti-CD 20 therapies in multiple sclerosis patients in Kenya. | Frontiers in neurology |
| 2026-08-08 | PublicationDifferential safety profiles of disease-modifying therapies in MS: Age- and sex-based analysis from a real-world cohort. | Multiple sclerosis and related disorders |
| 2026-08-08 | PublicationImproved Outcomes with Early Aggressive Therapy in Pediatric Pulmonary Hypertension. | The European respiratory journal |
| 2026-08-08 | PublicationErsodetug for Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors. | The Journal of clinical endocrinology and metabolism |
| 2026-08-08 | PublicationEarly treatment with ofatumumab increases the likelihood of stabilizing disease in patients with relapsing-remitting multiple sclerosis. | Archives of medical science : AMS |
| 2026-08-08 | PublicationNatalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naïve people with multiple sclerosis. | Journal of medical economics |
| 2026-08-08 | PublicationDiscontinuation of disease-modifying therapies in patients with multiple sclerosis: A retrospective case-control study. | Multiple sclerosis and related disorders |
| 2026-08-08 | PublicationThe elusive link: EBV in MS. | Expert review of clinical immunology |
| 2026-08-08 | PublicationUrinary tract infections, urosepsis, and multiple sclerosis disease modifying therapies: a disproportionality analysis of the FDA Adverse Event Reporting System. | Multiple sclerosis and related disorders |
| 2026-08-08 | PublicationChronic exposure to mining-contaminated borehole water impairs the entire male reproductive axis: partial mitigation by alpha-lipoic acid in Wistar rats. | Frontiers in toxicology |
| 2026-08-08 | PublicationLearnings from Patient Mortality after Delandistrogene Moxeparvovec Administration: A Report of Two Cases and Expert Committee Considerations for Future Mitigation and Management. | Human gene therapy |
| 2026-08-08 | PublicationClinical efficacy and cost per improved outcome of treatments for generalized myasthenia gravis: evidence from a network meta-analysis and cost-per-responder analysis. | Current medical research and opinion |
| 2026-08-08 | PublicationIdentifying molecular signatures underpinning treatment responses to novel therapeutics influencing COVID-19 outcomes. | Journal of immunology (Baltimore, Md. : 1950) |
| 2026-08-08 | PublicationEfficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization. | Frontiers in immunology |
| 2026-08-08 | PublicationLymphatic therapies open the valve in Marfan syndrome. | The Journal of clinical investigation |
| 2026-08-13 | Création de l’enregistrementNCT07213440 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT05885139 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT06724562 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT00068003 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT06692088 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT06764914 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07690696 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT05406349 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT01845883 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT03500328 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT05833633 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07052929 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT03816345 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT05610852 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT03621319 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07206355 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT03220113 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT00286078 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT00747812 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT05046119 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT04604977 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07313800 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07617441 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT02090998 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07720895 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07292090 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07763678 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT05374824 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07283913 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT00781872 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07521384 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT04294979 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT03910738 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT01465087 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT05359653 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07710105 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT03600779 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT06451159 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07753928 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT05658497 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07757568 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT07762040 | Registre d’essai clinique |
| 2026-08-13 | Création de l’enregistrementNCT00001248 | Registre d’essai clinique |
| 2026-08-13 | Dernière mise à jour du registreNCT07348783 | Registre d’essai clinique |
| 2026-08-13 | Dernière mise à jour du registreNCT07664124 | Registre d’essai clinique |
| 2026-08-13 | PublicationRepurposing monepantel in oncology: A conceptual mini-review of proposed mechanisms. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
| 2026-08-13 | PublicationMSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model. | Stem cell research & therapy |
| 2026-08-13 | PublicationLessons from a systematic review of family-based studies in ALS. | Amyotrophic lateral sclerosis & frontotemporal degeneration |
| 2026-08-13 | PublicationIn vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging. | eLife |
| 2026-08-13 | PublicationHuoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial. | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics |
| 2026-08-13 | PublicationTargeting TDP-43 in sporadic amyotrophic lateral sclerosis. | Journal of neurology |
| 2026-08-13 | PublicationEstablishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study. | PloS one |
| 2026-08-13 | PublicationLarge-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and functional capacity. | Journal of neuromuscular diseases |
| 2026-08-13 | PublicationCell-Based Therapies for Post-Traumatic Ankle Osteoarthritis and Osteochondral Lesions of the Talus: A Systematic Scoping Review of an Emerging and Heterogeneous Evidence Base. | Bioengineering (Basel, Switzerland) |
| 2026-08-13 | PublicationSwallowing therapy for dysphagia in acute and subacute stroke. | The Cochrane database of systematic reviews |
| 2026-08-13 | PublicationClinical Practice Recommendations for Non-Dermatologists on the Diagnostic Suspicion of GPP. | Journal of clinical medicine |
| 2026-08-13 | PublicationSGLT2 Inhibitors and Outcomes in Elderly Patients With Chronic Kidney Disease: A Narrative Review. | Diabetes, obesity & metabolism |
| 2026-08-13 | PublicationAAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects. | Gene therapy |
| 2026-08-13 | PublicationAn Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1. | The New England journal of medicine |
| 2026-08-13 | PublicationSubconjunctival Injection of Mesenchymal Stem Cells for Corneal Wound Healing After Chemical Injury: Impact on Epithelial Coverage, Limbal Ischemia, and Ocular Surface Inflammatory. | Frontiers in medicine |
| 2026-08-13 | PublicationBone marrow mesenchymal stem cell exosomes in osteonecrosis: pathological mechanisms and therapeutic strategies. | Molecular biology reports |
| 2026-08-13 | PublicationDevelopment of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHD. | Nucleic acids research |
| 2026-08-13 | PublicationIntegrative bioinformatics and molecular simulations identify HMGB3 as a key immune modulator in triple negative breast cancer. | Discover oncology |
| 2026-08-13 | PublicationApitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial. | Nature medicine |
| 2026-08-13 | PublicationComprehensive review of adverse reactions and toxicology in ASO-based therapies for Duchenne Muscular Dystrophy: From FDA-approved drugs to peptide-conjugated ASO. | Current research in toxicology |
| 2026-08-13 | PublicationGene therapy in Duchenne muscular dystrophy. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie |
| 2026-08-13 | PublicationComparative effects of low-level laser acupuncture and dry needling on clinical and functional outcomes in patients with chronic cervical myofascial pain syndrome: a randomized controlled trial. | Lasers in medical science |
| 2026-08-13 | PublicationCardiac Myosin Activators in Heart Failure: Experimental Advances Amid Clinical Uncertainty. | Drug design, development and therapy |
| 2026-08-13 | PublicationSpending on Targeted Therapies for Duchenne Muscular Dystrophy. | JAMA |
| 2026-08-13 | PublicationAuricular Vagus Nerve Stimulation in Inflammatory Bowel Disease: Mechanistic Insights and Biomarker-Based Evaluation of Therapeutic Response. | International journal of molecular sciences |
| 2026-08-13 | PublicationToward an Integrated Strategy for Volumetric Muscle Loss Regeneration. | Journal of clinical medicine |
| 2026-08-13 | PublicationRecalibrating Therapeutic Priorities for Duchenne Muscular Dystrophy: A Critical Synthesis of Approved and Emerging Strategies Through the Lens of an Underrepresented Population. | Genes |
| 2026-08-13 | PublicationStepping it Up on Temporary Mechanical Circulatory Support - Mobilization and Prehabilitation of patients in ICU. | Journal of cardiac failure |
| 2026-08-13 | PublicationIntrathecal Baclofen Pump Therapy for Medically Refractory Stiff Person Syndrome: A Multicenter Case Series. | Neuromodulation : journal of the International Neuromodulation Society |
| 2026-08-13 | PublicationMosunetuzumab: A bispecific CD20 × CD3 antibody for follicular lymphoma with promising evidence in other B-NHL subtypes. | Human vaccines & immunotherapeutics |
| 2026-08-13 | PublicationT-cell engaging antibodies for B-cell lymphomas. | Seminars in hematology |
| 2026-08-13 | PublicationComparative effectiveness and safety of biologics and targeted small-molecule therapies plus stable background therapy in systemic lupus erythematosus: a systematic review and network meta-analysis. | Frontiers in immunology |
| 2026-08-13 | PublicationTargeting the Roots of Kidney Disease: Systematic Review of the Therapies Targeting the Complement System. | Medicina (Kaunas, Lithuania) |
| 2026-08-13 | PublicationNew and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases. | Kidney medicine |
| 2026-08-13 | PublicationNivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis. | International journal of clinical oncology |
| 2026-08-13 | PublicationComparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia. | Leukemia |
| 2026-08-13 | PublicationObecabtagene Autoleucel in Relapsed/Refractory B-ALL: A Critical Review of Clinical Efficacy and Safety. | The Annals of pharmacotherapy |
| 2026-08-13 | PublicationLupus nephritis randomised controlled trials: evidence gaps and under-represented groups. | Lupus science & medicine |
| 2026-08-13 | PublicationSystematic Review and Network Meta-Analysis of Initial Treatments for Lupus Nephritis. | Kidney international reports |
| 2026-08-13 | PublicationLitifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus. | Expert opinion on investigational drugs |
| 2026-08-13 | PublicationEarly use of low dose rituximab in anti acetylcholine receptor generalized myasthenia gravis in South Wales - A retrospective study. | Journal of the neurological sciences |
| 2026-08-13 | PublicationEmerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma. | Oncology (Williston Park, N.Y.) |
| 2026-08-13 | PublicationNeuroimmunological overlap syndromes in optic neuritis, myelitis, and connective tissue diseases. | Frontiers in neurology |
| 2026-08-13 | PublicationNetwork meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis. | Lupus |
| 2026-08-13 | PublicationOdronextamab: a bispecific antibody for follicular lymphoma. | Expert opinion on investigational drugs |
| 2026-08-13 | PublicationCD20 × CD3 Bispecific Antibodies in B-Cell Non-Hodgkin Lymphomas: Current Evidence, Therapeutic Integration, and Future Directions. | Medicina (Kaunas, Lithuania) |
| 2026-08-13 | PublicationUpdate to the Sociedad Española de Reumatología Guidelines on the Use of Biological Therapy in Systemic Lupus Erythematosus. | Reumatologia clinica |
| 2026-08-13 | PublicationAdvances in the treatment of systemic lupus erythematosus: Biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic. | Journal of internal medicine |
| 2026-08-13 | PublicationGenetic basis of immune-mediated necrotizing myopathy: A genomic structural equation modeling and AI-driven structural analysis. | Computational biology and chemistry |
| 2026-08-13 | PublicationComparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma. | Transplantation and cellular therapy |
| 2026-08-13 | PublicationEfficacy and safety of emerging immunomodulatory agents versus standard therapies in refractory cutaneous lupus: A systematic review. | Dermatology online journal |
| 2026-08-13 | PublicationVoclosporin for the treatment of lupus nephritis flares in patients with inadequate response to mycophenolate mofetil and belimumab: a case series. | Journal of nephrology |
| 2026-08-13 | PublicationHormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve. | Rheumatology (Oxford, England) |
| 2026-08-13 | PublicationScleroderma Renal Crisis in Mixed Connective Tissue Disease. | The American journal of medicine |
| 2026-08-13 | PublicationAnti-CD38/Anti-CD20 Rescue Therapy for Posttransplant Recurrent FSGS. | Kidney international reports |
| 2026-08-13 | PublicationEngineering T cells in vivo to express a synthetic cytokine receptor enables preferential expansion and enrichment of anti-CD22 CAR T cells. | Molecular therapy : the journal of the American Society of Gene Therapy |
| 2026-08-13 | PublicationRadiation Therapy for Pancreatic Cancer: An ASTRO Clinical Practice Guideline. | Practical radiation oncology |
| 2026-08-13 | PublicationMetformin Attenuates Sepsis-Induced Cardiomyopathy via Inhibition of Reverse Electron Transfer at Mitochondrial Complex I. | Biology |
| 2026-08-13 | PublicationDelivery of Mitoxantrone by Biodegradable Cobalt-Doped Hollow Prussian Blue Nanoparticles for Synergetic Photothermal Amplified Chemodynamic Therapy/Chemotherapy/Metalloimmunotherapy Against Tumor. | Small (Weinheim an der Bergstrasse, Germany) |
| 2026-08-13 | PublicationIntravaginal Formulation Strategies for Vaginal Disorders: Optimizing Phytochemical and Biological Preparations-A Review. | Molecules (Basel, Switzerland) |
| 2026-08-13 | PublicationPapilledema is not the point: intracranial pressure dysregulation as a common pathway in migraine and idiopathic intracranial hypertension. | Brain communications |
| 2026-08-13 | PublicationPainful neuromas exhibit axonal phenotypic shift via nociceptive and mechanosensitive marker up-regulation. | PNAS nexus |
| 2026-08-13 | PublicationDigestive Hormones and Their Impact on Bariatric and Pharmacologic Weight-Loss Therapies. | Endocrine reviews |
| 2026-08-13 | PublicationBeyond GLP-1: Amylin-Based Pharmacotherapy and the Search for Better-Tolerated Weight-Loss Drugs. | Pharmacological research |
| 2026-08-13 | PublicationAntiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study. | The Lancet. Neurology |
| 2026-08-13 | PublicationAcute Pain Management in Children: A Systematic Review and GRADE-Based Recommendations. | Journal of clinical medicine |
| 2026-08-13 | PublicationPreserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization. | GeroScience |
| 2026-08-13 | PublicationMolecular mechanisms of exercise-induced neuroprotection against Parkinson's disease. | Sports medicine and health science |
| 2026-08-13 | PublicationSmell and the sinuses. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology |
| 2026-08-13 | PublicationOrthobiologic injections for hip osteoarthritis: A systematic review of clinical outcomes. | Orthopedic reviews |
| 2026-08-13 | PublicationThe Role of Nitric Oxide in Chronic Liver Disease: A Review. | Journal of clinical and translational hepatology |
| 2026-08-13 | PublicationResveratrol Modulates Phosphatidylcholine Metabolism-Related Enzymes and Enhances Chemosensitivity in Colorectal Cancer Models. | International journal of molecular sciences |
| 2026-08-13 | PublicationAntidepressant medications have differential effects on REM sleep without atonia quantified by chin and upper extremity EMG. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine |
| 2026-08-13 | PublicationSublingual apomorphine in the treatment of Parkinson's disease. | Journal of neural transmission (Vienna, Austria : 1996) |
| 2026-08-13 | PublicationSmall Triple-Negative and HER2-Positive Early Breast Cancer: Upfront Surgery or Neoadjuvant Chemotherapy? | Cancers |
| 2026-08-13 | PublicationLITESPARK-012: pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma. | Future oncology (London, England) |
| 2026-08-13 | PublicationComparison of Sex-Specific Treatment Outcomes in Clinical Trials and Subsequent Real-World Data on Systemic Therapies for Urothelial Carcinoma: A Systematic Review. | Aktuelle Urologie |
| 2026-08-13 | PublicationOutcomes and Prognostic Factors of Cetuximab-Based Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. | Journal of clinical medicine |
| 2026-08-13 | PublicationArtificial Intelligence Techniques in Cardiac Neuromodulation: Mechanisms, Applications, and Pathways to Clinical Translation. | Journal of arrhythmia |
| 2026-08-13 | PublicationDisruption of Plexin-A1 signaling by FTX-101: mode of action and effect on oligodendrocyte biology. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
| 2026-08-13 | PublicationtVNS and obesity-related inflammation: a prospective sham-controlled randomized crossover study protocol. | BMC psychology |
| 2026-08-13 | PublicationTreatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study. | Multiple sclerosis (Houndmills, Basingstoke, England) |
| 2026-08-13 | PublicationClemastine fumarate promotes myelin repair in a nonhuman primate model of demyelination characterized by absent spontaneous remyelination. | Proceedings of the National Academy of Sciences of the United States of America |
| 2026-08-13 | PublicationOptimizing Infusion Center Efficiency in Multiple Sclerosis: A Nursing Multicenter Survey on Organizational Impact of Ublituximab. | Healthcare (Basel, Switzerland) |
| 2026-08-13 | PublicationBalancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia. | Frontiers in public health |
| 2026-08-13 | PublicationTranslating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development Roadmap. | Clinical pharmacology and therapeutics |
| 2026-08-13 | PublicationAnti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD. | CNS drugs |
| 2026-08-13 | PublicationCladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights. | Frontiers in immunology |
| 2026-08-13 | PublicationEfficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study. | Journal of neurology |
| 2026-08-13 | PublicationEvaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry. | Journal of child neurology |
| 2026-08-13 | PublicationStructure-Property Relationship Analysis of α-Keto Ester Prodrugs of Monomethyl Fumarate as NRF2 Activators. | ACS chemical neuroscience |
| 2026-08-13 | PublicationComparative Effectiveness of Diroximel Fumarate vs. Dimethyl Fumarate in Persons with Multiple Sclerosis: A US Claims Analysis of Relapse Outcomes. | Advances in therapy |
| 2026-08-13 | PublicationSafety analyses of the INAVO120 randomised phase III trial of inavolisib or placebo with palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant advanced breast cancer. | ESMO open |
| 2026-08-13 | PublicationRelative increase of memory B-cell subsets under s.c. B-cell-depleting therapies in multiple sclerosis. | Frontiers in immunology |
| 2026-08-13 | PublicationComorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion. | European journal of neurology |
| 2026-08-13 | PublicationUSPIO enhanced MR imaging in CNS tumors (UMIC): a study protocol. | Nanomedicine (London, England) |
| 2026-08-13 | PublicationRecent advances in the medical management of thyroid eye disease. | Current opinion in endocrinology, diabetes, and obesity |
| 2026-08-13 | PublicationTime-Dependent Bias and Prognostic Confounding in Exposure-Response Analysis of Targeted Therapies: Lessons from Sunitinib in Metastatic Renal Cancer. | Clinical pharmacology and therapeutics |
| 2026-08-13 | PublicationBeyond Weight Loss: Gut Microenvironment Modulation to Enhance Cardiometabolic Outcomes and Long-Term Adherence During Incretin-Based Therapy. | Journal of clinical medicine |
| 2026-08-13 | PublicationImmune thrombocytopenia: Evolving mechanistic understanding and clinical development of new therapies. | Tzu chi medical journal |
| 2026-08-13 | Publication[Treatment of mast cell-mediated angioedema]. | Dermatologie (Heidelberg, Germany) |
| 2026-08-13 | PublicationReal-world adherence to and persistence with ofatumumab, infusion, oral, and other self-injectable disease-modifying therapies in patients with multiple sclerosis. | Multiple sclerosis journal - experimental, translational and clinical |
| 2026-08-13 | PublicationElectrospun PLA/PCL Membranes for Sustained Transdermal Rifampicin Delivery: Biocompatibility, Stability, and Antimycobacterial Activity. | Polymers |
| 2026-08-13 | PublicationEfficacy of eltrombopag in combination with recombinant human thrombopoietin (rhTPO) for lymphoma patients with chemotherapy-induced thrombocytopenia. | Frontiers in pharmacology |
| 2026-08-16 | Création de l’enregistrementNCT07233148 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT07499323 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT06861270 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT07721857 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT07721363 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT06155123 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT07487701 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT06864936 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT07743281 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT05083481 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT04115267 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT07419295 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT04276857 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT05363228 | Registre d’essai clinique |
| 2026-08-16 | Création de l’enregistrementNCT06586177 | Registre d’essai clinique |
| 2026-08-16 | Dernière mise à jour du registreNCT07052929 | Registre d’essai clinique |
| 2026-08-16 | Dernière mise à jour du registreNCT03816345 | Registre d’essai clinique |
| 2026-08-16 | Dernière mise à jour du registreNCT00781872 | Registre d’essai clinique |
| 2026-08-16 | PublicationEconomic analysis of triptan therapy for acute migraine: a Medicaid perspective. | Pharmacotherapy |
| 2026-08-16 | PublicationNovel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries. | Paediatric drugs |
| 2026-08-16 | PublicationOzanimod and other sphingosine-1-phosphate receptor 1 modulators normalize neuropathic injury-enhanced inhibition of central lateral amygdala neurons expressing corticotropin-releasing hormone. | Neuropharmacology |
| 2026-08-16 | PublicationDecoding the serotonin-alcohol crosstalk: the role of central serotonergic dysregulation in alcohol use disorder. | Pharmacological reports : PR |
| 2026-08-16 | PublicationBotulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions: a systematic review of clinical research. | Journal of neural transmission (Vienna, Austria : 1996) |
| 2026-08-16 | PublicationFrequent antecedent nodules and diagnostic gaps in adrenocortical carcinoma. | Journal of the Endocrine Society |
| 2026-08-16 | PublicationNeuroimmune circuits in respiratory pathophysiology: decoding molecular crosstalk for precision therapeutic targeting. | Annals of medicine |
| 2026-08-16 | PublicationNomogram prediction model for the clinical efficacy of flunarizine hydrochloride in patients with vertigo based on 5-HT and oxidative stress indicators. | Clinics (Sao Paulo, Brazil) |
| 2026-08-16 | PublicationA multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial. | Journal of Alzheimer's disease : JAD |
| 2026-08-16 | Publication[Migraine in men: biological, psychosocial and clinical characteristics]. | Schmerz (Berlin, Germany) |
| 2026-08-16 | PublicationPharmaceutical policy and off-label prescribing in pregnancy: A population-based historical cohort study analyzing inequality in access to antiemetics within Australia's Pharmaceutical Benefits Scheme. | Acta obstetricia et gynecologica Scandinavica |
| 2026-08-16 | PublicationExploring health professionals' perspectives and preferences in the treatment of post-stroke fatigue and mental health disorders: an Australian qualitative vignette-based study. | The International journal of pharmacy practice |
| 2026-08-16 | PublicationIn silico characterisation of a novel SARS-CoV-2 envelope protein inhibitor and in vitro validation against murine coronavirus. | Bioorganic chemistry |
| 2026-08-16 | PublicationPACAP in Parkinson's disease: A multifunctional neuropeptide at the crossroad of autophagy, inflammation, and metabolic repurposing. | Neuropharmacology |
| 2026-08-16 | PublicationMigraine relief: Solutions from natural bioactive products of Traditional Chinese medicine. | Journal of ethnopharmacology |
| 2026-08-16 | PublicationReal-world outcomes of zavegepant use in a tertiary care setting using the Migraine Treatment Optimization Questionnaire-5. | Headache |
| 2026-08-16 | PublicationAn Emerging Autoimmune Neuroinflammatory Disease: Myelin Oligodendrocyte Glycoprotein Antibody Disease. | Annals of African medicine |
| 2026-08-16 | PublicationLatent Patterns of Complementary and Integrative Health Therapy Utilization Among VHA Patients on Long-Term Opioid Therapy. | Pain medicine (Malden, Mass.) |
| 2026-08-16 | PublicationL5-S1 basivertebral nerve ablation for chronic vertebrogenic low back pain following lumbar fusion: a case report. | Journal of spine surgery (Hong Kong) |
| 2026-08-16 | PublicationEfficacy of acupuncture therapies for polycystic ovary syndrome: a network meta-analysis. | Frontiers in medicine |
| 2026-08-16 | PublicationSTS101 nasal powder as a new treatment option for acute migraine with or without aura in adults. | Expert review of neurotherapeutics |
| 2026-08-16 | PublicationTargeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention. | Expert opinion on emerging drugs |
| 2026-08-16 | PublicationThe Botox Paradox: How Rising Drug Costs and Reimbursement Failures Threaten Access to Botulinum Toxin Therapy in Neurology. | Cureus |
| 2026-08-16 | PublicationOnline interest in calcitonin gene-related peptide-therapies: An infodemiology study using Google trends. | Headache |
| 2026-08-16 | PublicationThe pharmacology of gepants in migraine: A scoping review on mechanisms, clinical applications, and combination strategies. | Headache |
| 2026-08-16 | PublicationNutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation. | Obesity pillars |
| 2026-08-16 | PublicationCommon Mechanisms in Migraine, Migraine-Related Neck Pain, and Low Back Pain: Implications for Treatment. | Pain and therapy |
| 2026-08-16 | PublicationPeer-delivered combined EMD and imagery rescripting for traumatized Chinese university students: a RCT. | European journal of psychotraumatology |
| 2026-08-16 | PublicationVagus nerve stimulation in drug-resistant epilepsy: Surgical technique from a tertiary epilepsy center. | Surgical neurology international |
| 2026-08-16 | PublicationPractice trends and the outcome of neuromodulation therapies in epilepsy: A single-center study. | Epilepsia open |
| 2026-08-16 | PublicationTargeting the virus-host interface for the development of therapeutics against filoviruses. | Current opinion in virology |
| 2026-08-16 | PublicationProgress of Immunotherapies in Parkinson's Disease. | CNS neuroscience & therapeutics |
| 2026-08-16 | PublicationThe conundrum of alpha-synuclein antibody failures in Parkinson's disease: a narrative review of mechanisms and alternative metabolic hypotheses. | Therapeutic advances in neurological disorders |
| 2026-08-16 | PublicationThe Efficacy and Safety of Monoclonal Antibodies That Target Alpha-Synuclein in Parkinson's Disease: A Systematic Review. | Parkinson's disease |
| 2026-08-16 | PublicationEfficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial. | Lancet (London, England) |
| 2026-08-16 | PublicationAmeliorating Seizures in Dravet Syndrome: A Review of Newly Approved and Investigational Drugs, RNA and Gene-Based Therapies. | CNS drugs |
| 2026-08-16 | PublicationApplication of kilohertz-frequency block to mitigate off-target motor effects of vagus nerve stimulation in swine. | Nature communications |
| 2026-08-16 | PublicationBeyond seizures: proceedings of the ERN EpiCARE working group 18 on developmental and epileptic encephalopathies. | Epilepsy & behavior : E&B |
| 2026-08-16 | PublicationRepurposing the antispasmodic drug pinaverium bromide as a novel antifungal agent and synergist against . | Virulence |
| 2026-08-16 | PublicationVitamin D in synergy with triple therapy to eradicate Helicobacter pylori infection in mice via the c-Raf/MEK/ERK pathway. | Tissue & cell |
| 2026-08-16 | PublicationPotassium Channelopathies and Precision Medicine Approaches in Epilepsy: A Systematic Review of Personalized Treatment Strategies. | Current neuropharmacology |
| 2026-08-16 | PublicationKCNQ2 Channel as a Druggable Epilepsy Target: Advances in Pharmacological Modifiers. | CNS & neurological disorders drug targets |
| 2026-08-16 | PublicationTimeTeller for timing health: The potential of circadian medicine to improve performance, prevent disease and optimize treatment. | Frontiers in digital health |
| 2026-08-16 | PublicationPotassium channel agonists emerging as treatment options for focal epilepsy: are we breaking new ground? | Expert opinion on emerging drugs |
| 2026-08-16 | PublicationProgress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development. | Epilepsia |
| 2026-08-16 | PublicationDrug-loaded biomorphic scaffolds for tissue regeneration and targeted antitumor therapy in bone metastasis models. | Biomaterials advances |
| 2026-08-16 | PublicationPatient perspectives on hemolytic disease of the fetus and newborn and fetal and neonatal alloimmune thrombocytopenia: common experiences and insights. | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians |
| 2026-08-16 | PublicationSLC6A1-Related Neurodevelopmental Disorder: A Scoping Review of Clinical Features and Emerging Therapeutic Strategies. | Pediatric neurology |
| 2026-08-16 | PublicationOvercoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease. | Drug delivery |
| 2026-08-16 | PublicationPatient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment. | The Journal of dermatological treatment |
| 2026-08-16 | PublicationGlobal burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. | The Lancet. Infectious diseases |
| 2026-08-16 | PublicationA Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. | Pharmacoepidemiology and drug safety |
| 2026-08-16 | PublicationCentromere protein I promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR-CDK2 cascade. | Cancer biology & therapy |
| 2026-08-16 | PublicationSodium Phenylbutyrate and Taurursodiol: A New Therapeutic Option for the Treatment of Amyotrophic Lateral Sclerosis. | The Annals of pharmacotherapy |
| 2026-08-16 | PublicationClinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review. | Journal of neuroimmunology |
| 2026-08-16 | PublicationNeuro-renal syndrome (NRS) in autoimmune nodopathies and paranodopathies: A warning to consider the diagnosis when anti-node and paranode antibody tests are difficult to perform. | Journal of the neurological sciences |
| 2026-08-16 | PublicationCombined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. | JAMA network open |
| 2026-08-16 | PublicationTherapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026. | Regenerative therapy |
| 2026-08-16 | PublicationThe role of cardiac PET imaging in cardiac amyloidosis. | Seminars in nuclear medicine |
| 2026-08-16 | PublicationGeographic atrophy: From slowing lesions to preserving vision. | Current opinion in ophthalmology |
| 2026-08-16 | PublicationReal-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies. | Hematology (Amsterdam, Netherlands) |
| 2026-08-16 | PublicationCost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria: implications for decision-making. | Journal of medical economics |
| 2026-08-16 | PublicationIn vivo antimalarial activity and acute toxicity of organic and aqueous leaf, stem and root extracts of Ajuga integrifolia Buch.-Ham. ex D. Don. | Journal of ethnopharmacology |
| 2026-08-16 | PublicationComparative efficacy of arthrocentesis, platelet-rich plasma (PRP), and conservative therapies for TMJ disorders: A systematic review and meta-analysis. | Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery |
| 2026-08-16 | PublicationEfficacy and durability of therapies for neurogenic lower urinary tract dysfunction: A network meta-analysis of Botulinum Toxin a, instillations, and neuromodulation. | Toxicon : official journal of the International Society on Toxinology |
| 2026-08-16 | PublicationComparative efficacy of intralesional therapies for keloid scars: a network meta-analysis. | Annals of medicine |
| 2026-08-16 | PublicationEvaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS). | The aging male : the official journal of the International Society for the Study of the Aging Male |
| 2026-08-16 | PublicationHost-state biomarkers and clinical factors for stratification and optimization of cell therapy trials in chronic limb-threatening ischemia: A review. | Regenerative therapy |
| 2026-08-16 | PublicationThe contribution of the sphingosine 1-phosphate signaling pathway to chronic kidney diseases: recent findings and new perspectives. | Pflugers Archiv : European journal of physiology |
| 2026-08-16 | PublicationA Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal Hemoglobinuria. | Advances in therapy |
| 2026-08-16 | PublicationImmune effector cell-associated hematotoxicity following CAR-T cell therapies: insights from a large national database. | Japanese journal of clinical oncology |
| 2026-08-16 | PublicationNipocalimab and other FcRn blockers in neuromuscular disorders. | Pharmacology & therapeutics |
| 2026-08-16 | PublicationOvercoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch. | Cancer gene therapy |
| 2026-08-16 | PublicationAtypical Lymphocytosis Induced by T Cell-Engaging Therapy in Patients With Hematological Malignancies. | International journal of laboratory hematology |
| 2026-08-16 | PublicationAnifrolumab versus Belimumab for Cardiovascular Disease Risk in Systemic Lupus Erythematosus. | Arthritis & rheumatology (Hoboken, N.J.) |
| 2026-08-16 | PublicationTherapeutic Approaches for Cutaneous Lupus Erythematosus: a Changing Landscape of Clinical Trials. | Journal of inflammation research |
| 2026-08-16 | PublicationFDA-approved IMPDH inhibitors synergize with ribavirin to inhibit respiratory syncytial virus by interfering with purine synthesis. | Emerging microbes & infections |
| 2026-08-16 | PublicationEffectiveness of tacrolimus in patients with lupus nephritis: A randomized controlled trials meta-analysis. | Clinical nephrology |
| 2026-08-16 | PublicationCAR-engineered cell therapies: current understandings and future perspectives. | Molecular biomedicine |
| 2026-08-16 | PublicationNiacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma. | Neurology(R) neuroimmunology & neuroinflammation |
| 2026-08-16 | PublicationLessons from Exceptional Responders with High-Grade Brain Tumors Treated with Precision Targeted Therapies. | Journal of immunotherapy and precision oncology |
| 2026-08-16 | PublicationSafety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center. | Clinics (Sao Paulo, Brazil) |
| 2026-08-16 | PublicationCost-efficiency modeling of conversion to biosimilar rituximab-based R-CHOP in diffuse large B-cell lymphoma in medicare. | Journal of medical economics |
| 2026-08-16 | PublicationComparative efficacy of tarlatamab and second-line therapies in extensive-stage small cell lung cancer: A network meta-analysis. | Lung cancer (Amsterdam, Netherlands) |
| 2026-08-16 | PublicationLurbinectedin in the therapeutic landscape of SCLC: key clinical evidence and evolving role in the era of emerging therapies. | Critical reviews in oncology/hematology |
| 2026-08-16 | PublicationWIN-MTB-2024017 - WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers. | Oncotarget |
| 2026-08-16 | PublicationFolate receptor-α targeted therapies in ovarian cancer: recent advances and emerging therapeutic strategies. | International immunopharmacology |
| 2026-08-16 | PublicationImpact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. | Bone marrow transplantation |
| 2026-08-16 | PublicationDNA methyltransferase inhibitors in oncology: clinical progress, limitations and future directions. | Epigenomics |
| 2026-08-16 | PublicationDeep learning-based automated identification of papillary bladder cancer from endoscopic still images using SE-ResNeXt-50. | World journal of urology |
| 2026-08-16 | PublicationProspective efficacy of a novel dual-pronged strategy combining the probiotic Lactobacillus casei and Microalga Chlorella vulgaris in preventing postmenopausal bone loss in ovariectomized rats. | Archives of microbiology |
| 2026-08-16 | PublicationThe association between interleukin-6 inhibitors as treatment for COVID-19 and mental health problems in ICU survivors. | Journal of critical care |
| 2026-08-16 | PublicationThe Efficacy and Safety of Systemic Treatment for Managing Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-analysis. | Journal of voice : official journal of the Voice Foundation |
| 2026-08-16 | PublicationZopapogene Imadenovec-Drba for Recurrent Respiratory Papillomatosis. | The Annals of pharmacotherapy |
| 2026-08-16 | PublicationDifferential Cytokine Profiles in Prostate Cancer Under Treatment: Implications for Prognosis and Synergistic Therapy Design. | Cancers |
| 2026-08-16 | PublicationSafety Framework for Gastric Mucosal Ablation (GMA) Using Hybrid Argon Plasma Coagulation (hAPC): International Expert Consensus. | Obesity surgery |
| 2026-08-16 | PublicationEstimation of airborne contamination during therapeutic radioiodine-131(I-131) administration: A comparative study between capsule and solution forms. | Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine |
| 2026-08-16 | PublicationCardiotoxic Effects of Antibody Drug Conjugates vs Standard Chemotherapy in ERBB2-Positive Advanced Breast Cancer: A Systematic Review and Meta-Analysis. | JAMA network open |
| 2026-08-16 | PublicationTumor-associated neutrophils in lung adenocarcinoma: from mechanisms to therapeutic targeting. | Frontiers in immunology |
| 2026-08-16 | PublicationMaintenance Therapy in Acute Myeloid Leukemia: Current Perspectives and Future Directions. | Current oncology (Toronto, Ont.) |
| 2026-08-16 | PublicationSOHO State of the Art Updates and Next Questions | Beyond Romidepsin: Novel Therapeutic Targets and Emerging Strategies for Relapsed and Refractory Peripheral T-Cell Lymphoma. | Clinical lymphoma, myeloma & leukemia |
| 2026-08-16 | PublicationA phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer. | Gynecologic oncology |
| 2026-08-16 | PublicationPooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies. | Oncoimmunology |
| 2026-08-16 | PublicationClinical characteristics of ALK-positive NSCLC patients treated with sequential ALK-TKI therapies in a single-centre. | Lung cancer management |
| 2026-08-16 | PublicationSubharmonics are not an infallible safety metric for cavitation dynamics. | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group |
| 2026-08-16 | PublicationMetabolic Dysfunction After Initiation of Androgen Receptor Pathway Inhibitors in Prostate Cancer. | JAMA oncology |
| 2026-08-16 | PublicationProcess optimization of hot-melt extruded filaments for FDM 3D printing of personalized low-dose fludrocortisone acetate oral dosage forms. | International journal of pharmaceutics |
| 2026-08-16 | PublicationSteroidogenesis inhibitor opevesostat (MK-5684) for metastatic castration-resistant prostate cancer: OMAHA-003 and OMAHA-004 trial designs. | Future oncology (London, England) |
| 2026-08-16 | PublicationThe ATR inhibitor tuvusertib (M1774) sensitizes prostate carcinoma to natural killer cell-mediated cytotoxicity, which is further augmented by the IL-15 receptor superagonist N-803. | Cancer immunology, immunotherapy : CII |
| 2026-08-16 | PublicationQuantitative dynamic granzyme B PET imaging to characterize novel combination immunotherapy response in preclinical glioblastoma models. | Theranostics |
| 2026-08-16 | PublicationClinical and translational progress in oncolytic virotherapy for pediatric CNS tumors. | Journal of neuro-oncology |
| 2026-08-16 | PublicationA B7-H3-Targeted CD28 Bispecific Antibody Enhances the Activity of Anti-PD-1 and CD3 T-cell Engager Immunotherapies. | Molecular cancer therapeutics |
| 2026-08-16 | PublicationCurrent Evidence on Medical Therapy for Sporadic Vestibular Schwannoma: A Systematic Review and Meta-analysis. | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology |
| 2026-08-16 | PublicationIdentifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile. | The Journal of pathology |
| 2026-08-16 | PublicationImmuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patients. | Genes and immunity |
| 2026-08-16 | PublicationPhase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research |
| 2026-08-16 | PublicationTandem extracorporeal blood purification therapies for sepsis and acute kidney injury in critically ill children: a state-of-the-art review. | Renal failure |
| 2026-08-16 | PublicationSpike-in probe-enhanced single-cell RNA-seq reveals post-infusion transcriptomic remodeling of "prime-and-kill" synNotch-CAR-T cells. | bioRxiv : the preprint server for biology |
| 2026-08-16 | PublicationAdult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review). | Seminars in arthritis and rheumatism |
| 2026-08-16 | Publication[Testicular Germ Cell Tumors and Penile Cancer: Molecular-Based Diagnosis and Treatment]. | Aktuelle Urologie |
| 2026-08-16 | PublicationImmune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine. | Skin appendage disorders |
| 2026-08-16 | PublicationUpdate on the management of leptomeningeal disease in solid organ malignancy: Systemic, intrathecal and novel therapies. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia |
| 2026-08-16 | PublicationRole of radiotherapy in refractory/relapsed classical Hodgkin lymphoma in the era of targeted therapies and immunotherapy. | Clinical and translational radiation oncology |
| 2026-08-16 | PublicationPolitical determinants of melanoma: Global inequities in skin cancer care. | JAAD international |
| 2026-08-16 | PublicationHistotripsy for multifocal breast cancer liver metastases with early complete metabolic response: a case report. | Frontiers in oncology |
| 2026-08-16 | PublicationModified Delphi consensus on the use of cladribine tablets in relapsing-remitting multiple sclerosis in North-West Africa. | Multiple sclerosis and related disorders |
| 2026-08-16 | PublicationEfficacy and safety of Ruxolitinib-based combination therapy in the patients with Myelofibrosis (MF): a systematic review and meta-analysis. | Annals of medicine |
| 2026-08-16 | PublicationIsolated hyperthermic perfusions for cutaneous melanoma in-transit metastasis of the limb and uveal melanoma metastasis to the liver. | Clinical & experimental metastasis |
| 2026-08-16 | PublicationProlonged intratumoral treatment with TLR7/8 agonist R848 regulates the tumor immune microenvironment resulting in enhanced antitumor activity. | Cancer biology & therapy |
| 2026-08-16 | PublicationSialic acid -ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity. | Oncoimmunology |
| 2026-08-16 | PublicationAddition of pulsed electric field ablation to SBRT for lung tumors: effect on health-related quality of life. | Lung cancer management |
| 2026-08-16 | PublicationPreclinical evaluation of zirconium-89 labeled anti-Trop2 antibody-drug conjugate (Trodelvy) for imaging in gastric cancer and triple-negative breast cancer. | European journal of nuclear medicine and molecular imaging |
| 2026-08-16 | PublicationMyelodysplastic Syndromes: 2026 Update on Diagnosis, Risk-Stratification and Management. | American journal of hematology |
| 2026-08-16 | PublicationDeubiquitinases in lung cancer: Oncogenic mechanisms, metabolic reprogramming, immune evasion, and therapeutic targeting. | Pathology, research and practice |
| 2026-08-16 | PublicationComparative study for CT-guided I seed implantation assisted by modified and conventional 3D printing non-coplanar template in malignant tumors. | BMC medical imaging |
| 2026-08-16 | PublicationEmodin alleviates renal fibrosis by targeting the ALKBH1/mC axis to sustain TRPV4 expression and inhibit TGF-β1/Smad2/3 signaling. | Toxicology and applied pharmacology |
| 2026-08-16 | PublicationPoint/Counterpoint: Dordaviprone for diffuse midline glioma - A landmark approval or a premature step? | Neuro-oncology |
| 2026-08-16 | PublicationLocal delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. | Oncoimmunology |
| 2026-08-16 | PublicationBreakthrough drugs in the treatment of hypertension-related disease. | Hypertension research : official journal of the Japanese Society of Hypertension |
| 2026-08-16 | PublicationHypertension at an Inflection Point: Aggressive Targets Meet Novel Mechanisms for Cardiovascular Prevention. | Journal of the American College of Cardiology |
| 2026-08-16 | Publication[Central invasive neuromodulation for the treatment of chronic pain : Epidural motor cortex stimulation and deep brain stimulation]. | Schmerz (Berlin, Germany) |
| 2026-08-16 | PublicationFrontiers of cardiovascular polypills: From atherosclerosis and beyond. | Trends in cardiovascular medicine |
| 2026-08-16 | PublicationQuality of Diabetes Care Among Older Adults in Germany-Results of the Study on Health of Older People 2022/2023 Compared With Previous National Health Surveys. | Diabetes, obesity & metabolism |
| 2026-08-16 | PublicationProphylactic and therapeutic effects of EsV3 on atherosclerotic lesions in ApoE mice. | BMC cardiovascular disorders |
| 2026-08-16 | PublicationNavigating the diagnostic 'gray zone': prospective evaluation of an integrated MRI-Biomarker model for renal allograft triage. | Annals of medicine |
| 2026-08-16 | PublicationBiomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring. | Pharmacology & therapeutics |
| 2026-08-16 | PublicationBibliometric analysis of sacubitril/valsartan in the management of chronic kidney disease (2013-2025). | Renal failure |
| 2026-08-16 | PublicationRenal nerves in physiology, pathophysiology and interoception. | Nature reviews. Nephrology |
| 2026-08-16 | PublicationAspirin protects trophoblast function against hypoxia-induced oxidative stress through activation of NRF2 signaling in preeclampsia. | Reproductive biology |
| 2026-08-16 | PublicationCurrent research hotspots and difficulties of chronic prostatitis/chronic pelvic pain syndrome: neuroendocrine mechanism. | Annals of medicine |
| 2026-08-16 | PublicationCombination Pharmacotherapies for Obesity-Current Evidence and Future Directions. | Endocrinology, diabetes & metabolism |
| 2026-08-16 | PublicationShared pathophysiology and therapeutic repurposing in Alzheimer's disease and type 2 diabetes: a critical review of convergent mechanisms and clinical challenges. | Bioorganic chemistry |
| 2026-08-16 | PublicationSecondary prevention strategies for patients with lower extremity peripheral artery disease after successful peripheral vascular intervention. | American heart journal |
| 2026-08-16 | PublicationReal-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in Japan. | Neurology and therapy |
| 2026-08-16 | PublicationBridging fibrosis and function: an integrated mechanistic and therapeutic framework for Peyronie's disease and related erectile dysfunction. | Sexual medicine |
| 2026-08-16 | PublicationHistorical Perspectives of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies. | Cold Spring Harbor perspectives in medicine |
| 2026-08-16 | PublicationInsights into neuropathic pain: From disease models to therapeutic interventions. | Neuroscience and biobehavioral reviews |
| 2026-08-16 | PublicationTherapeutic Silencing of Tmprss6 Reduces Iron-Induced Inflammation and Prolongs Survival in MDS Mice. | American journal of hematology |
| 2026-08-16 | PublicationWater-Solubilized Curcuminoids Suppress Influenza A Virus Replication and Ameliorate Virus-Induced T-Cell Immune Dysfunction and Inflammatory Responses. | Microorganisms |
| 2026-08-16 | PublicationClinical and economic outcomes of cabazitaxel versus Lu-PSMA in mCRPC: a US perspective. | Journal of medical economics |
| 2026-08-16 | PublicationRedefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer. | Biochimica et biophysica acta. Reviews on cancer |
| 2026-08-16 | PublicationA case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report. | SAGE open medical case reports |
| 2026-08-16 | PublicationAmino acid supplementation enhances in vivo efficacy of lipid nanoparticle-mediated mRNA delivery in preclinical models. | Science translational medicine |
| 2026-08-16 | PublicationMerkel cell carcinoma: A clinically oriented mini-review for dermatologists. | Dermatology (Basel, Switzerland) |
| 2026-08-16 | PublicationReal-world efficacy and sequential therapy patterns after avelumab maintenance in metastatic urothelial carcinoma: a Brazilian multicenter retrospective cohort study. | Cancer treatment and research communications |
| 2026-08-16 | PublicationLIFUS-driven engineered bacteria reprogram immunosuppressive niches via mechano-NOTCH signaling. | Cell reports. Medicine |
| 2026-08-16 | PublicationEarly neutrophil infiltration promotes TRIMELVax-induced antitumor immunity by linking local inflammation to tumor control. | Oncoimmunology |
| 2026-08-16 | PublicationEx vivo-generated conventional dendritic cells type 1 and type 2 from blood progenitors induce potent antigen-specific T-cell immunity. | Oncoimmunology |
| 2026-08-16 | PublicationEnhancing cognitive processing therapy via stellate ganglion blocks: A pilot randomized trial. | Journal of traumatic stress |
| 2026-08-16 | PublicationRecent Developments in the Drug Treatment of Parkinson's Disease. | Drugs |
| 2026-08-16 | PublicationRadiation Dose during Transarterial Radioembolization: A Dosimetric Comparison of Cone-Beam CT and Angio-CT Technologies. | Journal of vascular and interventional radiology : JVIR |
| 2026-08-16 | PublicationNovel bispecific T-cell engagers overcoming acquired EGFR resistance. | mAbs |
| 2026-08-16 | PublicationA Novel IDO1/NE Dual Inhibitor, IMM-H018 Prevents the Primary and Secondary Sepsis and Ameliorates the Kidney Injury Through Inhibiting the Cytokine Storm and Microthrombosis, and Reversing Immunosuppression. | Advanced science (Weinheim, Baden-Wurttemberg, Germany) |
| 2026-08-16 | PublicationThe role of systemic inflammation in hepatic encephalopathy: advances in inflammatory mechanisms, prevention and treatment research. | Annals of medicine |
| 2026-08-16 | PublicationA phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease. | Parkinsonism & related disorders |
| 2026-08-16 | PublicationLiposome-mediated delivery of a ruthenium-based metallodrug to overcome cisplatin resistance in osteosarcoma. | Drug delivery |
| 2026-08-16 | PublicationA technology framework for distributed preoperative planning and medical training in deep brain stimulation. | Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society |
| 2026-08-16 | PublicationBackbone-Minimised Nanoplasmid DNA Systems Enable High-Titre AAV Production in Suspension HEK293 Platforms. | Pharmaceutics |
| 2026-08-16 | Publication[Practice of obstetric medicine in neurological disorders: towards evidence-based shared decision-making (SDM)]. | Rinsho shinkeigaku = Clinical neurology |
| 2026-08-16 | PublicationOnasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial. | The Lancet. Neurology |
| 2026-08-16 | PublicationRisdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study. | Neurology and therapy |
| 2026-08-16 | PublicationAssessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential. | CNS drugs |
| 2026-08-16 | PublicationCost-utility of implantable tibial neuromodulation (Revi) versus conservative therapy for urgency urinary incontinence in adults: a US payer perspective. | Journal of medical economics |
| 2026-08-16 | PublicationExtrapolating from trials to clinic: a predictive model defining the boundaries of benefit for multiple sclerosis therapies in real-world populations based on systematic review. | BMC medicine |
| 2026-08-16 | PublicationBridging the Pregnancy Knowledge Gap: A Real-World Analysis of Medication Use and Drug-Drug Interaction Risk in Crohn's Disease and Multiple Sclerosis. | Clinical and translational science |
| 2026-08-16 | PublicationB cell tolerance checkpoint function in multiple sclerosis and transient CD52 depletion. | Journal of neuroimmunology |
| 2026-08-16 | PublicationFunctional near-infrared spectroscopy: Systematic mapping of abnormal brain function features in neurological disorders. | Neural regeneration research |
| 2026-08-16 | PublicationActhar Gel versus standard of care for adults with proteinuria in nephrotic syndrome due to focal segmental glomerulosclerosis: cost-per-response analysis from the US healthcare perspective. | Journal of comparative effectiveness research |
| 2026-08-16 | PublicationEndocrine Modulation of Inflammation: The Role of Adrenocorticotropic Hormone and Cortisol. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists |
| 2026-08-16 | PublicationThe Potential Role of Mesenchymal Stem Cell Therapy for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Human Clinical Trials. | Stem cells and development |
| 2026-08-16 | PublicationA more optimistic outlook about disease-modifying therapies and depressive symptoms in multiple sclerosis: A cross-sectional analysis. | Journal of affective disorders |
| 2026-08-16 | PublicationCombined immunosuppressive therapy in systemic sclerosis-associated interstitial lung disease: Phenotypes matter. | Autoimmunity reviews |
| 2026-08-16 | PublicationUpdates of spinal muscular atrophy in advanced therapies. | Journal of the Formosan Medical Association = Taiwan yi zhi |
| 2026-08-16 | PublicationA Retrospective Study of 116 Multiple Sclerosis Patients with Dimethyl Fumarate Treatment in a Single Institution in Japan. | Internal medicine (Tokyo, Japan) |
| 2026-08-16 | PublicationElectronic Health Diary Campaigns to Complement Longitudinal Assessments in Persons With Multiple Sclerosis: Nested Observational Study. | JMIR mHealth and uHealth |
| 2026-08-16 | PublicationAppendicitis and multiple sclerosis disease-modifying therapies: a disproportionality analysis of the FDA adverse event reporting system. | Multiple sclerosis and related disorders |
| 2026-08-16 | PublicationReal-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study. | Therapeutic advances in neurological disorders |
| 2026-08-16 | PublicationComparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data. | Journal of neurology, neurosurgery, and psychiatry |
| 2026-08-16 | PublicationTransitioning from intravenous to subcutaneous ocrelizumab in a high-volume infusion center: A time-and-motion-informed capacity and service-flow analysis. | Multiple sclerosis and related disorders |
| 2026-08-16 | PublicationValue of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis. | Neurology |
| 2026-08-16 | PublicationRepurposing loratadine to reverse colistin resistance in through targeting lipid A modification. | Emerging microbes & infections |
| 2026-08-16 | PublicationHigher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMS. | Multiple sclerosis and related disorders |
| 2026-08-16 | PublicationOn-label persistence in psoriasis after switching to guselkumab, tumor necrosis factor inhibitors, interleukin-17 inhibitors, or apremilast from other advanced therapies. | The Journal of dermatological treatment |
| 2026-08-16 | PublicationDermatologic Adverse Events Associated with T-Cell Engager Therapy. | American journal of clinical dermatology |
| 2026-08-16 | PublicationA UHPLC-MS/MS method for the simultaneous quantification of BTK inhibitors and their active metabolite in human plasma and cerebrospinal fluid. | Bioanalysis |
| 2026-08-16 | PublicationEarly Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis. | Neurology and therapy |
| 2026-08-16 | PublicationAdvances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and access. | The Lancet. Microbe |
| 2026-08-16 | PublicationAdvances in tuberculosis treatment: novel regimens, new drug pipelines, host-directed therapies, and updated management guidelines. | The Lancet. Microbe |
| 2026-08-16 | PublicationImlunestrant Is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wild-Type and Mutant Breast Cancer. | Cancer research |
| 2026-08-16 | PublicationMacrophage autophagy in allergic diseases: Regulatory mechanisms, immune crosstalk, and therapeutic implications. | International immunopharmacology |
| 2026-08-16 | PublicationA systematic assessment of the short- and long-term effects of commonly used breast cancer chemotherapeutics on the gut microbiome‒blood‒brain axis of female mice. | Gut microbes |
| 2026-08-16 | PublicationCombined inhibition of complement C5 and neonatal Fc receptor in refractory generalized myasthenia gravis: A report of two cases. | Journal of neuroimmunology |
| 2026-08-16 | PublicationEffect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review. | The Annals of pharmacotherapy |
| 2026-08-16 | PublicationReal-World, Long-Term Outcomes with Cladribine Tablets Versus Other Oral Treatments Among Patients with Multiple Sclerosis. | Neurology and therapy |
| 2026-08-16 | PublicationBruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis. | Drugs |
| 2026-08-16 | PublicationTherapeutic potential of astrocyte transdifferentiated neurons. | Neural regeneration research |
| 2026-08-16 | PublicationFrom options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis. | Journal of medical economics |
| 2026-08-26 | Création de l’enregistrementNCT07281027 | Registre d’essai clinique |
| 2026-08-26 | Création de l’enregistrementNCT07787169 | Registre d’essai clinique |
| 2026-08-26 | Création de l’enregistrementNCT05417711 | Registre d’essai clinique |
| 2026-08-26 | Création de l’enregistrementNCT04561557 | Registre d’essai clinique |
| 2026-08-26 | Création de l’enregistrementNCT06065670 | Registre d’essai clinique |
| 2026-08-26 | Création de l’enregistrementNCT05338450 | Registre d’essai clinique |
| 2026-08-26 | Création de l’enregistrementNCT03109288 | Registre d’essai clinique |
| 2026-08-26 | Création de l’enregistrementNCT07788573 | Registre d’essai clinique |
| 2026-08-26 | Dernière mise à jour du registreNCT07753928 | Registre d’essai clinique |
| 2026-08-30 | Fin de l’étude prévue / enregistréeNCT07272070 | Registre d’essai clinique |
| 2026-09-01 | Fin de l’étude prévue / enregistréeNCT05201248 | Registre d’essai clinique |
| 2026-09-01 | Début de l’étudeNCT07679906 | Registre d’essai clinique |
| 2026-09-01 | Création de l’enregistrementNCT07272070 | Registre d’essai clinique |
| 2026-09-01 | Création de l’enregistrementNCT07628751 | Registre d’essai clinique |
| 2026-09-01 | Création de l’enregistrementNCT00923065 | Registre d’essai clinique |
| 2026-09-01 | Création de l’enregistrementNCT06800313 | Registre d’essai clinique |
| 2026-09-01 | Création de l’enregistrementNCT07054190 | Registre d’essai clinique |
| 2026-09-01 | Création de l’enregistrementNCT05597033 | Registre d’essai clinique |
| 2026-09-01 | Création de l’enregistrementNCT02433028 | Registre d’essai clinique |
| 2026-09-01 | Création de l’enregistrementNCT06526000 | Registre d’essai clinique |
| 2026-09-01 | Début de l’étudeNCT07787169 | Registre d’essai clinique |
| 2026-09-01 | Dernière mise à jour du registreNCT07787169 | Registre d’essai clinique |
| 2026-09-01 | Fin de l’étude prévue / enregistréeNCT05417711 | Registre d’essai clinique |
| 2026-09-01 | Dernière mise à jour du registreNCT03109288 | Registre d’essai clinique |
| 2026-09-01 | Début de l’étudeNCT07721857 | Registre d’essai clinique |
| 2026-09-01 | Fin de l’étude prévue / enregistréeNCT03500328 | Registre d’essai clinique |
| 2026-09-01 | Début de l’étudeNCT07763678 | Registre d’essai clinique |
| 2026-09-01 | Début de l’étudeNCT07762040 | Registre d’essai clinique |
| 2026-09-01 | Publication[Treatment options for drug-induced sialorrhea: Prescribing guidelines]. | L'Encephale |
| 2026-09-01 | PublicationRetrospective study on allogeneic hematopoietic stem cell transplantation for the treatment of Hemophagocytic lymphohistiocytosis. | Transplant immunology |
| 2026-09-01 | PublicationLiving Donor Liver Transplantation as Salvage Therapy for Steroid-Refractory Chronic Hepatic GVHD Following Allogeneic Hematopoietic Stem Cell Transplantation. | Pediatric transplantation |
| 2026-09-01 | PublicationMagnetic resonance imaging-guided ultrasound ablation for prostate cancer - A contemporary review of performance. | Frontiers in oncology |
| 2026-09-01 | PublicationMR Imaging-Guided Prostate Cancer Therapies. | Radiologic clinics of North America |
| 2026-09-02 | Fin de l’étude prévue / enregistréeNCT06701526 | Registre d’essai clinique |
| 2026-09-02 | Début de l’étudeNCT07721363 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT04244630 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT07072988 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT06079567 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT03199469 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT06959979 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT06727565 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT07679906 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT06445972 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT01174498 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT06865274 | Registre d’essai clinique |
| 2026-09-03 | Création de l’enregistrementNCT04863586 | Registre d’essai clinique |
| 2026-09-03 | Dernière mise à jour du registreNCT03500328 | Registre d’essai clinique |
| 2026-09-03 | PublicationLong-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series. | Cell reports. Medicine |
| 2026-09-03 | PublicationNarrative Review: Efficacy, Safety, and Tolerability of Newer Third-Generation Antiseizure Medications for Focal Epilepsy: A New Benchmark in Treatment Outcomes? | Neurology and therapy |
| 2026-09-03 | PublicationVagus nerve stimulation therapy for treatment-resistant PTSD. | Brain stimulation |
| 2026-09-11 | Création de l’enregistrementNCT05081609 | Registre d’essai clinique |
| 2026-09-11 | Création de l’enregistrementNCT05201248 | Registre d’essai clinique |
| 2026-09-11 | Création de l’enregistrementNCT06701526 | Registre d’essai clinique |
| 2026-09-11 | Création de l’enregistrementNCT04938427 | Registre d’essai clinique |
| 2026-09-11 | Création de l’enregistrementNCT03010826 | Registre d’essai clinique |
| 2026-09-11 | Création de l’enregistrementNCT04495556 | Registre d’essai clinique |
| 2026-09-11 | Dernière mise à jour du registreNCT06891118 | Registre d’essai clinique |
| 2026-09-11 | PublicationHyperosmolar therapies for neurological deterioration in mild and moderate traumatic brain injury: towards new research. | Brain injury |
| 2026-09-14 | Création de l’enregistrementNCT07792590 | Registre d’essai clinique |
| 2026-09-14 | Création de l’enregistrementNCT07207343 | Registre d’essai clinique |
| 2026-09-14 | Création de l’enregistrementNCT07038252 | Registre d’essai clinique |
| 2026-09-14 | Création de l’enregistrementNCT07167966 | Registre d’essai clinique |
| 2026-09-14 | Création de l’enregistrementNCT06957418 | Registre d’essai clinique |
| 2026-09-14 | Création de l’enregistrementNCT02438202 | Registre d’essai clinique |
| 2026-09-14 | Création de l’enregistrementNCT05065060 | Registre d’essai clinique |
| 2026-09-14 | Dernière mise à jour du registreNCT00001248 | Registre d’essai clinique |
| 2026-09-14 | PublicationFrom food to function: Nutraceutical-based modulation of mitochondrial, inflammatory and epigenetic networks in retinal neurodegeneration. | Ageing research reviews |
| 2026-09-14 | PublicationRecent advances in the management of pediatric neuropsychiatric lupus from conventional therapies to novel immunomodulators. | Lupus |
| 2026-09-14 | PublicationCerium molybdate-doped polyaniline nanoplatform for GSH-depletion-enhanced chemodynamic/NIR-II photothermal synergistic therapy via ferroptosis and immune activation. | Bioactive materials |
| 2026-09-14 | PublicationAn oral coral-like resveratrol nanocomplex protects against dry eye disease through ocular and systemic redox homeostasis. | Bioactive materials |
| 2026-09-14 | PublicationEvaluating pitolisant as a narcolepsy treatment option. | Expert opinion on pharmacotherapy |
| 2026-09-14 | PublicationFocused ultrasound-induced blood-brain barrier modulation for drug delivery in recurrent glioblastoma: A systematic review. | The Indian journal of medical research |
| 2026-09-14 | PublicationAntiseizure Medications in Development: Novel Mechanisms, Precision Therapy, and the Move Towards Disease Modification. | Current issues in molecular biology |
| 2026-09-14 | PublicationUnexpected mechanisms of repurposed drugs in the pathogenic pathways of neurodegenerative diseases. Discovering new neuroprotective therapies in cellular models. | Neuropharmacology |
| 2026-09-15 | Début de l’étudeNCT06065670 | Registre d’essai clinique |
| 2026-09-30 | Début de l’étudeNCT07690696 | Registre d’essai clinique |
| 2026-10-01 | Fin de l’étude prévue / enregistréeNCT03888924 | Registre d’essai clinique |
| 2026-11-01 | Fin de l’étude prévue / enregistréeNCT06290713 | Registre d’essai clinique |
| 2026-11-03 | Début de l’étudeNCT07167966 | Registre d’essai clinique |
| 2026-11-07 | Fin de l’étude prévue / enregistréeNCT07757568 | Registre d’essai clinique |
| 2026-12-01 | Début de l’étudeNCT02438202 | Registre d’essai clinique |
| 2026-12-01 | Fin de l’étude prévue / enregistréeNCT04244630 | Registre d’essai clinique |
| 2026-12-01 | Début de l’étudeNCT07281027 | Registre d’essai clinique |
| 2026-12-30 | Fin de l’étude prévue / enregistréeNCT07292090 | Registre d’essai clinique |
| 2026-12-31 | Fin de l’étude prévue / enregistréeNCT07207343 | Registre d’essai clinique |
| 2026-12-31 | Fin de l’étude prévue / enregistréeNCT04276857 | Registre d’essai clinique |
| 2026-12-31 | Fin de l’étude prévue / enregistréeNCT06692088 | Registre d’essai clinique |
| 2026-12-31 | Fin de l’étude prévue / enregistréeNCT05374824 | Registre d’essai clinique |
| 2027-01-01 | Fin de l’étude prévue / enregistréeNCT04495556 | Registre d’essai clinique |
| 2027-01-01 | Fin de l’étude prévue / enregistréeNCT03865420 | Registre d’essai clinique |
| 2027-02-01 | Fin de l’étude prévue / enregistréeNCT06451159 | Registre d’essai clinique |
| 2027-02-28 | Fin de l’étude prévue / enregistréeNCT06959979 | Registre d’essai clinique |
| 2027-02-28 | Fin de l’étude prévue / enregistréeNCT06865274 | Registre d’essai clinique |
| 2027-03-01 | Fin de l’étude prévue / enregistréeNCT06727565 | Registre d’essai clinique |
| 2027-04-01 | Fin de l’étude prévue / enregistréeNCT07499323 | Registre d’essai clinique |
| 2027-04-01 | Fin de l’étude prévue / enregistréeNCT07213440 | Registre d’essai clinique |
| 2027-04-30 | Fin de l’étude prévue / enregistréeNCT05406349 | Registre d’essai clinique |
| 2027-05-31 | Fin de l’étude prévue / enregistréeNCT04561557 | Registre d’essai clinique |
| 2027-06-01 | Fin de l’étude prévue / enregistréeNCT05359653 | Registre d’essai clinique |
| 2027-07-30 | Fin de l’étude prévue / enregistréeNCT03535298 | Registre d’essai clinique |
| 2027-09-28 | Fin de l’étude prévue / enregistréeNCT07054190 | Registre d’essai clinique |
| 2027-10-01 | Fin de l’étude prévue / enregistréeNCT07072988 | Registre d’essai clinique |
| 2027-10-31 | Fin de l’étude prévue / enregistréeNCT07052929 | Registre d’essai clinique |
| 2027-11-05 | Fin de l’étude prévue / enregistréeNCT06724562 | Registre d’essai clinique |
| 2027-12-01 | Fin de l’étude prévue / enregistréeNCT07763678 | Registre d’essai clinique |
| 2027-12-01 | Fin de l’étude prévue / enregistréeNCT03910738 | Registre d’essai clinique |
| 2027-12-26 | Fin de l’étude prévue / enregistréeNCT07038252 | Registre d’essai clinique |
| 2027-12-30 | Fin de l’étude prévue / enregistréeNCT07348783 | Registre d’essai clinique |
| 2028-01-01 | Fin de l’étude prévue / enregistréeNCT02438202 | Registre d’essai clinique |
| 2028-01-01 | Fin de l’étude prévue / enregistréeNCT07337395 | Registre d’essai clinique |
| 2028-01-30 | Fin de l’étude prévue / enregistréeNCT06864936 | Registre d’essai clinique |
| 2028-02-05 | Fin de l’étude prévue / enregistréeNCT07051525 | Registre d’essai clinique |
| 2028-03-01 | Fin de l’étude prévue / enregistréeNCT06079567 | Registre d’essai clinique |
| 2028-03-01 | Fin de l’étude prévue / enregistréeNCT07313800 | Registre d’essai clinique |
| 2028-03-30 | Fin de l’étude prévue / enregistréeNCT03816345 | Registre d’essai clinique |
| 2028-05-01 | Fin de l’étude prévue / enregistréeNCT07679906 | Registre d’essai clinique |
| 2028-07-01 | Fin de l’étude prévue / enregistréeNCT07787169 | Registre d’essai clinique |
| 2028-07-11 | Fin de l’étude prévue / enregistréeNCT06800313 | Registre d’essai clinique |
| 2028-08-14 | Fin de l’étude prévue / enregistréeNCT03600779 | Registre d’essai clinique |
| 2028-08-31 | Fin de l’étude prévue / enregistréeNCT07167966 | Registre d’essai clinique |
| 2028-08-31 | Fin de l’étude prévue / enregistréeNCT06957418 | Registre d’essai clinique |
| 2028-10-30 | Fin de l’étude prévue / enregistréeNCT06065670 | Registre d’essai clinique |
| 2028-10-31 | Fin de l’étude prévue / enregistréeNCT07721857 | Registre d’essai clinique |
| 2028-12-01 | Fin de l’étude prévue / enregistréeNCT05610852 | Registre d’essai clinique |
| 2028-12-01 | Fin de l’étude prévue / enregistréeNCT07710105 | Registre d’essai clinique |
| 2028-12-01 | Fin de l’étude prévue / enregistréeNCT07762040 | Registre d’essai clinique |
| 2028-12-31 | Fin de l’étude prévue / enregistréeNCT06586177 | Registre d’essai clinique |
| 2029-01-01 | Fin de l’étude prévue / enregistréeNCT03109288 | Registre d’essai clinique |
| 2029-01-30 | Fin de l’étude prévue / enregistréeNCT07521384 | Registre d’essai clinique |
| 2029-05-01 | Fin de l’étude prévue / enregistréeNCT07617441 | Registre d’essai clinique |
| 2029-08-01 | Fin de l’étude prévue / enregistréeNCT05081609 | Registre d’essai clinique |
| 2029-09-02 | Fin de l’étude prévue / enregistréeNCT07721363 | Registre d’essai clinique |
| 2029-09-29 | Fin de l’étude prévue / enregistréeNCT07690696 | Registre d’essai clinique |
| 2029-12-31 | Fin de l’étude prévue / enregistréeNCT07788573 | Registre d’essai clinique |
| 2030-03-31 | Fin de l’étude prévue / enregistréeNCT03199469 | Registre d’essai clinique |
| 2030-04-23 | Fin de l’étude prévue / enregistréeNCT07419295 | Registre d’essai clinique |
| 2030-04-30 | Fin de l’étude prévue / enregistréeNCT07664124 | Registre d’essai clinique |
| 2030-08-08 | Fin de l’étude prévue / enregistréeNCT06445972 | Registre d’essai clinique |
| 2030-09-30 | Fin de l’étude prévue / enregistréeNCT07281027 | Registre d’essai clinique |
| 2030-09-30 | Fin de l’étude prévue / enregistréeNCT04115267 | Registre d’essai clinique |
| 2030-09-30 | Fin de l’étude prévue / enregistréeNCT07206355 | Registre d’essai clinique |
| 2031-01-01 | Fin de l’étude prévue / enregistréeNCT06764914 | Registre d’essai clinique |
| 2031-02-28 | Fin de l’étude prévue / enregistréeNCT07792590 | Registre d’essai clinique |
| 2032-04-01 | Fin de l’étude prévue / enregistréeNCT07628751 | Registre d’essai clinique |
| 2032-07-06 | Fin de l’étude prévue / enregistréeNCT05658497 | Registre d’essai clinique |
| 2033-06-30 | Fin de l’étude prévue / enregistréeNCT07753928 | Registre d’essai clinique |
| 2036-03-31 | Fin de l’étude prévue / enregistréeNCT07233148 | Registre d’essai clinique |
| 2041-12-01 | Fin de l’étude prévue / enregistréeNCT05065060 | Registre d’essai clinique |
| 2042-01-01 | Fin de l’étude prévue / enregistréeNCT02433028 | Registre d’essai clinique |
Début phase actuelle
Non disponible dans les sources synchronisées
Essais cliniques liés
116 essai(s)
Début phase actuelle
Non disponible dans les sources synchronisées
| NCT | Titre | Phase | Statut administratif | Pays | Sponsor |
|---|---|---|---|---|---|
| NCT07792590 | Registry for Prostate Cancer Focal Therapy | À vérifier | RECRUITING | Hong Kong | The University of Hong Kong |
| NCT07207343 | Symptomatic Abdominal Tumors Are Unsuitable for Surgical Resection, High-intensity Focused Ultrasound (HIFU) Treatment Will be Applied to the Tumors. Postoperatively, Continuous Evaluation and Analysis of the Ablation Effect Will be Performed Using CT or MRI Imaging. | Non applicable | ACTIVE_NOT_RECRUITING | Taiwan | National Taiwan University Hospital |
| NCT07038252 | SPIN-VA — The Effect of Oral SPM Supplementation on INflammation-induced Vascular Ageing in Obese Hypertensive Patients | Non applicable | RECRUITING | France | Assistance Publique - Hôpitaux de Paris |
| NCT07167966 | ATP — Alzheimer's Tau Platform: Regimen A - AADvac1 | Phase 2 | ENROLLING_BY_INVITATION | United States | Paul S. Aisen |
| NCT06957418 | ATP — Alzheimer's Tau Platform: Master Protocol | Phase 2 | RECRUITING | United States | Paul S. Aisen |
| NCT02438202 | ECTAD — Electroconvulsive Therapy for Treatment of Alzheimer´s Disease | Non applicable | NOT_YET_RECRUITING | Non communiqué | Central Institute of Mental Health, Mannheim |
| NCT05065060 | Parkinson Progression Marker Initiative Online (PPMI Online) | À vérifier | RECRUITING | United States | Michael J. Fox Foundation for Parkinson's Research |
| NCT05081609 | IL Believe — A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies | Phase 1/2 | ACTIVE_NOT_RECRUITING | United States, Australia, Belgium, Canada, Italy, Poland, Singapore, South Korea, Spain, Taiwan | Ascendis Pharma Oncology Division A/S |
| NCT05201248 | A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma | Phase 1/2 | ACTIVE_NOT_RECRUITING | China | Genmab |
| NCT06701526 | A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications | Phase 4 | COMPLETED | United States | H. Lundbeck A/S |
| NCT04938427 | A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome | Phase 3 | COMPLETED | United States, Australia, Belgium, Canada, China, France, Germany, Greece, Hungary, Italy, Japan, Latvia, Netherlands, Poland, Russia, Serbia, Spain, Ukraine | Takeda |
| NCT03010826 | Pharmacological Recruitment of Endogenous Neural Precursors to Promote Pediatric White Matter Repair: Establishing Correlations Between Visual Outcomes, Saccadic Function and MEG Oscillations in Children With Demyelinating Disorders in Comparison to Healthy Control Children | À vérifier | COMPLETED | Canada | The Hospital for Sick Children |
| NCT04495556 | CAVS-MS — Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis | À vérifier | ACTIVE_NOT_RECRUITING | United States, Canada | The Cleveland Clinic |
| NCT04244630 | Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial | Phase 2 | ACTIVE_NOT_RECRUITING | United States | Dallas VA Medical Center |
| NCT07072988 | OPTIMAGE — Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod | Phase 4 | RECRUITING | France | Centre Hospitalier Universitaire de Nice |
| NCT06079567 | INSIGHT FSHD2 — An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression | Non applicable | RECRUITING | Belgium, France, Italy, Netherlands, Spain | Centre Hospitalier Universitaire de Nice |
| NCT03199469 | ASPIRO — A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM) | Phase 2/3 | ACTIVE_NOT_RECRUITING | United States, Canada, France, Germany | Astellas Gene Therapies |
| NCT06959979 | Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma | Phase 1 | RECRUITING | Italy | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| NCT06727565 | VELOCITY-HNSCC — Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01 | Phase 2 | ACTIVE_NOT_RECRUITING | United States, Australia, China, France, Italy, Malaysia, Spain, Taiwan, United Kingdom | Gilead Sciences |
| NCT07679906 | ALZEVIT: Nationwide Digital APOE ε4 Cohort for Early Alzheimer's Disease Prevention and Trial Readiness | À vérifier | RECRUITING | France | Firalis SA |
| NCT06445972 | Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06) | Phase 1/2 | RECRUITING | United States, Brazil, Chile, China, France, Germany, Italy, Norway, South Korea, Switzerland, Taiwan | Merck Sharp & Dohme LLC |
| NCT01174498 | Pilot Study of the Effect of Transcutaneous Stimulation of the Vagus Nerve on Pain Perception and Parameters of the Autonomic Nervous System | Non applicable | COMPLETED | Germany | cerbomed GmbH |
| NCT06865274 | PoGe — Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis. | Non applicable | RECRUITING | Italy | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| NCT04863586 | COVID-19 and Multiple Sclerosis Disease Modifying Therapies | À vérifier | UNKNOWN | United Kingdom | Nottingham University Hospitals NHS Trust |
| NCT07272070 | The Effect of Home-Based Walking on Symptoms and Health Profile of Hemodialysis Patients | Non applicable | ACTIVE_NOT_RECRUITING | Turkey (Türkiye) | Figen Akay |
| NCT07628751 | SOCRATES HCC — A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC | Non applicable | RECRUITING | Australia, Canada | University Health Network, Toronto |
| NCT00923065 | Data Collection, Clinical Care and Interventions in CCR, NCI | À vérifier | ENROLLING_BY_INVITATION | United States | National Cancer Institute (NCI) |
| NCT06800313 | Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer | Phase 1/2 | RECRUITING | United States, United Kingdom | Janssen Research & Development, LLC |
| NCT07054190 | A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer | Phase 2 | RECRUITING | United States, Argentina, Brazil, Canada, Germany, South Korea, Spain | Hoffmann-La Roche |
| NCT05597033 | Exercise and Vascular Function in Postmenopausal Females With Hypertension | Non applicable | COMPLETED | United States | Michigan State University |
| NCT02433028 | SMSC — Swiss Multiple Sclerosis Cohort-Study | À vérifier | RECRUITING | Switzerland | University Hospital, Basel, Switzerland |
| NCT06526000 | Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies | À vérifier | COMPLETED | United States | Novartis |
| NCT07281027 | COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" | Phase 3 | NOT_YET_RECRUITING | United States, Canada, France, Italy, South Korea, Sweden, United Kingdom | Yale University |
| NCT07787169 | A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease | Phase 1 | NOT_YET_RECRUITING | United States | Eli Lilly and Company |
| NCT05417711 | Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus | Non applicable | NOT_YET_RECRUITING | Non communiqué | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
| NCT04561557 | CARTinNS — Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System | Phase 1 | RECRUITING | China | Tongji Hospital |
| NCT06065670 | ReINFORCE — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy | Phase 1/2 | NOT_YET_RECRUITING | United States | University of California, San Francisco |
| NCT05338450 | RESTORE — Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis | Phase 3 | TERMINATED | Netherlands | Amsterdam UMC, location VUmc |
| NCT03109288 | Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS) | Phase 1/2 | RECRUITING | United States | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT07788573 | The Role of the FCRL5 Protein in the Pathophysiology of Multiple Sclerosis and Response to Treatment | À vérifier | NOT_YET_RECRUITING | Belgium | Université Catholique de Louvain |
| NCT07233148 | Healing ALS Registry Observational Study (HAROS) | À vérifier | RECRUITING | United States | Healing Advocates Registry and Ministry |
| NCT07499323 | Talquetamab in Patients With Refractory Generalized Myasthenia Gravis | Non applicable | NOT_YET_RECRUITING | Non communiqué | First Affiliated Hospital of Chongqing Medical University |
| NCT06861270 | CouDuMyo — Estimation of Non-Reimbursable Costs for Patients With Duchenne Muscular Dystrophy in France | À vérifier | COMPLETED | France | Assistance Publique - Hôpitaux de Paris |
| NCT07721857 | Neutrophil Extracellular Traps and Lupus Nephritis | À vérifier | NOT_YET_RECRUITING | Non communiqué | Assiut University |
| NCT07721363 | OBLUMEN — Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial | Phase 2 | NOT_YET_RECRUITING | France | Assistance Publique - Hôpitaux de Paris |
| NCT06155123 | HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs | À vérifier | UNKNOWN | Italy | IRCCS National Neurological Institute "C. Mondino" Foundation |
| NCT07487701 | Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study | Non applicable | COMPLETED | United States | Theranica |
| NCT06864936 | Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis | Non applicable | RECRUITING | United States | University of Maryland, Baltimore |
| NCT07743281 | A Study of Treatment Patterns and Annualized Relapse Rate in Multiple Sclerosis Patients Who Escalate Versus Continue Disease-Modifying Therapies Following Relapse | À vérifier | COMPLETED | United States | Novartis Pharmaceuticals |
| NCT05083481 | A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors | Phase 1 | TERMINATED | United States, China, France, Japan, Puerto Rico, Spain | Astellas Pharma Global Development, Inc. |
| NCT04115267 | Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies | À vérifier | RECRUITING | Canada | Centre hospitalier de l'Université de Montréal (CHUM) |
| NCT07419295 | TroFuse-031 — A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) | Phase 3 | RECRUITING | United States, Argentina, Australia, Belgium, Brazil, Canada, China, France, Greece, Israel, Italy, Japan, Netherlands, Spain, Sweden, United Kingdom | Merck Sharp & Dohme LLC |
| NCT04276857 | SMART — Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer | Non applicable | RECRUITING | Canada | University of Saskatchewan |
| NCT05363228 | The Effect of Tai Chi and Therapy by Dance and Movement on Blood Irisin Levels in Older Adults Over 65 Years of Age. | Non applicable | UNKNOWN | Czechia | Charles University, Czech Republic |
| NCT06586177 | REBELLION-MS — Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies | À vérifier | RECRUITING | Germany | Heinrich-Heine University, Duesseldorf |
| NCT07213440 | PremodiALS — Identification of Early Markers for ALS | Non applicable | RECRUITING | France | Institut National de la Santé Et de la Recherche Médicale, France |
| NCT05885139 | EXOCEP2GER — Exopulse Mollii Suit, Motor Functions & CP Children With Cerebral Palsy | Non applicable | COMPLETED | Germany | Exoneural Network AB |
| NCT06724562 | IL1 Inhibition in FOP | À vérifier | RECRUITING | United States | University of California, San Francisco |
| NCT00068003 | Harvesting Cells for Experimental Cancer Treatments | À vérifier | ENROLLING_BY_INVITATION | United States | National Cancer Institute (NCI) |
| NCT06692088 | "Longitudinal Analysis of Amylin Levels in Migraine Patients Undergoing an Anti- CGRP/CGRPr Treatment" | À vérifier | NOT_YET_RECRUITING | Non communiqué | Fundación Marques de Valdecilla |
| NCT06764914 | NAMIKOS — Integrative and Complementary Therapy for Episodic Migraine and Tension-type Headache | À vérifier | NOT_YET_RECRUITING | Non communiqué | Kliniken Essen-Mitte |
| NCT07690696 | Tear Biomarkers for Migraine | À vérifier | NOT_YET_RECRUITING | Non communiqué | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| NCT05406349 | Neural Mechanisms of Spatial Representations Beyond the Self | Non applicable | RECRUITING | United States | Boston University Charles River Campus |
| NCT01845883 | Perceptual Decision Making Under Conditions of Visual Uncertainty | Non applicable | WITHDRAWN | United States | University of California, Los Angeles |
| NCT03500328 | TREAT-MS — Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial | Non applicable | ACTIVE_NOT_RECRUITING | United States | Johns Hopkins University |
| NCT05833633 | Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations | À vérifier | COMPLETED | Italy | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| NCT07052929 | Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators | Phase 1/2 | RECRUITING | United States, Canada | Astellas Gene Therapies |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | Phase 1 | RECRUITING | United States, Canada | National Cancer Institute (NCI) |
| NCT05610852 | Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound | Non applicable | RECRUITING | United States | Case Comprehensive Cancer Center |
| NCT03621319 | BURN — Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique | Non applicable | TERMINATED | United States | Erbe Elektromedizin GmbH |
| NCT07206355 | Map HPB — In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers | À vérifier | RECRUITING | United Kingdom | University of Nottingham |
| NCT03220113 | Treatment of Chronic Migraine Headaches. | Phase 1 | UNKNOWN | United States | Corona Doctors Medical Clinics, Inc. |
| NCT00286078 | Treatment for Migraines With an Implantable Device | Non applicable | COMPLETED | United States | Boston Scientific Corporation |
| NCT00747812 | PRISM UK — Study of Occipital Nerve Stimulation for Drug Refractory Migraine | Phase 2 | TERMINATED | United Kingdom | Boston Scientific Corporation |
| NCT05046119 | Psychological and Biological Markers of Refractory Migraine | À vérifier | UNKNOWN | Italy | IRCCS National Neurological Institute "C. Mondino" Foundation |
| NCT04604977 | Be-Home-Kids — Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine | Non applicable | COMPLETED | Italy | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta |
| NCT07313800 | EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Embolization | Non applicable | NOT_YET_RECRUITING | United States | Cortex Neurovascular |
| NCT07617441 | SIGMA — The Neuroanatomical and Psychological Correlates of Suggestibility in Patients With Non-Responsive Chronic Migraine | À vérifier | RECRUITING | Italy | Istituto per la Ricerca e l'Innovazione Biomedica |
| NCT02090998 | Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines | Phase 4 | TERMINATED | United States | Rutgers, The State University of New Jersey |
| NCT07720895 | Does not exist — Default Mode Network Connectivity and Nocebo Responses in Migraine: A Functional MRI Study | Non applicable | COMPLETED | Greece | Ioanna Spanou |
| NCT07292090 | Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study | Non applicable | ACTIVE_NOT_RECRUITING | Sweden | Karolinska Institutet |
| NCT07763678 | Efficacy of Ultrasound-Guided Combined Greater Occipital Nerve Block and Greater Auricular Nerve Block Versus Greater Occipital Nerve Block Alone in the Management of Chronic Migraine | Phase 4 | NOT_YET_RECRUITING | Non communiqué | Assiut University |
| NCT05374824 | SOM-L — Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome | À vérifier | RECRUITING | United States | Ann & Robert H Lurie Children's Hospital of Chicago |
| NCT07283913 | Non-invasive Ultrasonic Auricular Vagus Nerve Stimulation | Non applicable | RECRUITING | United Kingdom | University of Nottingham |
| NCT00781872 | Mesenchymal Stem Cells for the Treatment of MS | Phase 1/2 | COMPLETED | Non communiqué | Hadassah Medical Organization |
| NCT07521384 | MuSE-INSIGHT — Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy | À vérifier | ENROLLING_BY_INVITATION | Mexico | Healing Hope International |
| NCT04294979 | RehaMS — Exercise Therapy in Multiple Sclerosis | Non applicable | COMPLETED | Italy | IRCCS San Raffaele Roma |
| NCT03910738 | TOTEM-RRMS — TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis | Phase 2 | RECRUITING | France | University Hospital, Strasbourg, France |
| NCT01465087 | Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples | Non applicable | COMPLETED | Israel | Carmel Medical Center |
| NCT05359653 | ReVIVE — Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy | Phase 1 | RECRUITING | United States | University of California, San Francisco |
| NCT07710105 | Ocrevus Zunovo for MS: Mixed Methods | À vérifier | RECRUITING | United States | Northwestern University |
| NCT03600779 | ihMTMS — Application of ihMT MRI in Multiple Sclerosis | Non applicable | RECRUITING | France | Assistance Publique Hopitaux De Marseille |
| NCT06451159 | A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis | Phase 1 | ACTIVE_NOT_RECRUITING | United States | Bruce Cree |
| NCT07753928 | PENTAGON — MS-Related Disability Worsening and Thalamic Volume Loss | À vérifier | ENROLLING_BY_INVITATION | Germany | Jung Diagnostics GmbH |
| NCT05658497 | Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate) | À vérifier | RECRUITING | United States, Australia, Germany, Ireland, Spain, Switzerland, United Kingdom | Biogen |
| NCT07757568 | Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity) | À vérifier | ACTIVE_NOT_RECRUITING | United States | University of Colorado, Denver |
| NCT07762040 | RRMS — Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple Sclerosis | À vérifier | NOT_YET_RECRUITING | Egypt | Assiut University |
| NCT00001248 | Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS) | À vérifier | RECRUITING | United States | National Institute of Neurological Disorders and Stroke (NINDS) |
| NCT07051525 | ELSA-Adult — Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever | NA | RECRUITING | Australia | Peter MacCallum Cancer Centre, Australia |
| NCT06891118 | SGB-RCM — Stellate Ganglion Blockade for Refractory Chronic Migraine | Non applicable | COMPLETED | Turkey (Türkiye) | Ankara City Hospital Bilkent |
| NCT07348783 | Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD | Non applicable | RECRUITING | Sweden | Karolinska Institutet |
| NCT07664124 | Acti-nRoll — Digital Monitoring of Upper Limb Function in Non-Ambulant DMD | Non applicable | NOT_YET_RECRUITING | Belgium | Centre Hospitalier Universitaire de Liege |
| NCT07164924 | FERTIMUS — Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility | À vérifier | COMPLETED | France, Martinique | University Hospital, Clermont-Ferrand |
| NCT03853746 | Short-term B-cell Depletion in Relapsing Multiple Sclerosis | Phase 4 | COMPLETED | United States | Johns Hopkins University |
| NCT03535298 | DELIVER-MS — Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS | Phase 4 | ACTIVE_NOT_RECRUITING | United States, United Kingdom | The Cleveland Clinic |
| NCT03865420 | Amyotrophic Lateral Sclerosis (ALS) Families Project | À vérifier | RECRUITING | United States | Columbia University |
| NCT01738386 | Living With Frontotemporal Dementia | À vérifier | TERMINATED | United States | National Human Genome Research Institute (NHGRI) |
| NCT05403788 | Usability Study of a Neuropsychological Intervention Program Based on Virtual Reality in Adults With Parkinson's Disease | NA | COMPLETED | Chile | Corporación de Rehabilitación Club de Leones Cruz del Sur |
| NCT07337395 | Proteomic Changes in Patients With Myasthenia Gravis and Ravulizumab | À vérifier | NOT_YET_RECRUITING | Italy | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| NCT04017481 | Non Invasive Neuromodulation for Patients With Motor Control Disorders | NA | COMPLETED | Non communiqué | Universidad Francisco de Vitoria |
| NCT03088839 | Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS) | À vérifier | UNKNOWN | Italy | Neuromed IRCCS |
| NCT02780492 | Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study | À vérifier | COMPLETED | France, Netherlands, United Kingdom | University College, London |
| NCT04833673 | The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial | NA | COMPLETED | Turkey (Türkiye) | Hacettepe University |
| NCT06290713 | Vasodilator and Exercise Study for DMD (VASO-REx) | Phase 2 | RECRUITING | United States | University of Florida |
| NCT02968966 | Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies | Phase 2 | WITHDRAWN | Germany | University Hospital Tuebingen |
| NCT03888924 | Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS) | Phase 2 | RECRUITING | Italy | S. Andrea Hospital |
Publications liées
480 publication(s)Publications liées
480 publication(s)| Titre | PMID | DOI | Journal | Date |
|---|---|---|---|---|
| From food to function: Nutraceutical-based modulation of mitochondrial, inflammatory and epigenetic networks in retinal neurodegeneration. Voir source | 42586246 | 10.1016/j.arr.2026.103288 | Ageing research reviews | |
| Recent advances in the management of pediatric neuropsychiatric lupus from conventional therapies to novel immunomodulators. Voir source | 42370576 | 10.1177/09612033261466741 | Lupus | |
| Cerium molybdate-doped polyaniline nanoplatform for GSH-depletion-enhanced chemodynamic/NIR-II photothermal synergistic therapy via ferroptosis and immune activation. Voir source | 42620967 | 10.1016/j.bioactmat.2026.06.035 | Bioactive materials | |
| An oral coral-like resveratrol nanocomplex protects against dry eye disease through ocular and systemic redox homeostasis. Voir source | 42733589 | 10.1016/j.bioactmat.2026.08.039 | Bioactive materials | |
| Evaluating pitolisant as a narcolepsy treatment option. Voir source | 32941089 | 10.1080/14656566.2020.1817387 | Expert opinion on pharmacotherapy | |
| Focused ultrasound-induced blood-brain barrier modulation for drug delivery in recurrent glioblastoma: A systematic review. Voir source | 42397830 | 10.25259/IJMR_2529_2025 | The Indian journal of medical research | |
| Antiseizure Medications in Development: Novel Mechanisms, Precision Therapy, and the Move Towards Disease Modification. Voir source | 42651828 | 10.3390/cimb48080830 | Current issues in molecular biology | |
| Unexpected mechanisms of repurposed drugs in the pathogenic pathways of neurodegenerative diseases. Discovering new neuroprotective therapies in cellular models. Voir source | 42061810 | 10.1016/j.neuropharm.2026.110994 | Neuropharmacology | |
| Hyperosmolar therapies for neurological deterioration in mild and moderate traumatic brain injury: towards new research. Voir source | 38468599 | 10.1080/02699052.2024.2328807 | Brain injury | |
| Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series. Voir source | 42628528 | 10.1016/j.xcrm.2026.103000 | Cell reports. Medicine | |
| Narrative Review: Efficacy, Safety, and Tolerability of Newer Third-Generation Antiseizure Medications for Focal Epilepsy: A New Benchmark in Treatment Outcomes? Voir source | 42675241 | 10.1007/s40120-026-01013-y | Neurology and therapy | |
| Vagus nerve stimulation therapy for treatment-resistant PTSD. Voir source | 40097094 | 10.1016/j.brs.2025.03.007 | Brain stimulation | |
| [Treatment options for drug-induced sialorrhea: Prescribing guidelines]. Voir source | 35989107 | 10.1016/j.encep.2022.03.013 | L'Encephale | |
| Retrospective study on allogeneic hematopoietic stem cell transplantation for the treatment of Hemophagocytic lymphohistiocytosis. Voir source | 42336251 | 10.1016/j.trim.2026.102414 | Transplant immunology | |
| Living Donor Liver Transplantation as Salvage Therapy for Steroid-Refractory Chronic Hepatic GVHD Following Allogeneic Hematopoietic Stem Cell Transplantation. Voir source | 42531434 | 10.1111/petr.70415 | Pediatric transplantation | |
| Magnetic resonance imaging-guided ultrasound ablation for prostate cancer - A contemporary review of performance. Voir source | 36686753 | 10.3389/fonc.2022.1069518 | Frontiers in oncology | |
| MR Imaging-Guided Prostate Cancer Therapies. Voir source | 37973238 | 10.1016/j.rcl.2023.06.012 | Radiologic clinics of North America | |
| Economic analysis of triptan therapy for acute migraine: a Medicaid perspective. Voir source | 17655509 | 10.1592/phco.27.8.1092 | Pharmacotherapy | |
| Novel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries. Voir source | 42595931 | 10.1007/s40272-026-00766-1 | Paediatric drugs | |
| Ozanimod and other sphingosine-1-phosphate receptor 1 modulators normalize neuropathic injury-enhanced inhibition of central lateral amygdala neurons expressing corticotropin-releasing hormone. Voir source | 41966521 | 10.1016/j.neuropharm.2026.110967 | Neuropharmacology | |
| Decoding the serotonin-alcohol crosstalk: the role of central serotonergic dysregulation in alcohol use disorder. Voir source | 42329577 | 10.1007/s43440-026-00860-8 | Pharmacological reports : PR | |
| Botulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions: a systematic review of clinical research. Voir source | 40035830 | 10.1007/s00702-024-02869-w | Journal of neural transmission (Vienna, Austria : 1996) | |
| Frequent antecedent nodules and diagnostic gaps in adrenocortical carcinoma. Voir source | 42582611 | 10.1210/jendso/bvag161 | Journal of the Endocrine Society | |
| Neuroimmune circuits in respiratory pathophysiology: decoding molecular crosstalk for precision therapeutic targeting. Voir source | 41601146 | 10.1080/07853890.2026.2620337 | Annals of medicine | |
| Nomogram prediction model for the clinical efficacy of flunarizine hydrochloride in patients with vertigo based on 5-HT and oxidative stress indicators. Voir source | 41980299 | 10.1016/j.clinsp.2026.100936 | Clinics (Sao Paulo, Brazil) | |
| A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial. Voir source | 42231857 | 10.1177/13872877261453911 | Journal of Alzheimer's disease : JAD | |
| [Migraine in men: biological, psychosocial and clinical characteristics]. Voir source | 41995752 | 10.1007/s00482-026-00935-8 | Schmerz (Berlin, Germany) | |
| Pharmaceutical policy and off-label prescribing in pregnancy: A population-based historical cohort study analyzing inequality in access to antiemetics within Australia's Pharmaceutical Benefits Scheme. Voir source | 42281148 | 10.1111/aogs.70283 | Acta obstetricia et gynecologica Scandinavica | |
| Exploring health professionals' perspectives and preferences in the treatment of post-stroke fatigue and mental health disorders: an Australian qualitative vignette-based study. Voir source | 42580363 | 10.1093/ijpp/riag111 | The International journal of pharmacy practice | |
| In silico characterisation of a novel SARS-CoV-2 envelope protein inhibitor and in vitro validation against murine coronavirus. Voir source | 42119203 | 10.1016/j.bioorg.2026.109949 | Bioorganic chemistry | |
| PACAP in Parkinson's disease: A multifunctional neuropeptide at the crossroad of autophagy, inflammation, and metabolic repurposing. Voir source | 42107921 | 10.1016/j.neuropharm.2026.111013 | Neuropharmacology | |
| Migraine relief: Solutions from natural bioactive products of Traditional Chinese medicine. Voir source | 42392550 | 10.1016/j.jep.2026.122155 | Journal of ethnopharmacology | |
| Real-world outcomes of zavegepant use in a tertiary care setting using the Migraine Treatment Optimization Questionnaire-5. Voir source | 42429361 | 10.1111/head.70163 | Headache | |
| An Emerging Autoimmune Neuroinflammatory Disease: Myelin Oligodendrocyte Glycoprotein Antibody Disease. Voir source | 40952817 | 10.4103/aam.aam_343_25 | Annals of African medicine | |
| Latent Patterns of Complementary and Integrative Health Therapy Utilization Among VHA Patients on Long-Term Opioid Therapy. Voir source | 42503189 | 10.1093/pm/pnag097 | Pain medicine (Malden, Mass.) | |
| L5-S1 basivertebral nerve ablation for chronic vertebrogenic low back pain following lumbar fusion: a case report. Voir source | 42582823 | 10.21037/jss-2026-0097 | Journal of spine surgery (Hong Kong) | |
| Efficacy of acupuncture therapies for polycystic ovary syndrome: a network meta-analysis. Voir source | 42591356 | 10.3389/fmed.2026.1895421 | Frontiers in medicine | |
| STS101 nasal powder as a new treatment option for acute migraine with or without aura in adults. Voir source | 42217235 | 10.1080/14737175.2026.2681528 | Expert review of neurotherapeutics | |
| Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention. Voir source | 38337150 | 10.1080/14728214.2024.2317778 | Expert opinion on emerging drugs | |
| The Botox Paradox: How Rising Drug Costs and Reimbursement Failures Threaten Access to Botulinum Toxin Therapy in Neurology. Voir source | 42500787 | 10.7759/cureus.111414 | Cureus | |
| Online interest in calcitonin gene-related peptide-therapies: An infodemiology study using Google trends. Voir source | 42265869 | 10.1111/head.70136 | Headache | |
| The pharmacology of gepants in migraine: A scoping review on mechanisms, clinical applications, and combination strategies. Voir source | 42265882 | 10.1111/head.70114 | Headache | |
| Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation. Voir source | 42529748 | 10.1016/j.obpill.2026.100296 | Obesity pillars | |
| Common Mechanisms in Migraine, Migraine-Related Neck Pain, and Low Back Pain: Implications for Treatment. Voir source | 42521953 | 10.1007/s40122-026-00871-6 | Pain and therapy | |
| Peer-delivered combined EMD and imagery rescripting for traumatized Chinese university students: a RCT. Voir source | 42411718 | 10.1080/20008066.2026.2686577 | European journal of psychotraumatology | |
| Vagus nerve stimulation in drug-resistant epilepsy: Surgical technique from a tertiary epilepsy center. Voir source | 42559289 | 10.25259/SNI_280_2026 | Surgical neurology international | |
| Practice trends and the outcome of neuromodulation therapies in epilepsy: A single-center study. Voir source | 31440731 | 10.1002/epi4.12345 | Epilepsia open | |
| Targeting the virus-host interface for the development of therapeutics against filoviruses. Voir source | 42001552 | 10.1016/j.coviro.2026.101537 | Current opinion in virology | |
| Progress of Immunotherapies in Parkinson's Disease. Voir source | 42227981 | 10.1002/cns.70964 | CNS neuroscience & therapeutics | |
| The conundrum of alpha-synuclein antibody failures in Parkinson's disease: a narrative review of mechanisms and alternative metabolic hypotheses. Voir source | 42459575 | 10.1177/17562864261465665 | Therapeutic advances in neurological disorders | |
| The Efficacy and Safety of Monoclonal Antibodies That Target Alpha-Synuclein in Parkinson's Disease: A Systematic Review. Voir source | 42495570 | 10.1155/padi/8540084 | Parkinson's disease | |
| Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial. Voir source | 42532080 | 10.1016/S0140-6736(26)01248-1 | Lancet (London, England) | |
| Ameliorating Seizures in Dravet Syndrome: A Review of Newly Approved and Investigational Drugs, RNA and Gene-Based Therapies. Voir source | 41712149 | 10.1007/s40263-026-01276-x | CNS drugs | |
| Application of kilohertz-frequency block to mitigate off-target motor effects of vagus nerve stimulation in swine. Voir source | 41469406 | 10.1038/s41467-025-67823-0 | Nature communications | |
| Beyond seizures: proceedings of the ERN EpiCARE working group 18 on developmental and epileptic encephalopathies. Voir source | 42161158 | 10.1016/j.yebeh.2026.111112 | Epilepsy & behavior : E&B | |
| Repurposing the antispasmodic drug pinaverium bromide as a novel antifungal agent and synergist against . Voir source | 42226574 | 10.1080/21505594.2026.2682573 | Virulence | |
| Vitamin D in synergy with triple therapy to eradicate Helicobacter pylori infection in mice via the c-Raf/MEK/ERK pathway. Voir source | 42033901 | 10.1016/j.tice.2026.103551 | Tissue & cell | |
| Potassium Channelopathies and Precision Medicine Approaches in Epilepsy: A Systematic Review of Personalized Treatment Strategies. Voir source | 42003125 | 10.2174/011570159X407197251204124232 | Current neuropharmacology | |
| KCNQ2 Channel as a Druggable Epilepsy Target: Advances in Pharmacological Modifiers. Voir source | 42220125 | 10.2174/0118715273455571260523060433 | CNS & neurological disorders drug targets | |
| TimeTeller for timing health: The potential of circadian medicine to improve performance, prevent disease and optimize treatment. Voir source | 37153516 | 10.3389/fdgth.2023.1157654 | Frontiers in digital health | |
| Potassium channel agonists emerging as treatment options for focal epilepsy: are we breaking new ground? Voir source | 42153277 | 10.1080/14728214.2026.2675274 | Expert opinion on emerging drugs | |
| Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development. Voir source | 42470359 | 10.1002/epi.70346 | Epilepsia | |
| Drug-loaded biomorphic scaffolds for tissue regeneration and targeted antitumor therapy in bone metastasis models. Voir source | 42385450 | 10.1016/j.bioadv.2026.215029 | Biomaterials advances | |
| Patient perspectives on hemolytic disease of the fetus and newborn and fetal and neonatal alloimmune thrombocytopenia: common experiences and insights. Voir source | 42580888 | 10.1080/14767058.2026.2713843 | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians | |
| SLC6A1-Related Neurodevelopmental Disorder: A Scoping Review of Clinical Features and Emerging Therapeutic Strategies. Voir source | 42173049 | 10.1016/j.pediatrneurol.2026.04.014 | Pediatric neurology | |
| Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease. Voir source | 41863079 | 10.1080/10717544.2026.2645830 | Drug delivery | |
| Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment. Voir source | 42138161 | 10.1080/09546634.2026.2666469 | The Journal of dermatological treatment | |
| Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Voir source | 41412141 | 10.1016/S1473-3099(25)00689-9 | The Lancet. Infectious diseases | |
| A Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Voir source | 40095398 | 10.1002/pds.70124 | Pharmacoepidemiology and drug safety | |
| Centromere protein I promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR-CDK2 cascade. Voir source | 42124320 | 10.1080/15384047.2026.2667596 | Cancer biology & therapy | |
| Sodium Phenylbutyrate and Taurursodiol: A New Therapeutic Option for the Treatment of Amyotrophic Lateral Sclerosis. Voir source | 37269231 | 10.1177/10600280231172802 | The Annals of pharmacotherapy | |
| Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review. Voir source | 42372569 | 10.1016/j.jneuroim.2026.579015 | Journal of neuroimmunology | |
| Neuro-renal syndrome (NRS) in autoimmune nodopathies and paranodopathies: A warning to consider the diagnosis when anti-node and paranode antibody tests are difficult to perform. Voir source | 42497634 | 10.1016/j.jns.2026.126104 | Journal of the neurological sciences | |
| Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. Voir source | 32558914 | 10.1001/jamanetworkopen.2020.8279 | JAMA network open | |
| Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026. Voir source | 42359165 | 10.1016/j.reth.2026.101150 | Regenerative therapy | |
| The role of cardiac PET imaging in cardiac amyloidosis. Voir source | 42218056 | 10.1053/j.semnuclmed.2026.05.007 | Seminars in nuclear medicine | |
| Geographic atrophy: From slowing lesions to preserving vision. Voir source | 42105376 | 10.1097/ICU.0000000000001224 | Current opinion in ophthalmology | |
| Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies. Voir source | 42275288 | 10.1080/16078454.2026.2682009 | Hematology (Amsterdam, Netherlands) | |
| Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria: implications for decision-making. Voir source | 41518611 | 10.1080/13696998.2025.2606575 | Journal of medical economics | |
| In vivo antimalarial activity and acute toxicity of organic and aqueous leaf, stem and root extracts of Ajuga integrifolia Buch.-Ham. ex D. Don. Voir source | 42526550 | 10.1016/j.jep.2026.122257 | Journal of ethnopharmacology | |
| Comparative efficacy of arthrocentesis, platelet-rich plasma (PRP), and conservative therapies for TMJ disorders: A systematic review and meta-analysis. Voir source | 42302358 | 10.1016/j.jcms.2026.104596 | Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery | |
| Efficacy and durability of therapies for neurogenic lower urinary tract dysfunction: A network meta-analysis of Botulinum Toxin a, instillations, and neuromodulation. Voir source | 42203154 | 10.1016/j.toxicon.2026.109165 | Toxicon : official journal of the International Society on Toxinology | |
| Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis. Voir source | 41860092 | 10.1080/07853890.2026.2619295 | Annals of medicine | |
| Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS). Voir source | 41876378 | 10.1080/13685538.2026.2647019 | The aging male : the official journal of the International Society for the Study of the Aging Male | |
| Host-state biomarkers and clinical factors for stratification and optimization of cell therapy trials in chronic limb-threatening ischemia: A review. Voir source | 42571258 | 10.1016/j.reth.2026.101162 | Regenerative therapy | |
| The contribution of the sphingosine 1-phosphate signaling pathway to chronic kidney diseases: recent findings and new perspectives. Voir source | 39384640 | 10.1007/s00424-024-03029-5 | Pflugers Archiv : European journal of physiology | |
| A Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal Hemoglobinuria. Voir source | 39499488 | 10.1007/s12325-024-03001-w | Advances in therapy | |
| Immune effector cell-associated hematotoxicity following CAR-T cell therapies: insights from a large national database. Voir source | 42381271 | 10.1093/jjco/hyag103 | Japanese journal of clinical oncology | |
| Nipocalimab and other FcRn blockers in neuromuscular disorders. Voir source | 42398839 | 10.1016/j.pharmthera.2026.109071 | Pharmacology & therapeutics | |
| Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch. Voir source | 33414517 | 10.1038/s41417-020-00284-3 | Cancer gene therapy | |
| Atypical Lymphocytosis Induced by T Cell-Engaging Therapy in Patients With Hematological Malignancies. Voir source | 41013982 | 10.1111/ijlh.70007 | International journal of laboratory hematology | |
| Anifrolumab versus Belimumab for Cardiovascular Disease Risk in Systemic Lupus Erythematosus. Voir source | 42565362 | 10.1002/art.70293 | Arthritis & rheumatology (Hoboken, N.J.) | |
| Therapeutic Approaches for Cutaneous Lupus Erythematosus: a Changing Landscape of Clinical Trials. Voir source | 41890817 | 10.2147/JIR.S547944 | Journal of inflammation research | |
| FDA-approved IMPDH inhibitors synergize with ribavirin to inhibit respiratory syncytial virus by interfering with purine synthesis. Voir source | 41770611 | 10.1080/22221751.2026.2640289 | Emerging microbes & infections | |
| Effectiveness of tacrolimus in patients with lupus nephritis: A randomized controlled trials meta-analysis. Voir source | 42057645 | 10.5414/CN111685 | Clinical nephrology | |
| CAR-engineered cell therapies: current understandings and future perspectives. Voir source | 41559435 | 10.1186/s43556-025-00401-4 | Molecular biomedicine | |
| Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma. Voir source | 41632924 | 10.1212/NXI.0000000000200530 | Neurology(R) neuroimmunology & neuroinflammation | |
| Lessons from Exceptional Responders with High-Grade Brain Tumors Treated with Precision Targeted Therapies. Voir source | 41868199 | 10.36401/JIPO-25-34 | Journal of immunotherapy and precision oncology | |
| Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center. Voir source | 42520483 | 10.1016/j.clinsp.2026.101040 | Clinics (Sao Paulo, Brazil) | |
| Cost-efficiency modeling of conversion to biosimilar rituximab-based R-CHOP in diffuse large B-cell lymphoma in medicare. Voir source | 41941177 | 10.1080/13696998.2026.2651055 | Journal of medical economics | |
| Comparative efficacy of tarlatamab and second-line therapies in extensive-stage small cell lung cancer: A network meta-analysis. Voir source | 42229339 | 10.1016/j.lungcan.2026.109465 | Lung cancer (Amsterdam, Netherlands) | |
| Lurbinectedin in the therapeutic landscape of SCLC: key clinical evidence and evolving role in the era of emerging therapies. Voir source | 42603642 | 10.1016/j.critrevonc.2026.105548 | Critical reviews in oncology/hematology | |
| WIN-MTB-2024017 - WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers. Voir source | 42478852 | 10.18632/oncotarget.28899 | Oncotarget | |
| Folate receptor-α targeted therapies in ovarian cancer: recent advances and emerging therapeutic strategies. Voir source | 42322854 | 10.1016/j.intimp.2026.117042 | International immunopharmacology | |
| Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Voir source | 42469396 | 10.1038/s41409-026-02991-1 | Bone marrow transplantation | |
| DNA methyltransferase inhibitors in oncology: clinical progress, limitations and future directions. Voir source | 41762718 | 10.1080/17501911.2026.2637418 | Epigenomics | |
| Deep learning-based automated identification of papillary bladder cancer from endoscopic still images using SE-ResNeXt-50. Voir source | 42599325 | 10.1007/s00345-026-06694-6 | World journal of urology | |
| Prospective efficacy of a novel dual-pronged strategy combining the probiotic Lactobacillus casei and Microalga Chlorella vulgaris in preventing postmenopausal bone loss in ovariectomized rats. Voir source | 42565847 | 10.1007/s00203-026-05103-1 | Archives of microbiology | |
| The association between interleukin-6 inhibitors as treatment for COVID-19 and mental health problems in ICU survivors. Voir source | 41962414 | 10.1016/j.jcrc.2026.155558 | Journal of critical care | |
| The Efficacy and Safety of Systemic Treatment for Managing Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-analysis. Voir source | 42103572 | 10.1016/j.jvoice.2026.03.028 | Journal of voice : official journal of the Voice Foundation | |
| Zopapogene Imadenovec-Drba for Recurrent Respiratory Papillomatosis. Voir source | 42438380 | 10.1177/10600280261463225 | The Annals of pharmacotherapy | |
| Differential Cytokine Profiles in Prostate Cancer Under Treatment: Implications for Prognosis and Synergistic Therapy Design. Voir source | 41899568 | 10.3390/cancers18060967 | Cancers | |
| Safety Framework for Gastric Mucosal Ablation (GMA) Using Hybrid Argon Plasma Coagulation (hAPC): International Expert Consensus. Voir source | 42142234 | 10.1007/s11695-026-08685-3 | Obesity surgery | |
| Estimation of airborne contamination during therapeutic radioiodine-131(I-131) administration: A comparative study between capsule and solution forms. Voir source | 42229209 | 10.1016/j.apradiso.2026.112704 | Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine | |
| Cardiotoxic Effects of Antibody Drug Conjugates vs Standard Chemotherapy in ERBB2-Positive Advanced Breast Cancer: A Systematic Review and Meta-Analysis. Voir source | 41206886 | 10.1001/jamanetworkopen.2025.40336 | JAMA network open | |
| Tumor-associated neutrophils in lung adenocarcinoma: from mechanisms to therapeutic targeting. Voir source | 42548795 | 10.3389/fimmu.2026.1892405 | Frontiers in immunology | |
| Maintenance Therapy in Acute Myeloid Leukemia: Current Perspectives and Future Directions. Voir source | 42346269 | 10.3390/curroncol33060369 | Current oncology (Toronto, Ont.) | |
| SOHO State of the Art Updates and Next Questions | Beyond Romidepsin: Novel Therapeutic Targets and Emerging Strategies for Relapsed and Refractory Peripheral T-Cell Lymphoma. Voir source | 42414110 | 10.1016/j.clml.2026.06.003 | Clinical lymphoma, myeloma & leukemia | |
| A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer. Voir source | 33390325 | 10.1016/j.ygyno.2020.12.025 | Gynecologic oncology | |
| Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies. Voir source | 42322272 | 10.1080/2162402X.2026.2671491 | Oncoimmunology | |
| Clinical characteristics of ALK-positive NSCLC patients treated with sequential ALK-TKI therapies in a single-centre. Voir source | 42505144 | 10.1080/17581966.2026.2707910 | Lung cancer management | |
| Subharmonics are not an infallible safety metric for cavitation dynamics. Voir source | 41638992 | 10.1080/02656736.2026.2620728 | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group | |
| Metabolic Dysfunction After Initiation of Androgen Receptor Pathway Inhibitors in Prostate Cancer. Voir source | 42593785 | 10.1001/jamaoncol.2026.2790 | JAMA oncology | |
| Process optimization of hot-melt extruded filaments for FDM 3D printing of personalized low-dose fludrocortisone acetate oral dosage forms. Voir source | 41966428 | 10.1016/j.ijpharm.2026.126865 | International journal of pharmaceutics | |
| Steroidogenesis inhibitor opevesostat (MK-5684) for metastatic castration-resistant prostate cancer: OMAHA-003 and OMAHA-004 trial designs. Voir source | 41732008 | 10.1080/14796694.2025.2595914 | Future oncology (London, England) | |
| The ATR inhibitor tuvusertib (M1774) sensitizes prostate carcinoma to natural killer cell-mediated cytotoxicity, which is further augmented by the IL-15 receptor superagonist N-803. Voir source | 41417226 | 10.1007/s00262-025-04260-4 | Cancer immunology, immunotherapy : CII | |
| Quantitative dynamic granzyme B PET imaging to characterize novel combination immunotherapy response in preclinical glioblastoma models. Voir source | 41510159 | 10.7150/thno.123588 | Theranostics | |
| Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors. Voir source | 41741902 | 10.1007/s11060-026-05480-z | Journal of neuro-oncology | |
| A B7-H3-Targeted CD28 Bispecific Antibody Enhances the Activity of Anti-PD-1 and CD3 T-cell Engager Immunotherapies. Voir source | 39301613 | 10.1158/1535-7163.MCT-24-0327 | Molecular cancer therapeutics | |
| Current Evidence on Medical Therapy for Sporadic Vestibular Schwannoma: A Systematic Review and Meta-analysis. Voir source | 41952108 | 10.1097/MAO.0000000000004904 | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology | |
| Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile. Voir source | 42138099 | 10.1002/path.70075 | The Journal of pathology | |
| Immuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patients. Voir source | 41795032 | 10.1038/s41435-026-00385-3 | Genes and immunity | |
| Phase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer. Voir source | 41779004 | 10.1158/1078-0432.CCR-25-3052 | Clinical cancer research : an official journal of the American Association for Cancer Research | |
| Tandem extracorporeal blood purification therapies for sepsis and acute kidney injury in critically ill children: a state-of-the-art review. Voir source | 41978481 | 10.1080/0886022X.2026.2653939 | Renal failure | |
| Spike-in probe-enhanced single-cell RNA-seq reveals post-infusion transcriptomic remodeling of "prime-and-kill" synNotch-CAR-T cells. Voir source | 41929125 | 10.64898/2026.03.26.713760 | bioRxiv : the preprint server for biology | |
| Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review). Voir source | 28757235 | 10.1016/j.semarthrit.2017.06.006 | Seminars in arthritis and rheumatism | |
| [Testicular Germ Cell Tumors and Penile Cancer: Molecular-Based Diagnosis and Treatment]. Voir source | 42532107 | 10.1055/a-2915-1570 | Aktuelle Urologie | |
| Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine. Voir source | 41409530 | 10.1159/000548883 | Skin appendage disorders | |
| Update on the management of leptomeningeal disease in solid organ malignancy: Systemic, intrathecal and novel therapies. Voir source | 42140114 | 10.1016/j.jocn.2026.112076 | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia | |
| Role of radiotherapy in refractory/relapsed classical Hodgkin lymphoma in the era of targeted therapies and immunotherapy. Voir source | 42388465 | 10.1016/j.ctro.2026.101221 | Clinical and translational radiation oncology | |
| Political determinants of melanoma: Global inequities in skin cancer care. Voir source | 42292071 | 10.1016/j.jdin.2026.05.006 | JAAD international | |
| Histotripsy for multifocal breast cancer liver metastases with early complete metabolic response: a case report. Voir source | 42022317 | 10.3389/fonc.2026.1782397 | Frontiers in oncology | |
| Modified Delphi consensus on the use of cladribine tablets in relapsing-remitting multiple sclerosis in North-West Africa. Voir source | 42501585 | 10.1016/j.msard.2026.107393 | Multiple sclerosis and related disorders | |
| Efficacy and safety of Ruxolitinib-based combination therapy in the patients with Myelofibrosis (MF): a systematic review and meta-analysis. Voir source | 41761659 | 10.1080/07853890.2026.2634532 | Annals of medicine | |
| Isolated hyperthermic perfusions for cutaneous melanoma in-transit metastasis of the limb and uveal melanoma metastasis to the liver. Voir source | 37843790 | 10.1007/s10585-023-10234-6 | Clinical & experimental metastasis | |
| Prolonged intratumoral treatment with TLR7/8 agonist R848 regulates the tumor immune microenvironment resulting in enhanced antitumor activity. Voir source | 42124329 | 10.1080/15384047.2026.2670801 | Cancer biology & therapy | |
| Sialic acid -ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity. Voir source | 41928453 | 10.1080/2162402X.2026.2649988 | Oncoimmunology | |
| Addition of pulsed electric field ablation to SBRT for lung tumors: effect on health-related quality of life. Voir source | 41783980 | 10.1080/17581966.2026.2635332 | Lung cancer management | |
| Preclinical evaluation of zirconium-89 labeled anti-Trop2 antibody-drug conjugate (Trodelvy) for imaging in gastric cancer and triple-negative breast cancer. Voir source | 39878898 | 10.1007/s00259-025-07106-4 | European journal of nuclear medicine and molecular imaging | |
| Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk-Stratification and Management. Voir source | 42400116 | 10.1002/ajh.70405 | American journal of hematology | |
| Deubiquitinases in lung cancer: Oncogenic mechanisms, metabolic reprogramming, immune evasion, and therapeutic targeting. Voir source | 42208358 | 10.1016/j.prp.2026.156565 | Pathology, research and practice | |
| Comparative study for CT-guided I seed implantation assisted by modified and conventional 3D printing non-coplanar template in malignant tumors. Voir source | 40731322 | 10.1186/s12880-025-01840-9 | BMC medical imaging | |
| Emodin alleviates renal fibrosis by targeting the ALKBH1/mC axis to sustain TRPV4 expression and inhibit TGF-β1/Smad2/3 signaling. Voir source | 42203179 | 10.1016/j.taap.2026.117889 | Toxicology and applied pharmacology | |
| Point/Counterpoint: Dordaviprone for diffuse midline glioma - A landmark approval or a premature step? Voir source | 42172613 | 10.1093/neuonc/noag117 | Neuro-oncology | |
| Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. Voir source | 42246474 | 10.1080/2162402X.2026.2682058 | Oncoimmunology | |
| Breakthrough drugs in the treatment of hypertension-related disease. Voir source | 42443375 | 10.1038/s41440-026-02725-2 | Hypertension research : official journal of the Japanese Society of Hypertension | |
| Hypertension at an Inflection Point: Aggressive Targets Meet Novel Mechanisms for Cardiovascular Prevention. Voir source | 42307497 | 10.1016/j.jacc.2026.05.005 | Journal of the American College of Cardiology | |
| [Central invasive neuromodulation for the treatment of chronic pain : Epidural motor cortex stimulation and deep brain stimulation]. Voir source | 42059911 | 10.1007/s00482-026-00942-9 | Schmerz (Berlin, Germany) | |
| Frontiers of cardiovascular polypills: From atherosclerosis and beyond. Voir source | 34973412 | 10.1016/j.tcm.2021.12.013 | Trends in cardiovascular medicine | |
| Quality of Diabetes Care Among Older Adults in Germany-Results of the Study on Health of Older People 2022/2023 Compared With Previous National Health Surveys. Voir source | 42581634 | 10.1111/dom.71184 | Diabetes, obesity & metabolism | |
| Prophylactic and therapeutic effects of EsV3 on atherosclerotic lesions in ApoE mice. Voir source | 39865227 | 10.1186/s12872-025-04497-y | BMC cardiovascular disorders | |
| Navigating the diagnostic 'gray zone': prospective evaluation of an integrated MRI-Biomarker model for renal allograft triage. Voir source | 42305025 | 10.1080/07853890.2026.2687212 | Annals of medicine | |
| Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring. Voir source | 42492739 | 10.1016/j.pharmthera.2026.109089 | Pharmacology & therapeutics | |
| Bibliometric analysis of sacubitril/valsartan in the management of chronic kidney disease (2013-2025). Voir source | 41943607 | 10.1080/0886022X.2026.2644751 | Renal failure | |
| Renal nerves in physiology, pathophysiology and interoception. Voir source | 39363020 | 10.1038/s41581-024-00893-3 | Nature reviews. Nephrology | |
| Aspirin protects trophoblast function against hypoxia-induced oxidative stress through activation of NRF2 signaling in preeclampsia. Voir source | 42241790 | 10.1016/j.repbio.2026.101239 | Reproductive biology | |
| Current research hotspots and difficulties of chronic prostatitis/chronic pelvic pain syndrome: neuroendocrine mechanism. Voir source | 41555741 | 10.1080/07853890.2026.2616886 | Annals of medicine | |
| Combination Pharmacotherapies for Obesity-Current Evidence and Future Directions. Voir source | 42581493 | 10.1002/edm2.70307 | Endocrinology, diabetes & metabolism | |
| Shared pathophysiology and therapeutic repurposing in Alzheimer's disease and type 2 diabetes: a critical review of convergent mechanisms and clinical challenges. Voir source | 42247872 | 10.1016/j.bioorg.2026.110044 | Bioorganic chemistry | |
| Secondary prevention strategies for patients with lower extremity peripheral artery disease after successful peripheral vascular intervention. Voir source | 42069036 | 10.1016/j.ahj.2026.107446 | American heart journal | |
| Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in Japan. Voir source | 42177382 | 10.1007/s40120-026-00966-4 | Neurology and therapy | |
| Bridging fibrosis and function: an integrated mechanistic and therapeutic framework for Peyronie's disease and related erectile dysfunction. Voir source | 42592245 | 10.1093/sexmed/qfag070 | Sexual medicine | |
| Historical Perspectives of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies. Voir source | 38858084 | 10.1101/cshperspect.a041642 | Cold Spring Harbor perspectives in medicine | |
| Insights into neuropathic pain: From disease models to therapeutic interventions. Voir source | 42498091 | 10.1016/j.neubiorev.2026.106878 | Neuroscience and biobehavioral reviews | |
| Therapeutic Silencing of Tmprss6 Reduces Iron-Induced Inflammation and Prolongs Survival in MDS Mice. Voir source | 42240074 | 10.1002/ajh.70391 | American journal of hematology | |
| Water-Solubilized Curcuminoids Suppress Influenza A Virus Replication and Ameliorate Virus-Induced T-Cell Immune Dysfunction and Inflammatory Responses. Voir source | 42197537 | 10.3390/microorganisms14051152 | Microorganisms | |
| Clinical and economic outcomes of cabazitaxel versus Lu-PSMA in mCRPC: a US perspective. Voir source | 42565339 | 10.1080/13696998.2026.2709297 | Journal of medical economics | |
| Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer. Voir source | 42379327 | 10.1016/j.bbcan.2026.189649 | Biochimica et biophysica acta. Reviews on cancer | |
| A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report. Voir source | 36968984 | 10.1177/2050313X231160926 | SAGE open medical case reports | |
| Amino acid supplementation enhances in vivo efficacy of lipid nanoparticle-mediated mRNA delivery in preclinical models. Voir source | 41811986 | 10.1126/scitranslmed.adx4097 | Science translational medicine | |
| Merkel cell carcinoma: A clinically oriented mini-review for dermatologists. Voir source | 42599837 | 10.1159/000552053 | Dermatology (Basel, Switzerland) | |
| Real-world efficacy and sequential therapy patterns after avelumab maintenance in metastatic urothelial carcinoma: a Brazilian multicenter retrospective cohort study. Voir source | 42603544 | 10.1016/j.ctarc.2026.101368 | Cancer treatment and research communications | |
| LIFUS-driven engineered bacteria reprogram immunosuppressive niches via mechano-NOTCH signaling. Voir source | 41806839 | 10.1016/j.xcrm.2026.102658 | Cell reports. Medicine | |
| Early neutrophil infiltration promotes TRIMELVax-induced antitumor immunity by linking local inflammation to tumor control. Voir source | 42345602 | 10.1080/2162402X.2026.2680766 | Oncoimmunology | |
| Ex vivo-generated conventional dendritic cells type 1 and type 2 from blood progenitors induce potent antigen-specific T-cell immunity. Voir source | 42381384 | 10.1080/2162402X.2026.2695692 | Oncoimmunology | |
| Enhancing cognitive processing therapy via stellate ganglion blocks: A pilot randomized trial. Voir source | 42600065 | 10.1002/jts.70116 | Journal of traumatic stress | |
| Recent Developments in the Drug Treatment of Parkinson's Disease. Voir source | 42162439 | 10.1007/s40265-026-02327-9 | Drugs | |
| Radiation Dose during Transarterial Radioembolization: A Dosimetric Comparison of Cone-Beam CT and Angio-CT Technologies. Voir source | 33358328 | 10.1016/j.jvir.2020.10.021 | Journal of vascular and interventional radiology : JVIR | |
| Novel bispecific T-cell engagers overcoming acquired EGFR resistance. Voir source | 42152476 | 10.1080/19420862.2026.2674236 | mAbs | |
| A Novel IDO1/NE Dual Inhibitor, IMM-H018 Prevents the Primary and Secondary Sepsis and Ameliorates the Kidney Injury Through Inhibiting the Cytokine Storm and Microthrombosis, and Reversing Immunosuppression. Voir source | 42474642 | 10.1002/advs.76504 | Advanced science (Weinheim, Baden-Wurttemberg, Germany) | |
| The role of systemic inflammation in hepatic encephalopathy: advances in inflammatory mechanisms, prevention and treatment research. Voir source | 41904644 | 10.1080/07853890.2026.2650232 | Annals of medicine | |
| A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease. Voir source | 30503748 | 10.1016/j.parkreldis.2018.11.015 | Parkinsonism & related disorders | |
| Liposome-mediated delivery of a ruthenium-based metallodrug to overcome cisplatin resistance in osteosarcoma. Voir source | 42116576 | 10.1080/10717544.2026.2671485 | Drug delivery | |
| A technology framework for distributed preoperative planning and medical training in deep brain stimulation. Voir source | 40157051 | 10.1016/j.compmedimag.2025.102533 | Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society | |
| Backbone-Minimised Nanoplasmid DNA Systems Enable High-Titre AAV Production in Suspension HEK293 Platforms. Voir source | 42514892 | 10.3390/pharmaceutics18070814 | Pharmaceutics | |
| [Practice of obstetric medicine in neurological disorders: towards evidence-based shared decision-making (SDM)]. Voir source | 42572290 | 10.5692/clinicalneurol.cn-002243 | Rinsho shinkeigaku = Clinical neurology | |
| Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial. Voir source | 34536405 | 10.1016/S1474-4422(21)00251-9 | The Lancet. Neurology | |
| Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study. Voir source | 36780114 | 10.1007/s40120-023-00444-1 | Neurology and therapy | |
| Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential. Voir source | 30267385 | 10.1007/s40263-018-0575-8 | CNS drugs | |
| Cost-utility of implantable tibial neuromodulation (Revi) versus conservative therapy for urgency urinary incontinence in adults: a US payer perspective. Voir source | 42012858 | 10.1080/13696998.2026.2655592 | Journal of medical economics | |
| Extrapolating from trials to clinic: a predictive model defining the boundaries of benefit for multiple sclerosis therapies in real-world populations based on systematic review. Voir source | 41514302 | 10.1186/s12916-025-04603-z | BMC medicine | |
| Bridging the Pregnancy Knowledge Gap: A Real-World Analysis of Medication Use and Drug-Drug Interaction Risk in Crohn's Disease and Multiple Sclerosis. Voir source | 42601338 | 10.1111/cts.70695 | Clinical and translational science | |
| B cell tolerance checkpoint function in multiple sclerosis and transient CD52 depletion. Voir source | 41505925 | 10.1016/j.jneuroim.2026.578854 | Journal of neuroimmunology | |
| Functional near-infrared spectroscopy: Systematic mapping of abnormal brain function features in neurological disorders. Voir source | 41495620 | 10.4103/NRR.NRR-D-25-00595 | Neural regeneration research | |
| Acthar Gel versus standard of care for adults with proteinuria in nephrotic syndrome due to focal segmental glomerulosclerosis: cost-per-response analysis from the US healthcare perspective. Voir source | 41603094 | 10.57264/cer-2025-0155 | Journal of comparative effectiveness research | |
| Endocrine Modulation of Inflammation: The Role of Adrenocorticotropic Hormone and Cortisol. Voir source | 41825639 | 10.1016/j.eprac.2026.03.001 | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists | |
| The Potential Role of Mesenchymal Stem Cell Therapy for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Human Clinical Trials. Voir source | 42596527 | 10.1177/15473287261475857 | Stem cells and development | |
| A more optimistic outlook about disease-modifying therapies and depressive symptoms in multiple sclerosis: A cross-sectional analysis. Voir source | 42217643 | 10.1016/j.jad.2026.122056 | Journal of affective disorders | |
| Combined immunosuppressive therapy in systemic sclerosis-associated interstitial lung disease: Phenotypes matter. Voir source | 42214802 | 10.1016/j.autrev.2026.104092 | Autoimmunity reviews | |
| Updates of spinal muscular atrophy in advanced therapies. Voir source | 41109767 | 10.1016/j.jfma.2025.10.018 | Journal of the Formosan Medical Association = Taiwan yi zhi | |
| A Retrospective Study of 116 Multiple Sclerosis Patients with Dimethyl Fumarate Treatment in a Single Institution in Japan. Voir source | 41297949 | 10.2169/internalmedicine.6217-25 | Internal medicine (Tokyo, Japan) | |
| Electronic Health Diary Campaigns to Complement Longitudinal Assessments in Persons With Multiple Sclerosis: Nested Observational Study. Voir source | 36197713 | 10.2196/38709 | JMIR mHealth and uHealth | |
| Appendicitis and multiple sclerosis disease-modifying therapies: a disproportionality analysis of the FDA adverse event reporting system. Voir source | 41785834 | 10.1016/j.msard.2026.107106 | Multiple sclerosis and related disorders | |
| Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study. Voir source | 42602134 | 10.1177/17562864261472650 | Therapeutic advances in neurological disorders | |
| Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data. Voir source | 42601218 | 10.1136/jnnp-2026-339059 | Journal of neurology, neurosurgery, and psychiatry | |
| Transitioning from intravenous to subcutaneous ocrelizumab in a high-volume infusion center: A time-and-motion-informed capacity and service-flow analysis. Voir source | 42259159 | 10.1016/j.msard.2026.107267 | Multiple sclerosis and related disorders | |
| Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis. Voir source | 42525900 | 10.1212/WNL.0000000000218379 | Neurology | |
| Repurposing loratadine to reverse colistin resistance in through targeting lipid A modification. Voir source | 41678146 | 10.1080/22221751.2026.2623697 | Emerging microbes & infections | |
| Higher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMS. Voir source | 31132664 | 10.1016/j.msard.2019.04.036 | Multiple sclerosis and related disorders | |
| On-label persistence in psoriasis after switching to guselkumab, tumor necrosis factor inhibitors, interleukin-17 inhibitors, or apremilast from other advanced therapies. Voir source | 41732098 | 10.1080/09546634.2026.2631903 | The Journal of dermatological treatment | |
| Dermatologic Adverse Events Associated with T-Cell Engager Therapy. Voir source | 42228307 | 10.1007/s40257-026-01041-2 | American journal of clinical dermatology | |
| A UHPLC-MS/MS method for the simultaneous quantification of BTK inhibitors and their active metabolite in human plasma and cerebrospinal fluid. Voir source | 42453028 | 10.1080/17576180.2026.2700356 | Bioanalysis | |
| Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis. Voir source | 42217095 | 10.1007/s40120-026-00951-x | Neurology and therapy | |
| Advances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and access. Voir source | 42526489 | 10.1016/j.lanmic.2026.101443 | The Lancet. Microbe | |
| Advances in tuberculosis treatment: novel regimens, new drug pipelines, host-directed therapies, and updated management guidelines. Voir source | 42526491 | 10.1016/j.lanmic.2026.101442 | The Lancet. Microbe | |
| Imlunestrant Is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wild-Type and Mutant Breast Cancer. Voir source | 39652577 | 10.1158/0008-5472.CAN-24-2608 | Cancer research | |
| Macrophage autophagy in allergic diseases: Regulatory mechanisms, immune crosstalk, and therapeutic implications. Voir source | 42407178 | 10.1016/j.intimp.2026.117112 | International immunopharmacology | |
| A systematic assessment of the short- and long-term effects of commonly used breast cancer chemotherapeutics on the gut microbiome‒blood‒brain axis of female mice. Voir source | 41964565 | 10.1080/19490976.2026.2655149 | Gut microbes | |
| Combined inhibition of complement C5 and neonatal Fc receptor in refractory generalized myasthenia gravis: A report of two cases. Voir source | 42030590 | 10.1016/j.jneuroim.2026.578944 | Journal of neuroimmunology | |
| Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review. Voir source | 41482809 | 10.1177/10600280251407146 | The Annals of pharmacotherapy | |
| Real-World, Long-Term Outcomes with Cladribine Tablets Versus Other Oral Treatments Among Patients with Multiple Sclerosis. Voir source | 42321508 | 10.1007/s40120-026-00968-2 | Neurology and therapy | |
| Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis. Voir source | 42126690 | 10.1007/s40265-026-02324-y | Drugs | |
| Therapeutic potential of astrocyte transdifferentiated neurons. Voir source | 41467429 | 10.4103/NRR.NRR-D-25-00554 | Neural regeneration research | |
| From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis. Voir source | 42339705 | 10.1080/13696998.2026.2688699 | Journal of medical economics | |
| Repurposing monepantel in oncology: A conceptual mini-review of proposed mechanisms. Voir source | 42176570 | 10.1016/j.biopha.2026.119528 | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | |
| MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model. Voir source | 33468250 | 10.1186/s13287-021-02143-w | Stem cell research & therapy | |
| Lessons from a systematic review of family-based studies in ALS. Voir source | 42584174 | 10.1080/21678421.2026.2713969 | Amyotrophic lateral sclerosis & frontotemporal degeneration | |
| In vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging. Voir source | 42576606 | 10.7554/eLife.107661 | eLife | |
| Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial. Voir source | 42508294 | 10.1016/j.neurot.2026.e00953 | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | |
| Targeting TDP-43 in sporadic amyotrophic lateral sclerosis. Voir source | 42541567 | 10.1007/s00415-026-14023-5 | Journal of neurology | |
| Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study. Voir source | 41379803 | 10.1371/journal.pone.0331163 | PloS one | |
| Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and functional capacity. Voir source | 41544176 | 10.1177/22143602251410443 | Journal of neuromuscular diseases | |
| Cell-Based Therapies for Post-Traumatic Ankle Osteoarthritis and Osteochondral Lesions of the Talus: A Systematic Scoping Review of an Emerging and Heterogeneous Evidence Base. Voir source | 42510508 | 10.3390/bioengineering13070843 | Bioengineering (Basel, Switzerland) | |
| Swallowing therapy for dysphagia in acute and subacute stroke. Voir source | 42573047 | 10.1002/14651858.CD000323.pub4 | The Cochrane database of systematic reviews | |
| Clinical Practice Recommendations for Non-Dermatologists on the Diagnostic Suspicion of GPP. Voir source | 42590188 | 10.3390/jcm15156087 | Journal of clinical medicine | |
| SGLT2 Inhibitors and Outcomes in Elderly Patients With Chronic Kidney Disease: A Narrative Review. Voir source | 42587349 | 10.1111/dom.71174 | Diabetes, obesity & metabolism | |
| AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects. Voir source | 40817386 | 10.1038/s41434-025-00561-6 | Gene therapy | |
| An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1. Voir source | 41707138 | 10.1056/NEJMoa2407326 | The New England journal of medicine | |
| Subconjunctival Injection of Mesenchymal Stem Cells for Corneal Wound Healing After Chemical Injury: Impact on Epithelial Coverage, Limbal Ischemia, and Ocular Surface Inflammatory. Voir source | 42454124 | 10.3389/fmed.2026.1849667 | Frontiers in medicine | |
| Bone marrow mesenchymal stem cell exosomes in osteonecrosis: pathological mechanisms and therapeutic strategies. Voir source | 42550377 | 10.1007/s11033-026-12513-3 | Molecular biology reports | |
| Development of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHD. Voir source | 41994867 | 10.1093/nar/gkag301 | Nucleic acids research | |
| Integrative bioinformatics and molecular simulations identify HMGB3 as a key immune modulator in triple negative breast cancer. Voir source | 42056342 | 10.1007/s12672-026-05032-x | Discover oncology | |
| Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial. Voir source | 42260100 | 10.1038/s41591-026-04440-4 | Nature medicine | |
| Comprehensive review of adverse reactions and toxicology in ASO-based therapies for Duchenne Muscular Dystrophy: From FDA-approved drugs to peptide-conjugated ASO. Voir source | 38983605 | 10.1016/j.crtox.2024.100182 | Current research in toxicology | |
| Gene therapy in Duchenne muscular dystrophy. Voir source | 41391912 | 10.1016/S0929-693X(25)00254-4 | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie | |
| Comparative effects of low-level laser acupuncture and dry needling on clinical and functional outcomes in patients with chronic cervical myofascial pain syndrome: a randomized controlled trial. Voir source | 42430011 | 10.1007/s10103-026-04915-3 | Lasers in medical science | |
| Cardiac Myosin Activators in Heart Failure: Experimental Advances Amid Clinical Uncertainty. Voir source | 41858918 | 10.2147/DDDT.S568587 | Drug design, development and therapy | |
| Spending on Targeted Therapies for Duchenne Muscular Dystrophy. Voir source | 38466271 | 10.1001/jama.2024.2776 | JAMA | |
| Auricular Vagus Nerve Stimulation in Inflammatory Bowel Disease: Mechanistic Insights and Biomarker-Based Evaluation of Therapeutic Response. Voir source | 42589612 | 10.3390/ijms27156958 | International journal of molecular sciences | |
| Toward an Integrated Strategy for Volumetric Muscle Loss Regeneration. Voir source | 42590005 | 10.3390/jcm15155901 | Journal of clinical medicine | |
| Recalibrating Therapeutic Priorities for Duchenne Muscular Dystrophy: A Critical Synthesis of Approved and Emerging Strategies Through the Lens of an Underrepresented Population. Voir source | 42510866 | 10.3390/genes17070826 | Genes | |
| Stepping it Up on Temporary Mechanical Circulatory Support - Mobilization and Prehabilitation of patients in ICU. Voir source | 42521141 | 10.1016/j.cardfail.2026.07.017 | Journal of cardiac failure | |
| Intrathecal Baclofen Pump Therapy for Medically Refractory Stiff Person Syndrome: A Multicenter Case Series. Voir source | 42578902 | 10.1016/j.neurom.2026.05.018 | Neuromodulation : journal of the International Neuromodulation Society | |
| Mosunetuzumab: A bispecific CD20 × CD3 antibody for follicular lymphoma with promising evidence in other B-NHL subtypes. Voir source | 42532836 | 10.1080/21645515.2026.2712177 | Human vaccines & immunotherapeutics | |
| T-cell engaging antibodies for B-cell lymphomas. Voir source | 41539896 | 10.1053/j.seminhematol.2025.12.002 | Seminars in hematology | |
| Comparative effectiveness and safety of biologics and targeted small-molecule therapies plus stable background therapy in systemic lupus erythematosus: a systematic review and network meta-analysis. Voir source | 42170175 | 10.3389/fimmu.2026.1739946 | Frontiers in immunology | |
| Targeting the Roots of Kidney Disease: Systematic Review of the Therapies Targeting the Complement System. Voir source | 40731834 | 10.3390/medicina61071205 | Medicina (Kaunas, Lithuania) | |
| New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases. Voir source | 42165056 | 10.1016/j.xkme.2025.101133 | Kidney medicine | |
| Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis. Voir source | 42579028 | 10.1007/s10147-026-03116-w | International journal of clinical oncology | |
| Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Voir source | 42469475 | 10.1038/s41375-026-03045-7 | Leukemia | |
| Obecabtagene Autoleucel in Relapsed/Refractory B-ALL: A Critical Review of Clinical Efficacy and Safety. Voir source | 42572849 | 10.1177/10600280261470829 | The Annals of pharmacotherapy | |
| Lupus nephritis randomised controlled trials: evidence gaps and under-represented groups. Voir source | 39706676 | 10.1136/lupus-2024-001331 | Lupus science & medicine | |
| Systematic Review and Network Meta-Analysis of Initial Treatments for Lupus Nephritis. Voir source | 40980661 | 10.1016/j.ekir.2025.06.047 | Kidney international reports | |
| Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus. Voir source | 37148249 | 10.1080/13543784.2023.2212154 | Expert opinion on investigational drugs | |
| Early use of low dose rituximab in anti acetylcholine receptor generalized myasthenia gravis in South Wales - A retrospective study. Voir source | 42419026 | 10.1016/j.jns.2026.126087 | Journal of the neurological sciences | |
| Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma. Voir source | 42329247 | 10.46883/2026.25921166 | Oncology (Williston Park, N.Y.) | |
| Neuroimmunological overlap syndromes in optic neuritis, myelitis, and connective tissue diseases. Voir source | 42558877 | 10.3389/fneur.2026.1887536 | Frontiers in neurology | |
| Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis. Voir source | 42557215 | 10.1177/09612033261474940 | Lupus | |
| Odronextamab: a bispecific antibody for follicular lymphoma. Voir source | 42287116 | 10.1080/13543784.2026.2689652 | Expert opinion on investigational drugs | |
| CD20 × CD3 Bispecific Antibodies in B-Cell Non-Hodgkin Lymphomas: Current Evidence, Therapeutic Integration, and Future Directions. Voir source | 42356069 | 10.3390/medicina62061056 | Medicina (Kaunas, Lithuania) | |
| Update to the Sociedad Española de Reumatología Guidelines on the Use of Biological Therapy in Systemic Lupus Erythematosus. Voir source | 42552165 | 10.1016/j.reumae.2026.502201 | Reumatologia clinica | |
| Advances in the treatment of systemic lupus erythematosus: Biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic. Voir source | 42554215 | 10.1111/joim.70146 | Journal of internal medicine | |
| Genetic basis of immune-mediated necrotizing myopathy: A genomic structural equation modeling and AI-driven structural analysis. Voir source | 41775122 | 10.1016/j.compbiolchem.2026.108982 | Computational biology and chemistry | |
| Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma. Voir source | 42341926 | 10.1016/j.jtct.2026.06.035 | Transplantation and cellular therapy | |
| Efficacy and safety of emerging immunomodulatory agents versus standard therapies in refractory cutaneous lupus: A systematic review. Voir source | 42522483 | 10.25251/52gar039 | Dermatology online journal | |
| Voclosporin for the treatment of lupus nephritis flares in patients with inadequate response to mycophenolate mofetil and belimumab: a case series. Voir source | 42584031 | 10.1093/joneph/aajag126 | Journal of nephrology | |
| Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve. Voir source | 42584071 | 10.1093/rheumatology/keag413 | Rheumatology (Oxford, England) | |
| Scleroderma Renal Crisis in Mixed Connective Tissue Disease. Voir source | 42562041 | 10.1016/j.amjmed.2026.07.029 | The American journal of medicine | |
| Anti-CD38/Anti-CD20 Rescue Therapy for Posttransplant Recurrent FSGS. Voir source | 42571438 | 10.1016/j.ekir.2026.106668 | Kidney international reports | |
| Engineering T cells in vivo to express a synthetic cytokine receptor enables preferential expansion and enrichment of anti-CD22 CAR T cells. Voir source | 42576385 | 10.1016/j.ymthe.2026.08.003 | Molecular therapy : the journal of the American Society of Gene Therapy | |
| Radiation Therapy for Pancreatic Cancer: An ASTRO Clinical Practice Guideline. Voir source | 42580553 | 10.1016/j.prro.2026.07.002 | Practical radiation oncology | |
| Metformin Attenuates Sepsis-Induced Cardiomyopathy via Inhibition of Reverse Electron Transfer at Mitochondrial Complex I. Voir source | 42589134 | 10.3390/biology15151267 | Biology | |
| Delivery of Mitoxantrone by Biodegradable Cobalt-Doped Hollow Prussian Blue Nanoparticles for Synergetic Photothermal Amplified Chemodynamic Therapy/Chemotherapy/Metalloimmunotherapy Against Tumor. Voir source | 42591056 | 10.1002/smll.75225 | Small (Weinheim an der Bergstrasse, Germany) | |
| Intravaginal Formulation Strategies for Vaginal Disorders: Optimizing Phytochemical and Biological Preparations-A Review. Voir source | 42588524 | 10.3390/molecules31152676 | Molecules (Basel, Switzerland) | |
| Papilledema is not the point: intracranial pressure dysregulation as a common pathway in migraine and idiopathic intracranial hypertension. Voir source | 42582597 | 10.1093/braincomms/fcag259 | Brain communications | |
| Painful neuromas exhibit axonal phenotypic shift via nociceptive and mechanosensitive marker up-regulation. Voir source | 42582843 | 10.1093/pnasnexus/pgag257 | PNAS nexus | |
| Digestive Hormones and Their Impact on Bariatric and Pharmacologic Weight-Loss Therapies. Voir source | 42584007 | 10.1210/endrev/bnag032 | Endocrine reviews | |
| Beyond GLP-1: Amylin-Based Pharmacotherapy and the Search for Better-Tolerated Weight-Loss Drugs. Voir source | 42586227 | 10.1016/j.phrs.2026.108382 | Pharmacological research | |
| Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study. Voir source | 42586099 | 10.1016/S1474-4422(26)00216-4 | The Lancet. Neurology | |
| Acute Pain Management in Children: A Systematic Review and GRADE-Based Recommendations. Voir source | 42589904 | 10.3390/jcm15155802 | Journal of clinical medicine | |
| Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization. Voir source | 42576130 | 10.1007/s11357-026-02467-6 | GeroScience | |
| Molecular mechanisms of exercise-induced neuroprotection against Parkinson's disease. Voir source | 41646181 | 10.1016/j.smhs.2025.05.004 | Sports medicine and health science | |
| Smell and the sinuses. Voir source | 42219147 | 10.1016/j.anai.2026.05.036 | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | |
| Orthobiologic injections for hip osteoarthritis: A systematic review of clinical outcomes. Voir source | 41450485 | 10.52965/001c.151461 | Orthopedic reviews | |
| The Role of Nitric Oxide in Chronic Liver Disease: A Review. Voir source | 42559000 | 10.14218/JCTH.2026.00173 | Journal of clinical and translational hepatology | |
| Resveratrol Modulates Phosphatidylcholine Metabolism-Related Enzymes and Enhances Chemosensitivity in Colorectal Cancer Models. Voir source | 42589348 | 10.3390/ijms27156691 | International journal of molecular sciences | |
| Antidepressant medications have differential effects on REM sleep without atonia quantified by chin and upper extremity EMG. Voir source | 42426312 | 10.1007/s44470-026-00127-2 | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine | |
| Sublingual apomorphine in the treatment of Parkinson's disease. Voir source | 38743091 | 10.1007/s00702-024-02777-z | Journal of neural transmission (Vienna, Austria : 1996) | |
| Small Triple-Negative and HER2-Positive Early Breast Cancer: Upfront Surgery or Neoadjuvant Chemotherapy? Voir source | 42588641 | 10.3390/cancers18152422 | Cancers | |
| LITESPARK-012: pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma. Voir source | 37882432 | 10.2217/fon-2023-0283 | Future oncology (London, England) | |
| Comparison of Sex-Specific Treatment Outcomes in Clinical Trials and Subsequent Real-World Data on Systemic Therapies for Urothelial Carcinoma: A Systematic Review. Voir source | 42551842 | 10.1055/a-2897-1443 | Aktuelle Urologie | |
| Outcomes and Prognostic Factors of Cetuximab-Based Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Voir source | 42589956 | 10.3390/jcm15155852 | Journal of clinical medicine | |
| Artificial Intelligence Techniques in Cardiac Neuromodulation: Mechanisms, Applications, and Pathways to Clinical Translation. Voir source | 42499589 | 10.1002/joa3.70434 | Journal of arrhythmia | |
| Disruption of Plexin-A1 signaling by FTX-101: mode of action and effect on oligodendrocyte biology. Voir source | 40435840 | 10.1016/j.biopha.2025.118186 | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | |
| tVNS and obesity-related inflammation: a prospective sham-controlled randomized crossover study protocol. Voir source | 42552546 | 10.1186/s40359-026-05219-5 | BMC psychology | |
| Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study. Voir source | 42218618 | 10.1177/13524585261448789 | Multiple sclerosis (Houndmills, Basingstoke, England) | |
| Clemastine fumarate promotes myelin repair in a nonhuman primate model of demyelination characterized by absent spontaneous remyelination. Voir source | 41719338 | 10.1073/pnas.2520161123 | Proceedings of the National Academy of Sciences of the United States of America | |
| Optimizing Infusion Center Efficiency in Multiple Sclerosis: A Nursing Multicenter Survey on Organizational Impact of Ublituximab. Voir source | 42512610 | 10.3390/healthcare14142094 | Healthcare (Basel, Switzerland) | |
| Balancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia. Voir source | 41404557 | 10.3389/fpubh.2025.1713092 | Frontiers in public health | |
| Translating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development Roadmap. Voir source | 42244451 | 10.1002/cpt.70352 | Clinical pharmacology and therapeutics | |
| Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD. Voir source | 42334795 | 10.1007/s40263-026-01311-x | CNS drugs | |
| Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights. Voir source | 42148068 | 10.3389/fimmu.2026.1727925 | Frontiers in immunology | |
| Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study. Voir source | 42371147 | 10.1007/s00415-026-13960-5 | Journal of neurology | |
| Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry. Voir source | 40956912 | 10.1177/08830738251367460 | Journal of child neurology | |
| Structure-Property Relationship Analysis of α-Keto Ester Prodrugs of Monomethyl Fumarate as NRF2 Activators. Voir source | 42412905 | 10.1021/acschemneuro.6c00139 | ACS chemical neuroscience | |
| Comparative Effectiveness of Diroximel Fumarate vs. Dimethyl Fumarate in Persons with Multiple Sclerosis: A US Claims Analysis of Relapse Outcomes. Voir source | 42060157 | 10.1007/s12325-026-03608-1 | Advances in therapy | |
| Safety analyses of the INAVO120 randomised phase III trial of inavolisib or placebo with palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant advanced breast cancer. Voir source | 42202490 | 10.1016/j.esmoop.2026.107735 | ESMO open | |
| Relative increase of memory B-cell subsets under s.c. B-cell-depleting therapies in multiple sclerosis. Voir source | 42375380 | 10.3389/fimmu.2026.1812392 | Frontiers in immunology | |
| Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion. Voir source | 42226439 | 10.1111/ene.70656 | European journal of neurology | |
| USPIO enhanced MR imaging in CNS tumors (UMIC): a study protocol. Voir source | 42267547 | 10.1080/17435889.2026.2681555 | Nanomedicine (London, England) | |
| Recent advances in the medical management of thyroid eye disease. Voir source | 42590938 | 10.1097/MED.0000000000000972 | Current opinion in endocrinology, diabetes, and obesity | |
| Time-Dependent Bias and Prognostic Confounding in Exposure-Response Analysis of Targeted Therapies: Lessons from Sunitinib in Metastatic Renal Cancer. Voir source | 42587360 | 10.1002/cpt.70447 | Clinical pharmacology and therapeutics | |
| Beyond Weight Loss: Gut Microenvironment Modulation to Enhance Cardiometabolic Outcomes and Long-Term Adherence During Incretin-Based Therapy. Voir source | 42590012 | 10.3390/jcm15155909 | Journal of clinical medicine | |
| Immune thrombocytopenia: Evolving mechanistic understanding and clinical development of new therapies. Voir source | 42453522 | 10.4103/tcmj.TCMJ-D-25-00206 | Tzu chi medical journal | |
| [Treatment of mast cell-mediated angioedema]. Voir source | 42489912 | 10.1007/s00105-026-05753-8 | Dermatologie (Heidelberg, Germany) | |
| Real-world adherence to and persistence with ofatumumab, infusion, oral, and other self-injectable disease-modifying therapies in patients with multiple sclerosis. Voir source | 42572537 | 10.1177/20552173261464369 | Multiple sclerosis journal - experimental, translational and clinical | |
| Electrospun PLA/PCL Membranes for Sustained Transdermal Rifampicin Delivery: Biocompatibility, Stability, and Antimycobacterial Activity. Voir source | 42589744 | 10.3390/polym18151814 | Polymers | |
| Efficacy of eltrombopag in combination with recombinant human thrombopoietin (rhTPO) for lymphoma patients with chemotherapy-induced thrombocytopenia. Voir source | 42577528 | 10.3389/fphar.2026.1879712 | Frontiers in pharmacology | |
| Drugs and Cell-Based Therapies for the Prevention and Treatment of Neonatal Brain Injury. Voir source | 42556987 | 10.1016/j.clp.2026.05.003 | Clinics in perinatology | |
| Simultaneous Analysis of a Combination of Anti-Hypertensive Drugs, Fimasartan, Amlodipine, and Hydrochlorothiazide, in Rats Using LC-MS/MS and Subsequent Application to Pharmacokinetic Drug Interaction with Red Ginseng Extract. Voir source | 36287856 | 10.3390/toxics10100576 | Toxics | |
| Assessment of periodontal regeneration with blood derivatives: a systematic review and network meta-analysis. Voir source | 42547721 | 10.1007/s10266-026-01516-y | Odontology | |
| Concurrent herpetic hypertensive anterior uveitis and cytomegalovirus retinitis in a non-HIV patient with melanoma differentiation-associated gene-5 dermatomyositis: intravenous immunoglobulin comes to the rescue. Voir source | 42017386 | 10.4081/reumatismo.2026.1826 | Reumatismo | |
| Artificial Intelligence and Advanced Digital Health for Hypertension: Evolving Tools for Precision Cardiovascular Care. Voir source | 41010987 | 10.3390/medicina61091597 | Medicina (Kaunas, Lithuania) | |
| CGRP-pathway exposure during the pre-EBP interval in spontaneous intracranial hypotension: an exploratory retrospective case series. Voir source | 42432562 | 10.1186/s12883-026-05172-1 | BMC neurology | |
| Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when? Voir source | 42493477 | 10.1080/14737175.2026.2706794 | Expert review of neurotherapeutics | |
| Non-Pharmacological Treatment of Primary Headaches-A Focused Review. Voir source | 37891800 | 10.3390/brainsci13101432 | Brain sciences | |
| 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. Voir source | 41321235 | 10.1111/head.70016 | Headache | |
| Peripheral Neuromodulation for the Management of Headache. Voir source | 34150578 | 10.5812/aapm.110515 | Anesthesiology and pain medicine | |
| Species-specific functions of CSRP3 in satellite cell-driven muscle regeneration and relevance to porcine stem cell therapy. Voir source | 42566102 | 10.1186/s13619-026-00294-w | Cell regeneration (London, England) | |
| Chronic Migraine Resistance: A Case Report Highlights an Overlooked Factors in Family Medicine Clinics. Voir source | 42450884 | 10.3390/healthcare14131874 | Healthcare (Basel, Switzerland) | |
| Review: An Update on CGRP Monoclonal Antibodies for the Preventive Treatment of Episodic Migraine. Voir source | 39998706 | 10.1007/s11916-025-01365-4 | Current pain and headache reports | |
| Effectiveness of acupuncture and related therapies for post-stroke insomnia: A systematic review and Bayesian network analysis. Voir source | 42566606 | 10.1097/MD.0000000000050081 | Medicine | |
| A multi-centre, tolerability study of a cannabidiol-enriched Cannabis Herbal Extract for chronic headaches in adolescents: The CAN-CHA protocol. Voir source | 39302982 | 10.1371/journal.pone.0290185 | PloS one | |
| Post-Craniotomy Headache: Current Concepts and Emerging Procedural Therapies. Voir source | 42554893 | 10.1007/s11916-026-01541-0 | Current pain and headache reports | |
| Emerging Neurovascular Interventions for the Prevention of Cerebral Vasospasm and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review. Voir source | 42540693 | 10.7759/cureus.111891 | Cureus | |
| Long-term neuropsychiatric outcomes after neuromodulation in epilepsy patients: a systematic review and meta-analysis. Voir source | 42530840 | 10.1007/s13760-026-03113-w | Acta neurologica Belgica | |
| Parvalbumin interneuron activation rescues both seizures and impaired social novelty in digenic absence epilepsy mice. Voir source | 42536722 | 10.1126/sciadv.aec6065 | Science advances | |
| Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes. Voir source | 38145469 | 10.1002/alz.13532 | Alzheimer's & dementia : the journal of the Alzheimer's Association | |
| Immunotherapeutic approaches for Alzheimer's disease: Exploring active and passive vaccine progress. Voir source | 38782231 | 10.1016/j.brainres.2024.149018 | Brain research | |
| Adjunctive EGb 761 treatment in patients with Parkinson's disease: a case series. Voir source | 42539673 | 10.3389/fnagi.2026.1767148 | Frontiers in aging neuroscience | |
| Adherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence. Voir source | 42566123 | 10.1007/s40256-026-00818-4 | American journal of cardiovascular drugs : drugs, devices, and other interventions | |
| Cognitive Impairment Associated with Chemotherapy: Neuroimmunological Interactions, Gut-Brain Axis, and Therapeutic Approaches. Voir source | 42512539 | 10.3390/brainsci16070765 | Brain sciences | |
| Efficacy of citicoline as an add-on therapy in Parkinson's disease: a randomized, double-blind trial. Voir source | 42561742 | 10.1016/j.parkreldis.2026.108911 | Parkinsonism & related disorders | |
| Decoding pre-movement neural activity from thalamic LFPs for adaptive neurostimulation in tremor patients. Voir source | 42404288 | 10.1016/j.neucom.2026.132899 | Neurocomputing | |
| A Translational Readiness Checklist for Stem-Cell-Based Trials in Movement Disorders: A Practical Roadmap. Voir source | 42482997 | 10.1177/11795735261463495 | Journal of central nervous system disease | |
| A Transgenic mouse tolerant to syngeneic cancer cells expressing truncated human epidermal growth factor receptor. Voir source | 42566443 | 10.1371/journal.pone.0355841 | PloS one | |
| Experience of using anti-CD 20 therapies in multiple sclerosis patients in Kenya. Voir source | 41669530 | 10.3389/fneur.2025.1681527 | Frontiers in neurology | |
| Differential safety profiles of disease-modifying therapies in MS: Age- and sex-based analysis from a real-world cohort. Voir source | 42107470 | 10.1016/j.msard.2026.107220 | Multiple sclerosis and related disorders | |
| Improved Outcomes with Early Aggressive Therapy in Pediatric Pulmonary Hypertension. Voir source | 42562588 | 10.1183/13993003.00327-2026 | The European respiratory journal | |
| Ersodetug for Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors. Voir source | 42557582 | 10.1210/clinem/dgag318 | The Journal of clinical endocrinology and metabolism | |
| Early treatment with ofatumumab increases the likelihood of stabilizing disease in patients with relapsing-remitting multiple sclerosis. Voir source | 42312094 | 10.5114/aoms/205112 | Archives of medical science : AMS | |
| Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naïve people with multiple sclerosis. Voir source | 42323726 | 10.1080/13696998.2026.2681352 | Journal of medical economics | |
| Discontinuation of disease-modifying therapies in patients with multiple sclerosis: A retrospective case-control study. Voir source | 42385519 | 10.1016/j.msard.2026.107343 | Multiple sclerosis and related disorders | |
| The elusive link: EBV in MS. Voir source | 42541696 | 10.1080/1744666X.2026.2713626 | Expert review of clinical immunology | |
| Urinary tract infections, urosepsis, and multiple sclerosis disease modifying therapies: a disproportionality analysis of the FDA Adverse Event Reporting System. Voir source | 42435648 | 10.1016/j.msard.2026.107351 | Multiple sclerosis and related disorders | |
| Chronic exposure to mining-contaminated borehole water impairs the entire male reproductive axis: partial mitigation by alpha-lipoic acid in Wistar rats. Voir source | 42541147 | 10.3389/ftox.2026.1899884 | Frontiers in toxicology | |
| Learnings from Patient Mortality after Delandistrogene Moxeparvovec Administration: A Report of Two Cases and Expert Committee Considerations for Future Mitigation and Management. Voir source | 41681118 | 10.1177/10430342261423168 | Human gene therapy | |
| Clinical efficacy and cost per improved outcome of treatments for generalized myasthenia gravis: evidence from a network meta-analysis and cost-per-responder analysis. Voir source | 42495790 | 10.1080/03007995.2026.2700048 | Current medical research and opinion | |
| Identifying molecular signatures underpinning treatment responses to novel therapeutics influencing COVID-19 outcomes. Voir source | 42566685 | 10.1093/jimmun/vkag189 | Journal of immunology (Baltimore, Md. : 1950) | |
| Efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization. Voir source | 42558431 | 10.3389/fimmu.2026.1861624 | Frontiers in immunology | |
| Lymphatic therapies open the valve in Marfan syndrome. Voir source | 42544580 | 10.1172/JCI209169 | The Journal of clinical investigation | |
| Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination. Voir source | 42518007 | 10.1007/s10787-026-02350-y | Inflammopharmacology | |
| MicroRNA Expression Profiles as Biomarkers of Response to Disease-Modifying Therapies in Multiple Sclerosis: A Systematic Review. Voir source | 42511484 | 10.3390/ijms27146138 | International journal of molecular sciences | |
| Comparative Endophthalmitis Rates of Anti-VEGF, Corticosteroid Implants and Anti-Complement Injections: An IRIS® Registry Analysis. Voir source | 42472569 | 10.1016/j.ajo.2026.07.030 | American journal of ophthalmology | |
| Mechanisms of open and hidden placebo in stroke recovery: targeting neuroplasticity insights of the placebo effect - study protocol for a controlled, parallel, randomised clinical trial. Voir source | 42486522 | 10.1136/bmjopen-2025-113119 | BMJ open | |
| Age outweighs route for AAV-PHP.eB transgene distribution via inner ear delivery. Voir source | 42487092 | 10.1007/s13346-026-02191-w | Drug delivery and translational research | |
| Efficacy and Safety of Canakinumab Compared With Standard Therapy for the Treatment of Non-Small Cell Lung Cancer (NSCLC): A Systematic Review. Voir source | 42486074 | 10.1002/cnr2.70627 | Cancer reports (Hoboken, N.J.) | |
| Drug repurposing as a promising therapeutic strategy against renal cell carcinoma. Voir source | 42479152 | 10.1007/s00280-026-04923-8 | Cancer chemotherapy and pharmacology | |
| Cross-task, explainable and real-time decoding of human emotion states by integrating gray and white matter intracranial neural activity. Voir source | 42487023 | 10.1038/s43588-026-01021-w | Nature computational science | |
| Efficacy and Safety of Mesenchymal Stem Cell Therapy for Alzheimer's Disease: A Systematic Review and Meta-Analysis. Voir source | 42483783 | 10.1177/15473287261468404 | Stem cells and development | |
| A Phase II Study to Evaluate the Efficacy of Commercially Available Molecularly Matched Targeted Therapies in the Second-Line Setting. Voir source | 42485262 | 10.1093/oncolo/oyag279 | The oncologist | |
| A bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β1 (SHR1701) enhanced preclinical antitumor activity in oral squamous cell carcinoma. Voir source | 42485683 | 10.1016/j.oraloncology.2026.108078 | Oral oncology | |
| Diagnostic performance of plasma p-Tau217, p-Tau181, and p-Tau231 across the Alzheimer's disease continuum: a network meta-analysis. Voir source | 42318558 | 10.3389/fnagi.2026.1834591 | Frontiers in aging neuroscience | |
| Comparative efficacy and safety of photobiomodulation, transcranial direct current stimulation, and repetitive transcranial magnetic stimulation in Alzheimer's disease: a network meta-analysis of randomized controlled trials. Voir source | 42487022 | 10.1007/s10103-026-04962-w | Lasers in medical science | |
| Targeting progressive multiple sclerosis: Toward mechanism-informed precision medicine. Voir source | 42482223 | 10.1111/joim.70125 | Journal of internal medicine | |
| Potential benefits of music-based therapies on rehabilitation outcomes in people with multiple sclerosis: a systematic review. Voir source | 42486519 | 10.1136/bmjopen-2026-116420 | BMJ open | |
| Investigating the role of serum NfL, FGF21, NCAM1 and GDF15 as disease biomarkers for Charcot-Marie-Tooth type 2A. Voir source | 42020662 | 10.1038/s41598-026-49537-5 | Scientific reports | |
| Co-development of a genetic care pathway for ALS: real-world perspectives from the North of England. Voir source | 42310788 | 10.1186/s13023-026-04417-z | Orphanet journal of rare diseases | |
| Unraveling the Potential of Stem Cell Therapy in Motor Neuron Disease: A Narrative Review. Voir source | 41088992 | 10.2174/0118715273382519250918103218 | CNS & neurological disorders drug targets | |
| Generalizable structure-function covariation predictive of antidepressant response revealed by target-oriented multimodal fusion. Voir source | 42460432 | 10.1038/s44220-025-00541-0 | Nature. Mental health | |
| From Visceral Pain to Emotional Distress: Comparative Effectiveness of Antispasmodics and Antidepressants in Irritable Bowel Syndrome - Systematic Review and Network Meta-analysis. Voir source | 42470701 | 10.15403/jgld-6815 | Journal of gastrointestinal and liver diseases : JGLD | |
| Six approved drugs for alcohol use disorder: algorithms for their use according to the aims of treatment. Voir source | 42476146 | 10.1093/alcalc/agag052 | Alcohol and alcoholism (Oxford, Oxfordshire) | |
| Successful Trifarotene Treatment of a Typical Kyrle's Disease With Overview of Topical Therapies. Voir source | 42480558 | 10.1111/srt.70359 | Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) | |
| From Molecular Pathophysiology to Clinical Trial Design in Sjögren's Disease: A Three-Axis Framework. Voir source | 42449965 | 10.3390/ijms27135692 | International journal of molecular sciences | |
| Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives. Voir source | 35295486 | 10.3389/fpain.2021.705276 | Frontiers in pain research (Lausanne, Switzerland) | |
| The role and interaction of hypothalamic-related neurotransmitters in migraine. Voir source | 40350428 | 10.1186/s10194-025-02044-w | The journal of headache and pain | |
| Beyond intraocular pressure: vascular and metabolic modifiers of optic nerve vulnerability in glaucoma. Voir source | 42484773 | 10.1007/s10792-026-04189-2 | International ophthalmology | |
| Timing of Mortality Benefit in Outcomes Trials in Transthyretin Amyloidosis. Voir source | 41225306 | 10.1016/j.jacc.2025.09.1512 | Journal of the American College of Cardiology | |
| Non-Pharmacological Treatments of Migraine: Current Evidence and Clinical Practice. Voir source | 42484949 | 10.1007/s11916-026-01531-2 | Current pain and headache reports | |
| French guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder. Voir source | 42481362 | 10.1016/j.neurol.2026.06.004 | Revue neurologique | |
| Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder. Voir source | 42460632 | 10.1177/02698811261464988 | Journal of psychopharmacology (Oxford, England) | |
| Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis. Voir source | 42458195 | 10.1007/s40120-026-00989-x | Neurology and therapy | |
| Knowledge graph visualization and bibliometric analysis of research on coronary artery lesions in Kawasaki disease. Voir source | 42470076 | 10.1097/MD.0000000000049678 | Medicine | |
| Two Cases of Malaria-Associated Acute Respiratory Distress Syndrome and Severe Pulmonary Complications From Plasmodium falciparum in Tanzania. Voir source | 42464474 | 10.12659/AJCR.951737 | The American journal of case reports | |
| In situ engineering of a self-healing drug-scaffold hydrogel to block platelet-driven postoperative metastasis. Voir source | 42468382 | 10.1016/j.biomaterials.2026.124459 | Biomaterials | |
| RAS signaling at the crossroads of radioresistance and tumor immunity. Voir source | 42468991 | 10.1136/jitc-2026-015274 | Journal for immunotherapy of cancer | |
| Facial solitary morphea profunda presenting with painful trigeminal neuropathy: A case report. Voir source | 30213201 | 10.1177/0333102418801580 | Cephalalgia : an international journal of headache | |
| Rational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells. Voir source | 42462519 | 10.1016/j.bioorg.2026.110245 | Bioorganic chemistry | |
| Plant-Based Therapies to Ameliorate Neuroinflammation in Parkinson's Disease, Alzheimer's Disease, and Epilepsy: A Narrative Review. Voir source | 40237742 | 10.1002/cbdv.202500038 | Chemistry & biodiversity | |
| Treatment strategies for motor fluctuations in Parkinson's disease: a systematic review of efficacy, functionality, and drug accessibility with a focus on Latin America. Voir source | 41415581 | 10.3389/fphar.2025.1725248 | Frontiers in pharmacology | |
| The Art of Sequencing Disease-Modifying Therapies in Multiple Sclerosis. Voir source | 42462178 | 10.1212/NXI.0000000000200621 | Neurology(R) neuroimmunology & neuroinflammation | |
| IGF2R: a new player in the IGF2 loop sustaining adrenocortical carcinogenesis. Voir source | 42458462 | 10.1186/s12964-026-03057-x | Cell communication and signaling : CCS | |
| Safety and Microvascular Effect of Four-Year Aminaphtone Administration in Systemic Sclerosis Patients. Voir source | 42445479 | 10.2147/OARRR.S613596 | Open access rheumatology : research and reviews | |
| High Volume Hemofiltration : what are the last indications in 2026 - a narrative review. Voir source | 42447139 | 10.1159/000553509 | Blood purification | |
| Impact of anti-TNF and anti-IL-12/IL-23 antibody therapy on periodontal inflammation and gingival crevicular fluid IL-6 in patients with inflammatory bowel diseases. Voir source | 42445195 | 10.3389/fimmu.2026.1832952 | Frontiers in immunology | |
| Topical resiniferatoxin for the treatment of vestibulodynia: a prospective observational trial. Voir source | 42434379 | 10.1016/j.xagr.2026.100660 | AJOG global reports | |
| Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances. Voir source | 40515614 | 10.1080/1061186X.2025.2520306 | Journal of drug targeting | |
| Efficacy at a cost: camrelizumab and famitinib within the expanding landscape of combination therapies. Voir source | 42428453 | 10.21037/gpm-2025-1-73 | Gynecology and pelvic medicine | |
| Pharmacological and non-pharmacological therapies for chronic pancreatitis pain: a narrative review. Voir source | 42440464 | 10.3389/fphys.2026.1857141 | Frontiers in physiology | |
| Virus-biomimetic melanin nanoparticles with spiky structures and neutral zwitterionic shell for non-invasive prevention of dry AMD. Voir source | 42419576 | 10.1016/j.jconrel.2026.115168 | Journal of controlled release : official journal of the Controlled Release Society | |
| BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial. Voir source | 41514039 | 10.1038/s41591-025-04170-z | Nature medicine | |
| Therapeutic progress in rosacea: targeting the neuro-vascular-immune triad. Voir source | 42440475 | 10.3389/fimmu.2026.1876564 | Frontiers in immunology | |
| Advanced on Minimally Invasive Techniques in Facial Rejuvenation: A Comprehensive Review. Voir source | 42441192 | 10.61882/wjps.15.1.3 | World journal of plastic surgery | |
| Plant-derived mitochondria mitigate aging-related neurodegeneration by reprogramming microglial mitochondrial energy metabolism. Voir source | 42421121 | 10.1186/s40035-026-00565-1 | Translational neurodegeneration | |
| [Modality strategy in Eisai drug discovery: challenges toward next-generation therapeutics using proximity-inducing compound]. Voir source | 42091470 | 10.1254/fpj.25095 | Nihon yakurigaku zasshi. Folia pharmacologica Japonica | |
| Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies. Voir source | 42440541 | 10.3389/fendo.2026.1851074 | Frontiers in endocrinology | |
| Dual resistance to asparaginase and PD-1 blockade in extranodal natural killer/T-cell lymphoma: dismal outcomes from a multicenter cohort. Voir source | 42421618 | 10.3324/haematol.2026.300670 | Haematologica | |
| Discovery of Tivumecirnon (FLX475), a Potent and Selective CCR4 Antagonist That Inhibits the Migration of Immunosuppressive Regulatory T Cells into the Tumor Microenvironment to Restore Antitumor Immunity. Voir source | 42444067 | 10.1021/acs.jmedchem.6c00683 | Journal of medicinal chemistry | |
| Pulvinar subdivisions and connectivity patterns across primate species: a comparative perspective. Voir source | 42130669 | 10.3389/fnana.2026.1794659 | Frontiers in neuroanatomy | |
| Real-world pharmacovigilance analysis of the association between multiple sclerosis disease-modifying therapies and intervertebral disc herniation. Voir source | 42440544 | 10.3389/fphar.2026.1877458 | Frontiers in pharmacology | |
| Pontine Autosomal Dominant Microangiopathy with Leukoencephalopathy in a Hispanic Man Without a Family History. Voir source | 42437605 | 10.1016/j.jstrokecerebrovasdis.2026.108700 | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | |
| Developments in Pharmacotherapy for Acromegaly: Current and Emerging Approaches. Voir source | 41964795 | 10.1007/s40265-026-02312-2 | Drugs | |
| Ensemble Machine Learning- and Deep Learning-Driven Identification and Validation of Sennidin B as a Novel Dipeptidyl Peptidase-4 Inhibitor. Voir source | 42353251 | 10.3390/ijms27125536 | International journal of molecular sciences | |
| Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids. Voir source | 42418817 | 10.1021/acs.jmedchem.6c00777 | Journal of medicinal chemistry | |
| S-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancers. Voir source | 42432251 | 10.1038/s41418-026-01808-4 | Cell death and differentiation | |
| Antimetabolites synergize with non-genotoxic antibody drug conjugate conditioning in hematopoietic stem cell lentiviral gene therapy. Voir source | 42436858 | 10.1016/j.omta.2026.201780 | Molecular therapy. Advances | |
| Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson's Disease. Voir source | 40198538 | 10.1007/s40263-025-01179-3 | CNS drugs | |
| West Nile Neuroinvasive Disease: Current Management, Emerging Therapies and Future Clinical Trial Priorities. Voir source | 42431607 | 10.1002/rmv.70182 | Reviews in medical virology | |
| Beyond motor symptoms: efficacy of pharmacotherapies on motor, functional, and cognitive domains in Huntington's disease - a systematic review. Voir source | 42162688 | 10.1016/j.ejphar.2026.178993 | European journal of pharmacology | |
| Autologous bone marrow mononuclear cell administration for neurological sequelae after traumatic brain injury: a matched control study. Voir source | 41063968 | 10.1093/braincomms/fcaf361 | Brain communications | |
| 2025 Update of Cellular Immunotherapy for Plasma Cell Disorders. Voir source | 41428622 | 10.4274/tjh.galenos.2025.2025.0330 | Turkish journal of haematology : official journal of Turkish Society of Haematology | |
| [Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits (PGNMID) Associated with Marginal Zone B-cell Lymphoma: A Case of MGRS in a Patient with Nephrotic Syndrome and Rapidly Progressive Renal Failure]. Voir source | 42423062 | 10.69097/43-03-2026-10 | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia | |
| [Atypical hemolytic uremic syndrome: key points in differential diagnosis and recent advances in treatment]. Voir source | 42419994 | 10.11406/rinketsu.67.600 | [Rinsho ketsueki] The Japanese journal of clinical hematology | |
| Complement System Inhibitors in Nephrology: A Comprehensive Review. Voir source | 42423060 | 10.69097/43-03-2026-08 | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia | |
| The efficacy and safety of hyoscyamine, dicyclomine, and desipramine in the treatment of irritable pouch syndrome-a retrospective cohort study. Voir source | 42381757 | 10.1093/crocol/otag063 | Crohn's & colitis 360 | |
| FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook. Voir source | 42324661 | 10.1080/15476286.2026.2689117 | RNA biology | |
| The Efficacy of Laser and Botox Therapies for Post-Thyroidectomy Scar Management: A Comprehensive Systematic Review and Meta-Analysis. Voir source | 42420659 | 10.1007/s00266-026-05981-2 | Aesthetic plastic surgery | |
| Engineered iMSCs delivering wild-type IL-2 achieve dose-sparing tumor control via CD25-dependent CD8 T-cell activation. Voir source | 42374407 | 10.1186/s12916-026-05035-z | BMC medicine | |
| Helping Underdeveloped Lungs with Cells (HULC-2): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - a study protocol of a phase 2 multicentre double blind randomised controlled trial in Canada. Voir source | 42409407 | 10.1136/bmjopen-2025-112385 | BMJ open | |
| Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial. Voir source | 40866583 | 10.1038/s41591-025-03899-x | Nature medicine | |
| Pathway-level proteomics identifies subcellular trafficking dysregulation as a molecular signature in severe traumatic brain injury. Voir source | 42373949 | 10.1007/s00011-026-02287-6 | Inflammation research : official journal of the European Histamine Research Society ... [et al.] | |
| Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions. Voir source | 41096667 | 10.3390/ijms26199398 | International journal of molecular sciences | |
| The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry. Voir source | 42283727 | 10.1007/s00415-026-13885-z | Journal of neurology | |
| Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reports. Voir source | 42415834 | 10.1093/ckj/sfag189 | Clinical kidney journal | |
| CD19-CAR-DNT cells (RJMty19) in patients with relapsed or refractory large B-cell lymphoma: a phase 1, first-in-human study. Voir source | 38444429 | 10.1016/j.eclinm.2024.102516 | EClinicalMedicine | |
| Enigmatic Case of Adult-Onset Langerhans Cell Histiocytosis with Aggressive Bony Involvement. Voir source | 42405367 | 10.56305/001c.162643 | Journal of Brown hospital medicine | |
| Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 Activity. Voir source | 38887198 | 10.1002/cmdc.202400292 | ChemMedChem | |
| Time to Meaningful Clinical Response Across Approved and Emerging Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Network Meta-Analysis. Voir source | 42355792 | 10.3390/jcm15124622 | Journal of clinical medicine | |
| Emerging Role of BTK Inhibitors in Multiple Sclerosis: From Immunobiology to Clinical Translation. Voir source | 42352643 | 10.3390/brainsci16060634 | Brain sciences | |
| [Pharmacological properties and clinical efficacy of sphingosine 1-phosphate (S1P) receptor modulator, Ozanimod (ZEPOSIA)]. Voir source | 41485936 | 10.1254/fpj.25053 | Nihon yakurigaku zasshi. Folia pharmacologica Japonica | |
| Initial specialist validation of clinical decision support recommendations from a machine learning-enabled digital cognitive assessment. Voir source | 42388698 | 10.3389/fneur.2026.1806000 | Frontiers in neurology | |
| Single low-dose daratumumab enhances rituximab efficacy for sustained remission in treatment-refractory autoimmune cytopenias. Voir source | 42417837 | 10.1007/s00277-026-07159-x | Annals of hematology | |
| H3K27M-mutant diffuse midline glioma pharmacotherapy: Clinical evidence and practice implications of dordaviprone. Voir source | 42317168 | 10.1177/10781552261461529 | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | |
| CancerHERVdb: Human Endogenous Retrovirus (HERV) Expression Database for Human Cancer Accelerates Studies of the Retrovirome and Predictions for HERV-Based Therapies. Voir source | 37255431 | 10.1128/jvi.00059-23 | Journal of virology | |
| Nose-to-brain delivery of riluzole-loaded nanoemulsion in a controlled cortical impact-induced traumatic brain injury: Insights fromIn vitro,Ex vivo, andIn vivostudies. Voir source | 42391660 | 10.1016/j.colsurfb.2026.115955 | Colloids and surfaces. B, Biointerfaces | |
| Recent advances in universal chimeric antigen receptor T cell therapy. Voir source | 40883768 | 10.1186/s13045-025-01737-8 | Journal of hematology & oncology | |
| Universal CAR-T Cell Therapy for Cancer Treatment: Advances and Challenges. Voir source | 41179303 | 10.32604/or.2025.067445 | Oncology research | |
| Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial. Voir source | 40818473 | 10.1016/S1474-4422(25)00225-X | The Lancet. Neurology | |
| A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple Sclerosis. Voir source | 42247185 | 10.1007/s40120-026-00959-3 | Neurology and therapy | |
| Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion. Voir source | 42384032 | 10.1177/13524585261459228 | Multiple sclerosis (Houndmills, Basingstoke, England) |
Sources officielles
liens de rechercheDernière mise à jour des données : 2026-06-04
Ces sources sont proposées pour vérification. Les informations de la fiche doivent être confirmées dans les registres officiels ou les publications originales.